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Multielectron redox reactions often require enzymes with active sites that contain one or more 
metal centers, called metalloenzymes. Metalloenzymes may contain single metal ions, such as iron 
or copper, bound to the protein directly or through an organic ligand that chelates the metal, such 
as porphyrins (heme). Transition metals are especially useful catalytic centers because they can 
access multiple oxidation states with redox potentials that are tuned by the organic ligand or protein 
environment to facilitate coupled electron and proton movement. Metalloenzymes that accomplish 
some of the most challenging natural chemical reactions, such as the reduction of oxygen to water 
or of sulfite to hydrogen sulfide in a continuous process, require more than one metal ion as a 
combination of different elements or as two or more unique cofactors that contain the same 
metallic element; such enzymes are said to possess heteronuclear metal centers. 
In order to understand metalloenzymes and to translate that information into catalysts for 
biotechnological applications, scientists and engineers have designed artificial metalloenzymes as 
both structural and functional mimics of native enzymes. However, it is challenging to design 
artificial enzymes with heteronuclear centers because they tend to be structurally and functionally 
complex. Decades of research has cemented the understanding that biomimicry of the primary 
coordination shell around active metal ions is rarely sufficient to reproduce the fine control and 
stability of natural enzyme metal centers; secondary effects induced by the protein environment 
are required. A complementary approach to synthetic biomimicry and top-down mutation of native 
enzymes is biosynthetic modeling. By beginning with stable, natural enzymes that are small, but 
which share some crucial features with more complex metalloenzymes of interest, there has been 
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significant success in building protein-derived interactions that are necessary and sufficient to 
engineer the activity and stability of natural enzyme catalysts. 
A prime example of heteronuclear metalloenzymes is sulfite reductase (SiR), which is an 
essential enzyme in sulfur assimilation and energy production pathways in bacteria and plants that 
reduces sulfite (SO3
2-) to hydrogen sulfide (HS-) at a single heteronuclear metal active center. SiR 
active sites comprise either a heme cofactor (siroheme) covalently linked to an iron-sulfur cluster 
([4Fe-4S]) through a shared Cys ligand or a heme-copper center with linearly coordinated Cu(I) 
situated ~4 Å above the heme Fe. Both cofactors are biologically unique, reserved only for the six-
electron process of sulfite reduction (and closely related nitrite reduction). Despite decades of 
research into the nature of the siroheme-[4Fe-4S] cofactor, it remains largely a mystery why such 
a complex cofactor is necessary for sulfite reduction and precisely how its structure and 
composition are related to efficient catalysis. In this dissertation, I describe the creation of a new 
structural and functional biosynthetic model of SiR by creating a designed heteronuclear heme-
[4Fe-4S] cofactor in cytochrome c peroxidase (CcP). The model (SiRCcP) exhibits spectroscopic 
and ligand-binding properties of the native enzyme, and sulfite reduction activity was improved—
through rational tuning of the secondary sphere interactions around the [4Fe-4S] and the substrate-
binding sites—to be close to that of a native enzyme. SiRCcP represents the most complex 
synthetic metalloenzyme to-date, and the design process provides new insight into the boundaries 
of biosynthetic engineering. 
I also describe the design and characterization of a heme-Cu SiR biosynthetic model in the 
same CcP scaffold (CuICcP) for direct comparison of the mechanisms and structures of these two 
evolutionarily distinct enzymes. The structure and metal-binding properties of CuICcP are 
described, as is a relationship to the catalytic properties of heme-copper oxidase, which shares key 
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active site structures with heme-Cu SiR. Additionally, I will describe the creation of the first 
binuclear Cu binding site with purple copper center properties in a natural protein that is not based 
on the cupredoxin fold. Together, these studies are explorations into the plasticity of enzyme active 
sites and their ability to meet design goals that diverge substantially from native structures and 
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Metal ions are essential for life on Earth, and a vast number of proteins are dedicated to 
protecting cells from specific metals, shuttling metals around, and leveraging the unique properties 
of specific elements for catalysis. A protein is considered a “metalloprotein” so long as at least a 
single metal ion is bound in a naturally selected site or coordinated by a bound organic framework 
(a metallocofactor) within the protein matrix. Proteins with a single bound metal ion are 
mononuclear, and bi-, tri-, tetra-… nuclear centers may be homonuclear (the same metallic 
elements) or heteronuclear (two or more different metallic elements or two or more different metal-
containing cofactors). By far, the most abundant metals bound by metalloproteins are Fe, Cu, Zn, 
Mg, Ca, or Mn while other transition metals including Ni, Co, W, V, and Mo are less common but 
often critical components of protein catalysts for biological cofactors. Any metal that can be 
substituted for the native metal constituent is considered a “biological” metal and includes the 
entire first row transition series1. 
The simplest functions of metalloenzymes are of use of metals as structural elements and for 
metal storage. For example, ferritin is a massive, nearly spherical protein complex made of 24 
subunits that can store up to 4500 Fe(III) atoms2. In the enzyme alcohol dehydrogenase, there are 
two different Zn(II) binding sites that each serves a different function: one is a Zn atom 
tetrahedrally coordinated by four Cys residues that stabilizes the tertiary structure of the molecule, 
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Figure 1.1. Metal bonding interactions with endogenous protein ligands. Reprinted with 




Ligands of the metal ions can be divided into broad categories based on whether they are 
directly coordinated to the metal (primary ligands) or whether they are near the metal ion and 
influence its properties but do not directly coordinate to it (secondary ligands). The geometry and 
spin states of the metal are determined by its primary ligands based on the positions of the ligands 
as enforced by the protein matrix and on metal-ligand orbital interactions. The most common and 
most strongly coordinating protein ligands (Fig. 1.1) are imidazolyl (His), carboxylate (Asp/Glu), 
phenolate (Tyr), and thiolate (Cys) with more weakly coordinating alkoxide (Ser/Thr), thioether 
(Met), and backbone amide and carbonyl groups also acting as common ligands. Amino 
coordination from Lys and N-termini occurs as well but much lesson commonly. Each of these 
endogenous protein ligands conforms to the basic theory of “hard” and “soft” ligands and their 
preference for hard/soft metals, respectively; for example, the “softest” first row transition metals 
Zn(II) and Cu(I) are strongly coordinated by Cys and Met residues. Furthermore, the structure of 
the protein matrix can modulate every primary interaction, altering bond length, bond angle, 
distorting binding geometry, and strengthening or weakening the metal-ligand bond. 
Much of the protein-induced modulation of a metal-binding site is accomplished by secondary 
coordination interactions. Secondary ligands are organized the secondary coordination sphere 
(SCS) around the bound metal ion, typically the first set of ligands within hydrogen bonding 
distance of primary ligands. Secondary ligands can alter or stabilize the charge character of a 
primary ligand, such as hydrogen bonding between the heme Fe proximal axial ligand (Tyr) and 
Arg in catalase. The positively charged SCS ligand stabilizes the phenolate character of the heme-
Tyr bond to generate stronger electron donation from Tyr to heme Fe5,6. Alternatively, SCS 
interactions can stabilize primary ligand that is vulnerable to oxidative damage, such as in the case 
of cytochrome P450 thiolate (Cys) heme proximal axial ligand. Oxidation of the proximal Cys to 
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cysteine sulfenic acid or protonation to a neutral thiol inactivates the P450 oxidase activity by 
disrupting the thiolate character of the axial ligand, but backbone amide hydrogen bonds to the 
Cys sulfur atom stabilize it against protonation/oxidation while simultaneously promoting greater 
thiolate character of the bond6,7. Interactions with the SCS have nearly limitless influence over the 
properties of a protein metal center. The hydrophilicity/hydrophobicity and solvent access of the 
metal binding pocket can modulate the redox potential of the metal center over large ranges, as 
can local dipole moments and hydrogen bonding that modulates the electron donating/withdrawing 
character of the primary ligands8,9. The redox potential of a metal center is one of the most 
important parameters for catalytic function, and the entire physiological range of metalloprotein 
redox potentials (-1 V to +1 V) can be surveyed with only two elements, Fe and Cu. The low 
potential species are typically iron-sulfur clusters, the highest potentials are achieved by Cu 
electron transfer proteins (cupredoxins or cupredoxin-like motifs), and while there is significant 
overlap between these two categories, proteins containing heme are often found at intermediate 
redox potentials. Each of these categories—iron-sulfur proteins, hemoproteins, and cupredoxins—
are discussed in-depth in Chapter 2 (iron-containing metalloproteins) and Chapter 7 (cupredoxins), 
respectively. 
 
1.2. Computational Approaches to Metalloprotein Design 
Naturally evolved metalloproteins can accomplish some of the most difficult chemical 
reactions under mild conditions and (for the most part) with low energy input by manipulating the 
redox potential and geometry of the metal binding site to facilitate catalysis. In biological systems, 
metalloenzymes are optimized to function within an evolutionary framework, cooperate with a 
large suite of partner proteins and cofactors, and exist in an environment replete with 
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repair/replacement mechanisms for the catalysts as they break down. Though some native 
metalloenzymes are accessible to human exploitation, they comprise a tiny fraction of all enzymes 
that efficiently perform useful reactions. It is extremely valuable—indeed, it has been the work of 
entire lifetimes—to design stable catalysts that function like natural enzymes or, alternatively, to 
bend or build enzymes that function effectively for human purposes. A huge variety of bio-inspired 
catalysts have been developed that perform difficult and valuable reactions like water oxidation10, 
nitrogen fixation11–15, and hydrogen evolution16–19, but with few exceptions small molecule 
catalysts are far less durable and far less efficient than enzymes. Designing custom-made, stable 
enzymes for a given reaction is a major goal of biological and chemical engineering, but bottom-
up enzyme design is an inconceivably complex task. 
For a protein composed of 100 amino acids, the sequence space using only the common 
canonical amino acids is 10020, an inconceivably large number that would be impossible to search 
experimentally. Only a small subset of possible sequences results in stable folds, and nature has 
only sampled a small subset of those; computationally aided design, therefore, hold the potential 
to access new folds and cofactor binding motifs that have not been naturally selected. A number 
of computational tools, such as ORBIT20,21 and Rosetta22–24, have been developed to streamline 
the process of protein design for a variety of purposes. Early design efforts relied on pre-
established protein backbone structures25 such as grafting Ca-binding loops into natural proteins 
to stabilize their structures26–28, but in recent years there has been much progress toward backbone 
structure and folding prediction29–36 that allow the design of de novo proteins37–42 or to predict the 
structure of a small, designed proteins ab initio43,44 (Fig. 1.2). The most important advances in 
computational protein design have been improvements in discriminating between stable packing 
and folding motifs to transition to stable folds from molten globules33,45 and to improve methods 
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for overcoming the largely “flat” energy landscapes of arbitrary protein sequences, such as the 
introduction of discrete sidechain rotamer libraries32. An understanding of the “folding funnel” 
energy landscape and protein subdomain folding have vastly streamlined the problem of ab initio 
dynamics and narrowed the search space for stable structures41. These improvements have led to 
an explosion of designs of “repeat” proteins: oligomers composed of identical subunits or a small 




Figure 1.2. Computationally designed de novo proteins. (Left) Examples of repeat protein 
structures of TIM barrels and coiled helical bundles; reprinted with permission from reference41. 
(Center) Helical bunds with designed, ordering hydrogen bonding interactions; reprinted with 
permission from reference42. (Right) A designed transmembrane Zn transporter; reprinted with 
permission from reference48. 
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New protein designs can be generated from fragments of known structures by locally or 
completely redesigning the sidechain sequence to impart new function. In an early success in 
enzyme design, thioredoxin was redesigned into a superoxide dismutase by creating a non-heme 
iron binding site50. New stable packing sequences have been developed in a similar manner, for 
instance by eliminating the structural Zn site from a Zn-finger fragment to create a small, stable, 
stand-alone peptide20. Homology modeling offers an alternative approach to designing new 
sequences and folds. Proteins that retain as little as 30% sequence identity tend to diverge little in 
terms of fold and overall structure51,52 while below this (soft) limit, there is, quite abruptly, very 
little relationship between sequence and structure. A number of homology modeling tools that rely 
on sequence threading through backbone coordinates have been developed including the Rosetta 
comparative modeling module53, the web-based, automated Rosetta platform, Robetta54, I-
TASSER55, SWISS-MODEL56, and Phyre57. Comparative modeling can identify similar motifs 
with unique sequences or to combine sequence strings to generate new or more stable structures, 
such as with the SCHEMA algorithm for selecting stable positions for sequence hybridization58,59. 
The Rosetta suite in particular, developed largely by the Baker lab, contains a large number of 
modules for various, distinct aspects of protein design. Aside from comparative modeling, Rosetta 
has been a valuable tool for protein-protein interface design60–62, molecular docking63–67, and 
protein-ligand interface design68–71. Recent successes include the construction of large de novo 
peptide and peptide macrocycle libraries with potential therapeutic properties72,73. The matcher 
and enzyme design utilities in particular will be discussed in-depth in Chapter 3: they provide a 
highly customizable process for defining and optimizing ligand binding sites within a known 
protein structure. The current wealth of computational tools for protein design are a new 
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complement to existing methods of studying metalloproteins by mutation of native enzymes and 
rational design. 
 
1.3. Biosynthetic modeling 
A subset of protein design uses natural proteins as scaffolds onto which to design functional 
catalytic centers of complex metalloproteins. Biosynthetic modeling in its simplest form leverages 
basic computation resources to analyze selected protein scaffolds for promising sites for rational 
design. Distinct from other forms of protein design such as directed evolution and the 
computational design approaches mentioned above, the goal of biosynthetic modeling is not 
necessarily to produce a novel or highly active enzyme; rather, once a biosynthetic model of a 
metalloenzyme has been established as an appropriate structural and functional model of a native 
enzyme, the model serves as a platform for rational probing into the function of structural elements 
present in the template native protein that yields predictable, quantitative information about the 
structure/function relationship of an active metal center. In this way, biosynthetic modeling is a 
complementary approach to studying natural enzymes that bridges the gap between top-down 
probes into the functional components of naturally evolved enzymes and the bottom-up approach 






Figure 1.3. X-ray crystal structures and computational rendering of biosynthetic models for 
manganese peroxidase, HCO, and NOR. Top three panels: (top left) crystal structure of Mn(II)-
MnCcP.1 depicting the designed Mn binding site. (top center/right) Comparison of the I40G 
mutant equilibrated by molecular dynamics simulation showing a reduction in the Mn-
Glu37/Glu45 distances. Bottom three panels: crystal structure of FeBMb co-crystallized with Fe 
(left), Mn (center), and Co (right). Reprinted with permission from references74,75. 
 
Biosynthetic models of heme copper oxidase (HCO) and nitric oxide reductase (NOR) in sperm 
whale myoglobin (called CuBMb
76 and FeBMb
77) have successfully elucidated the role of the non-
heme metal ion in the catalytic function of these two structurally homologous enzymes that are 
catalytically distinct (Fig. 1.3). Facile replacement of the non-heme metal in CuBMb and FeBMb 
models revealed the role of metal atomic radius and coordination geometry on O2 activation, 
quantifying why Cu was selected over Fe for oxygen reduction and why Fe was selected for NO 
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reduction74,78. Replacement of native Mb heme b in the same models with synthetic hemes bearing 
electron-withdrawing groups of varying degree revealed the relationship between heme reduction 
potential, oxygen activation, and cross-reactivity between HCO and NOR. Because the 
biosynthetic model scaffolds are specifically chosen for their simplicity and genetic tractability, it 
is fairly simple to incorporate unnatural amino acids (UAA) into their primary sequences to probe 
the effects of SCS interactions beyond what can be easily achieved with the 20 abundant natural 
amino acids. The catalytic importance of a conserved, post-translationally modified His-Tyr 
crosslink in HCO was investigated by incorporation of a His-Tyr cross-link analogue (imiTyr) into 
CuBMb
79, and the pKa of the active site Tyr was also directly probed with 3-methoxytyrosine and 
mono-/di-/tri-fluorotyrosine UAAs80. 
A biosynthetic model of lignin-digesting manganese peroxidase (MnCcP) was able to achieve 
native-like activity by modifying SCS interaction of the Mn binding site to tune catalytic 
parameters, a study that highlighted the importance of a balanced approach to SCS tradeoff in 
terms of structural stability, flexibility, and substrate affinity75,81,82. Recently, a biosynthetic model 
of sulfite reductase has been designed through application of more complex computational tools 
to yield an functional model to use as a tool to begin to unravel the complexities of the sulfite 
reductase active site83, and it is this work that is a major subject of this thesis. 
 
1.4. Thesis Goals and Outlook 
The goals of my thesis are threefold: First, with few exceptions, the utility of biosynthetic 
modeling of metalloenzymes has been restricted to relatively simple metal centers with relatively 
low catalytic activity. The most electronically complex reaction accomplished by a biosynthetic 
model is O2 reduction, a four-electron process, that has been accomplished in CuBMb. Even in this 
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model, the non-native metal binding site accommodates only a single metal atom. Similar models 
of non-native cupredoxin centers have been accomplished by transposing the binding loops of 
native cupredoxins, type-II centers, or CuA centers into the biosynthetic model scaffold. Though 
the biosynthetic approach has accomplished much already and holds great future promise as an 
investigative tool, the potential for complex metal centers remains largely untapped. The single 
greatest barrier limiting progress toward the goal of modeling complex metalloenzyme active 
centers is the complexity of designing such a site. The possible orientations and sequence space 
for many complex centers is simply too great to search by visual inspection and rational design, 
and directed evolution methods of optimization are incompatible with the philosophy of 
deliberately designed perturbation inherent to biosynthetic modeling. With the aid of 
computational tools that can efficiently design complex protein-ligand interfaces, I aim to show 
that it is possible to expand the current boundaries of biosynthetic modeling to design complex, 
coupled metal centers in biosynthetic scaffolds. This computationally aided design approach has 
been applied toward the design of a coupled heme-[4Fe-4S] center to create a biosynthetic model 
of the 6-electron reducing catalyst in sulfite reductase. 
The second and third aims are outgrowths of the first: next, the design of a complementary 
non-heme Cu binding site in the host scaffold to model both known forms of sulfite reductase in a 
single biosynthetic scaffold; finally, the full characterization of a fortuitous purple Cu center that 
arose during the design of the heme-Cu center. The goals of the second aim are analogous to the 
motivation to study both a heme/non-heme Fe center and a heme-Cu center in the single 
biosynthetic scaffold myoglobin. By using only one protein scaffold to study the active sites of 
several related enzymes, it becomes possible to study and perturb structural elements that lead to 
native function in a manner isolated from each other; any effects on the designed metal site 
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imposed by the biosynthetic scaffold are systematic rather than unique complexities to be 
accounted for in each native system. This connection is especially poignant for the heme-[4Fe-4S] 
center in connection to the HCO heme-Cu center that is bridged in structure and function by the 
heme-Cu sulfite reductase metal center. It may be possible—with the appropriate biosynthetic 
models—to uncover common structure/catalysis themes for multi-electron reduction reactions in 
structurally unrelated enzymes that could otherwise not be directly examined. Construction and 
demonstration of such models will be an important first step toward a deeper understanding of how 
structural elements that promote multi-electron catalysis are selected by nature, what structures are 
needed to support them, and why those elements are superior to others. 
The final goals—the complete construction and characterization of a purple Cu electron 
transfer center in a natural protein scaffold that shares essentially no homology to native 
cupredoxins—are an exploration into the plasticity of proteins. The first course of action in 
biosynthetic modeling is to find a protein with similar features to the target native protein—for 
instance, a hemoprotein as a base scaffold for a target heme-containing enzyme—which is 
generally a well-founded, effort-saving tactic. However, this approach can lead to an information 
trap: only looking for crucial information in similar places not because this is approach is 
objectively best but because it requires fewer steps to accomplish. More work creating active 
centers in non-homologous host proteins is necessary to understand how new binding sites are 
developed and what essential features are required to imbue a metal center with a certain function. 
While some active site structural features are often conserved among enzymes with homologous 
function but low sequence homology, this is not always the case, and more than one arrangement 
of protein backbone and sidechains certainly exists to support a given function. Creating new, non-
homologous binding sites for existing metal centers is certain to reveal new pathways for enzyme 
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and artificial catalyst design that are not limited by the relatively small set of biological folds and 
binding motifs. 
Taken together, the contents of my thesis work are evidence of the versatility of proteins to 
provide flexible frameworks for an unexpected variety of purposes. If this document is to help 
others in the future, it is my sincere hope that it helps them to view complex systems as imperfect 
things that are products of conflicting forces and that—if they are reading this—that they can at 
least find what they were looking for. 
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SULFITE REDUCTASE AND BIOLOGICAL HEME AND IRON-SULFUR COFACTORS 
 
The fundamental importance of sulfate metabolism to life on earth cannot be overstated. 
Sulfate remains the primary source of oxidizing potential in anaerobic and light-poor environments 
such as the deep ocean and bogs. In such biomes, sulfate rather than molecular oxygen provides 
an electron sink for cellular respiration. The first step in this process is reduction of sulfate by 
sulfate reductase in an ATP-dependent two-electron process that yields sulfite and water. The 
subsequent complete reduction of sulfite to hydrogen sulfide is accomplished in bacteria and plants 
by sulfite reductases (SiR) where the full six-electron reduction cycle can be performed in a single 
enzyme active site. All SiR are heteronuclear metalloenzymes whose active sites consist of one 
iron-chelating macrocycle and a closely positioned non-heme metal cofactor. The multimeric 
active forms of these enzymes contain a flavoprotein subunit that facilitates NAD+-dependent 
transfer of strongly reducing electrons to the catalytic hemoproteins. In the case of the most well-
studied SiR, the active site of the hemoprotein subunit contains a uniquely covalently coupled 
heteronuclear cofactor comprising a cubane iron-sulfur cluster and siroheme, a tetrapyrroline 
macrocycle that is specific in biology to SiR. Such directly coupled cofactors are exceptionally 
rare in biology (having only three structurally characterized examples in SiR and in the similarly 
structured [FeFe]-hydrogenase and [Ni,Ni]-carbon monoxide dehydrogenase/acetyl CoA 
synthase), making both their existence and specific purpose of great interest. SiR are grouped into 
two broad categories based on their metabolic function. Dissimilatory enzymes are essential to 
energy production while assimilatory enzymes function to sequester sulfur into a biologically 
useful form for the synthesis of amino acids and sulfur-containing cofactors. This chapter discusses 
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the current understanding of SiR structure and function as well as their component cofactors, 
sulfite metabolism, and the importance of studying such unique heteronuclear metalloenzymes. 
 
2.1. Assimilatory sulfate reduction 
The respiration of sulfate preceded aerobic respiration by life on earth by hundreds of millions 
of years. The final reduced product of this reaction is hydrogen sulfide, a corrosive and extremely 
toxic gas that is a waste product from sulfate reducing bacteria, but it is also the essential sulfur 
compound assimilated from inorganic sources to generate sulfur-containing amino acids and 
enzyme cofactors. The sulfur uptake process is facilitated by sulfate and sulfite reductases. Both 
enzymes utilize NAD(P)+ for reducing equivalents throughout the process. The complete 8-
electron reaction is given below1 
 
4H2 + SO42- + 1.5H+ → 0.5HS- + 0.5H2S + 4 H2O  ΔG°’ = -155 kJ/mole (E0’ = -516 mV) 
 
Each reduction cycle requires two reducing equivalents, resulting in the dehydration of the 
substrate. The first step, reduction of sulfate to sulfite, is performed by sulfate reductases2. Sulfate 
reduction is initiated by an adenylylation reaction catalyzed by ATP sulfurylase to generate 
adenosine 5'-phosphosulfate (APS). APS is reduced by two electrons in a glutathione-mediated 
reaction to yield sulfite (SO3
2-) and AMP. Sulfite is then further reduced by assimilatory sulfite 
reductases (aSiR) or dissimilatory sulfite reductases (dSiR). In all SiR, sulfite binds to the ferrous 
siroheme iron through the sulfur atom where three sequential dehydration reactions result in H2S 
as the final product (HS- under physiological conditions). The full pathway is depicted in Fig. 2.1, 
which depicts that the oxidation state of the sulfur atom in the bound sulfite ion (SIV) is reduced to 





Figure 2.1 Biological sulfite reduction 
 
Assimilatory SiR were the first to be structurally characterized, and the first crystal structure 
was solved to 1.6 Å by Crane, et al, in 1995, providing the 3D structure of the Escherichia coli 
aSiR siroheme-[4Fe-4S] hemoprotein subunit (SiRHP)3. It had previously been determined that 
the physiological composition of the NADPH-dependent sulfite reductase complex consists of 8 
flavoprotein subunits of approx. 66 kDa each, comprising 4 flavin adenine dinucleotide (FAD) and 
4 flavin mononucleotide (FMN) subunits, and 4 SiRHP subunits of 64 kDa each4. The FAD/FMN 
subunits work cooperatively to transfer electrons toward the active center, so the holoenzyme is 
considered an α8β4 structure
4–6. Electrons enter the complex from NADPH via FAD and are 








The essential sulfur-containing product of inorganic sulfur assimilation is L-cysteine (Cys). 
This reaction is catalyzed by the pyridoxal phosphate (PLP)-dependent enzyme O-acetylserine 
(thiol)-lyase that binds O-acetyl-L-serine, eliminates acetate, and releases Cys after nucleophilic 
attack by sulfide7,8. 
 
2.2. Dissimilatory sulfate reduction 
Dissimilatory SiR are soluble hemoproteins that share highly conserved active site domains 
with aSiR but are otherwise structurally distinct. The holo structure of dSiR is composed of two 
subunits arranged as α2β2. Each subunit contains a ferredoxin domain, the intramolecular source 
of electrons, but only one subunit (DsrA) contains an active siroheme-[4Fe-4S] active site while 
the nearly identical DsrB contains a structural siroheme-[4Fe-4S] site. Product analyses of in vitro 
assays conducted with dSiR have shown that the majority of electron flux does not produce HS- 
but instead goes toward production of sulfur oxyanions of intermediate oxidation states, principally 
thiosulfate and trithionate9–12. These species contain multiple sulfur atoms and therefore 
necessitate bimolecular reactions between sulfite and the partially reduced intermediate products 
in solution or by invasion of additional sulfite into the enzyme active site pocket. This process 
results in a cyclic side pathway (Fig. 2.1, inner cycle) whereby thiosulfate (SIV,02O3
2-) may form 
by reaction with a heme-bound S0 intermediate, or trithionate (SIV,IV,II3O6
2-, E0’ = -173 mV)
1 may 
form via reaction between 2 SIVO3
2- and an SII intermediate before proceeding through thiosulfate 
(or radical intermediates) to sulfide12.  This cyclic reaction would be energetically favorable to the 
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organism. The reduction of sulfite and the side pathway for thiosulfate are both yield net energy 
gains13,14: 
 
3H2 + SO32- + 2H+ → H2S + 3H2O  ΔG°’ = -171 kJ/mole (E0’ = -116 mV) 
4H2 + S2O32- + 2H+ → 2H2S +3H2O ΔG°’ = -173 kJ/mole (E0’ = -402 mV) 
 
Trithionate reduction (ΔG°’ = -2.1 kJ/mole) continuously releases sulfite to sustain the cycle, 
which may be further mediated by the release of HS- from the active site by sulfite binding. It 
should be noted, however, that while this reaction is favorable in solution under conditions that 
supply SII and S0 species, this effect has only been observed in vitro, and high intracellular 
thiosulfate levels in sulfate metabolizing bacteria have not been detected. Essentially, though the 
isolated hemoprotein subunits are decidedly “leaky” with respect to intermediate products by in 
vitro assays, the only product detected by whole-cell assays is sulfide15. Mixed products were again 
found, however, when the membrane fraction was separated. Obtaining crystal structures of the 
Desulfovibrio vulgaris Hildenborough dSiR (Dvir) revealed the binding site for a third subunit 
(DsrC), resulting in an α2β2γ2 arrangement, that positions a Cys residue near the active siroheme 
distal site and within 2.4 Å of the bound substrate16. The authors hypothesized that, distinctly from 
aSiR, only the first 4 electrons are transferred to the substrate in dSiR, yielding an S0 intermediate 
that is transferred to Cys-104DsrC in the form of a Cys persulfide that is further reduced to sulfide 
by the membrane quinol pool. Earlier, the crystal structure of the dSiR of Mycobacterium 
tuberculosis was found to have a catalytically important Tyr-Cys cross link in a position similar to 
Cys-104DsrC,
17 indicating that oxidation of Cys at this site may be important to the dSiR 
mechanism. Interestingly, the structure of Dvir contained a demetallated sirohydrochlorin 
molecule in the DsrB subunit, a result that is consistent with whole-cell spectroscopy18, but which 
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is absent in other dSiR. The presence of a structure siro(heme/hydrochlorin)-[4Fe-4S] site in Dvir 
is consistent with the structure of the Archaeoglobus fulgidus dSiR that contains a fully metallated 
site that lacks the positively charged substrate binding site, presumably rendering it inactive19. 
Additional features that distinguish the active sites of dSiR from aSiR include a larger number 
of direct interactions between basic residues and siroheme carboxylates, a conserved Tyr near the 
210 position that replaces Arg in aSiR and Thr near the 140 position that interacts with an 
unbridged carboxylate in aSiR, and the replacement of the aSiR conserved Gln121 by a conserved 
Arg in dSiR16,19. It is thought that these differences may in part be responsible for the differences 
in catalysis observed in dSiR vs aSiR, but it is not known how or to what extent. 
 
2.3. Iron-sulfur proteins 
Iron-sulfur proteins constitute a major fraction of all metalloproteins and may represent the 
oldest form of electron transport (ET) center. Iron-sulfur (FeS) proteins have since diverged into 
highly varied groups of redox-active, charged species ranging from 1Fe rubredoxins, the 
ferredoxin-type [2Fe-2S]1+/2+ and Rieske clusters, and the widely employed 3Fe and 4Fe cubane 
clusters (Fig. 2.2). As such, FeS clusters are often categorized by the number of iron and sulfur 
atoms they contain. The geometry among and between FeS centers is similar: the Fe adopts a 
distorted tetrahedral geometry, is coordinated by four ligands, and where more than one Fe atom 
is present, the Fe—Fe distances are shorter than the S—S distances by ~1.3 fold20,21. Sulfur is a 
weak ligand, so the Fe atoms in FeS clusters are always in the high-spin (HS) state, and sulfur can 
mix well with the iron 3d orbitals while its nuclear charge is negligible, causing strong Fe—S 
covalency. The strong Fe—S covalency imparts very low reorganization energy for redox 
transitions and charge delocalization through the inorganic sulfurs between Fe atoms22–25. By the 
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same token, sulfur is easily oxidized, and FeS clusters are in general vulnerable to hydroxylation, 
oxidation, and acid extraction21,24,26. 
 
 
Figure 2.2. Redox potentials of iron-sulfur clusters (reproduced with permission from20). 
 
With low reorganization energy, FeS clusters make excellent ET centers, and they are found 
performing this role in all domains of life. The simplest FeS centers with the narrowest redox 
potential range are the monoiron rubredoxins (-100 to +50 mV vs SHE)20 comprising a single Fe 
atom coordinated by four Cys sidechains ([Fe(Cys4)]. Rubredoxin-like monoiron metal binding 
sites have been the focus of numerous successful de novo peptide models. Minimal models of the 
rubredoxin fold have successfully reproduced the redox potential of native monoiron sites in a 
moderately stable site27,28. So-called “due ferri” helical peptides have also been constructed to 
mimic rubredoxins that contain two Fe binding sites; though carboxylates replaces sulfur in these 
models29,30. The reduction potential of the [Fe(Cys4)] center, as with other FeS centers, is thought 
to depend strongly on NH‧‧‧S hydrogen bonding interactions. Variations in redox potential of 100 
mV have been achieved by rational mutation of the secondary coordination sphere of the 
[Fe(Cys4)] center by perturbing the native NH‧‧‧S interactions, which modulate the degree of 
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electron donation from sulfur31–33, or by changes to the local electrostatics; though, in the case of 
electrostatics multiple processes are needed to adequately explain the observed changes to redox 
potentials34–36,20. 
Ferredoxins and ferredoxin domains are dedicated ET centers that bind [2Fe-2S] and [4Fe-4S] 
clusters. Ferredoxins are brown in color and possess somewhat featureless, weak UV-visible 
absorption broadly from 300-500 nm with a somewhat sharper peak centered near 380-400 nm. 
Proteins containing [2Fe-2S] clusters, also referred to as “plant type” ferredoxins (though, [2Fe-
2S] clusters are also found in bacteria despite the tetrairon clusters being more abundant), are 
single ET proteins. The [2Fe-2S]1+/2+ clusters have redox potentials ranging from -300 to -450 mV 
(vs SHE) with the average being close to -400 mV20,37 with the exception of the Rieske clusters. 
In Rieske clusters, two Cys ligands are replaced by His on a single iron atom, [2Fe-
2S(SCys)2(NHis)2]
1+/2+, and while their reduction potentials tend to be much more positive than other 
ferredoxins, all are involved in hydroquinone oxidation38. Studies of the low potential [2Fe-2S] 
centers have provided the most insight into the nature of FeS centers in terms of their electronic 
structure and magnetism. Iron-sulfur clusters were first identified by their puzzling electron 
paramagnetic resonance (EPR) spectra in the reduced state, the g = 1.94 peak arising from a S = 
½ state whose description required the incorporation of Heisenberg superexchange between sulfur-
bridged iron atoms and antiferromagnetic coupling of Fe spin states. The Fe atoms in FeS clusters 
are maintained in a HS state by the strong Fe—S covalency; therefore, Fe3+ is S = 5/2 and Fe2+ is 
S = 2. Pairs of Fe atoms in FeS clusters spin couple antiferromagnetically (Fig. 2.3) to yield their 
characteristic EPR spectra. Experimental results of electron-nuclear double resonance (ENDOR), 
Mössbauer, and x-ray absorption spectroscopy all indicate that the acquired electron in reduced 
[2Fe-2S]+ clusters tends to localize as an Fe3+/Fe2+ pair; though, the extent of delocalization 
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Figure 2.3. Simplified model of spin-dependent delocalization of a symmetric Fe2+ Fe3+ pair with 
the lowest and highest spin states shown on the right, reproduced with permission from reference39. 
Resonance delocalization between each Fe site is depicted by ovals spanning the spin systems. In 
the antiferromagnetic case, delocalization is disfavored, and the degree of localization varies 
among FeS clusters of differing structure.  
 
Cubane [4Fe-4S] clusters can typically access two redox pairs, [4Fe-4S]1+/2+ and [4Fe-4S]2+/3+; 
though, no single FeS center has been found to utilize both redox pairs in its physiological role. 
The (2+/3+) pair is found in the so-called high potential iron proteins (HiPIP) that exhibit large, 
positive redox potentials (+100-500 mV). The reversible “super reduction” of some HiPIP has 
been reported41, achieving [4Fe-4S]+1/+2/+3 redox couples in a single metal cluster. The so-called 
low potential [4Fe-4S]1+/2+ clusters (-250 to -650 mV)20,42 also have redox potentials that vary 
across a large range that is tuned by the protein scaffold. The midpoint potential of such clusters 
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is increased both by the number of backbone amide NH‧‧‧S hydrogen bonds, which reduce electron 
density on the inorganic sulfurs to stabilize the reduced state, and the hydrophobicity of the cluster 
environment42–45. The torsional angles of the coordinating Cys residues also play a role in the 
variability of redox potentials of clusters in protein environments with similar overall dipole 
moment. 
Unlike the [2Fe-2S] cluster, [4Fe-4S] are valence delocalized in their normal oxidized state, 
[4Fe-4S]2+, which results from strong antiferromagnetic coupling of Fe—Fe pairs. Further, there 
is antiferromagnetic coupling between the Fe pair, resulting in the EPR silence (S = 0) observed 
for the oxidized [4Fe-4S]2+ species and the S = ½ rhombic EPR signal observed for the one electron 
reduced [4Fe-4S]+ species (S = (5/2-2)delocalized – (2-2) = ½). Mössbauer studies of [4Fe-4S]
1+/2+ 
further confirmed that the four irons in the oxidized state are fully delocalized {2Fe2.5+-2Fe2.5+} 
high-spin species in the oxidized state, giving a characteristic isomer shift of δ ≈ 0.45 mm/s that is 
equivalent across all four Fe. Addition of one electron gives rise to one delocalized Fe2.5+ pair (δ1 
= 0.50 mm/s) and one pair of Fe2+ (δ1 = 0.50 mm/s)
39,46. The effects of superexchange on 
paramagnetic cluster species should obviate the impact of additional paramagnetic species, such 
as the (super)exchange coupled siroheme in SiR, to an iron-sulfur cluster. The general effects that 
have been predicted and subsequently observed from proteins with multiple paramagnetic centers 
are the appearance of S = 3/2 and S = 9/2 species from coupling to additional S = 5/2 and integer 
spin species and also separation of cluster g∥ and g⊥ stemming from ligand field effects from the 
coupled heme iron47. 
Ferredoxin-like FeS binding sites have been studied extensively by generation of artificial 
small molecule48 and peptide binding sites49. Most of the artificial FeS-binding peptides have been 
helical maquettes. One early example incorporated a CxxxCxxCxxC ferredoxin-like binding loop 
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into a two-helical maquette and incorporated two bis-His coordinated hemes as staples between 
the two helices; although, the heme and [4Fe-4S] cofactors were not designed to interact50. More 
recent examples have focused on improving computational methods for FeS cofactor binding, 
informed by experimental results, and have made both single-chain and two-fold symmetry dual 
chain helical maquettes capable of binding a heme and [4Fe-4S] or pair of [4Fe-4S] clusters, both 
in series, toward the goal of generating artificial redox chains51–54. Significant gaps still exist, 
however, in the realm of synthetic biology of FeS proteins. For instance, while ET has been 
demonstrated from a bis-[4Fe-4S] maquette to a biological redox center (cytochrome c), a 
completely artificial intramolecular redox chain with precisely tuned redox cofactors has yet to be 
engineered. Likewise, while helical maquettes and minimal peptides have been successful at 
creating binding sites for single metal ions and the kinetically stable [4Fe-4S], designing more 
complex binding sites remains difficult, and there have been few examples. 
Additional classes of iron-sulfur proteins include the high-potential iron proteins (HiPIP), 
proteins that bind cubane [4Fe-4S] clusters with positive redox potentials of 100-500 mV, and 
proteins that bind [3Fe-4S] clusters. The iron-sulfur clusters of HiPIPs contain fewer electrons 
than the [4Fe-4S] clusters of ferredoxins, and they functional normally in the [4Fe-4S]2+/3+ redox 
couple. HiPIPs have been conserved only in photosynthetic bacteria where they likely play a role 
as ET centers in the intermembrane space; though, their precise function is not completely 
understood20. Sequence conservation among HiPIPs is low despite a high degree of structural 
homology, indicating that certain structural elements are important for stabilizing and tuning the 
high redox potential states of these clusters. Principally, the [4Fe-4S] cluster is enfolded by loops 
that contain hydrophobic residues that pack against the edges of the cluster, including a conserved, 
buried Tyr residue that is oriented variably to the cluster, adopting conformations that favor both 
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edge‧‧‧S and aromatic‧‧‧S interactions in various HiPIPs, as well as Phe and Trp residues in similar 
orientations. The orientations of these residues, across HiPIPs, is not correlated with their 
reduction potentials55. The backbone of HiPIPs donates fewer NH‧‧‧S hydrogen bonds to the [4Fe-
4S] inorganic sulfurs than is donated by ferredoxins, and a lowering of measured reduction 
potential tracks well with an increase in NH‧‧‧S hydrogen bond donation20. The abundance of 
hydrophobic residues protects the cluster from solvent access and hydrolysis, which has been 
reported to result in Fe loss to form a [3Fe-4S] damaged cluster, and HiPIPs in general much more 
hydrophobic than the low-potential ferredoxin [4Fe-4S] clusters. X-ray absorption studies of the 
ligand K-edge spectra in HiPIPs have shown that there is greater Fe—SCys covalency (50%) than 
in ferredoxins, and that increased solvent access decreases covalency56,57. The consequence of 
increased ligand covalency is most probably to facilitated ET with the buried cluster, which is also 
a postulated function for the abundance of aromatic residues. 
Like the HiPIP clusters, [3Fe-4S] clusters are found only in bacteria and are frequently found 
alongside [4Fe-4S] clusters. While [3Fe-4S] clusters can be generated from oxidative damage of 
[4Fe-4S] clusters, such as by treatment with ferricyanide, they are induced to form in their native 
protein hosts by—in most cases—replacement of one Cys residue with Asp and are found in the 
[3Fe-4S]0/1+ states with reduction potentials similar to the low-potential [4Fe-4S] clusters (Fig. 
2.2). The redox potential of [3Fe-4S] is pH dependent, with some studies finding that the pH 
dependence is due to protonation of the conserved Asp residue while others found that it is the 
cluster itself that is protonated58,59. In the oxidized state, [3Fe-4S]1+ have small, isotropic 
Mössbauer isomer shifts (δFe = 0.27 mm/s) that become a pair of doublets in the reduced state (+0) 
consisting of a small shift (δFe = 0.32 mm/s) and a larger shift associated with a delocalized Fe
2.5+ 
pair similar to the low-potential [4Fe-4S] oxidized state (δFe = 0.46 mm/s)
39. EPR spectra of [3Fe-
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4S] are paramagnetic in the oxidized state and give signals that are nearly isotropic with closely 
spaced g-values near g = 2 and relaxation times (and temperature dependencies) that are 
intermediate between the fast-relaxing [2Fe-2S] and slow-relaxing low-potential [4Fe-4S]60. 
Replacement of the Asp with Cys can transform a [3Fe-4S] site into to [4Fe-4S] binding site, and 
the reverse has also been achieved by inserting additional residues inside the ferredoxin CxxC 
sequence61,62. All-in-all, the differences between [3/4Fe-4S] clusters are minor, and the two types 
of ferredoxin cluster can usually be easily distinguished by their spectroscopic properties, which 
are also distinct from the [2Fe-2S] clusters in terms of temperature dependence and isomer shifts. 
 
2.4. Complex iron-sulfur clusters 
There exist several forms of iron-sulfur cluster that are more structurally complex than the 
[4Fe-4S] clusters in ferredoxins and HiPIPs. These clusters contain a higher number of iron and 
sulfur atoms, contain additional elements, or are conjugated to auxiliary metal clusters. Among the 
most well-known of the complex iron-sulfur clusters is the catalytic M-cluster, or FeMo cofactor, 
from nitrogenase, a [{Mo/V/Fe}-7Fe-9S] cluster with a central carbon atom; the FeMo cofactor 
will not be discussed here. The FeMo subunit of nitrogenase also contains the P-cluster, a [8Fe-
7S] cluster that is structurally equivalent to two conjoined [4Fe-4S] clusters, joined at a shared Si 
vertex, with two bridging Cys ligands. The P-cluster undergoes a structural transition upon 
oxidation (POx + 2e- → PN) in which one bond between an Fe and the central S atom is replaced 
by a bond between the amide N of bridging Cys8863,64. The P-cluster is involved in ET to the FeMo 
cofactor, and the conformational changes involved in redox activity are thought to facilitate 




Figure 2.3. Structures of active heteronuclear metal centers that contain auxiliary [4Fe-4S] 
clusters. NiFeS cluster reprinted with permission from reference65; H-cluster reprinted with 
permission from reference66; siroheme-[4Fe-4S] cofactor generated in VMD from PDB: 2gep67. 
 
Enzymes with auxiliary iron-sulfur clusters are widely distributed in biology, being employed 
for essential reactions in the organisms that produce them, but the strategy of evolving a 
heteronuclear Fe center for catalysis has been a rare development. Only three extant examples of 
metal centers with auxiliary iron-sulfur clusters have been characterized: The H-cluster in [FeFe]-
hydrogenase (HydA), the NiFeS A-cluster in carbon monoxide dehydrogenase/acetyl CoA 
synthase (CODH/ACS), and the siroheme-[4Fe-4S] cofactor in sulfite and nitrite reductases 
(SiR/NiR). In all three of these systems, the auxiliary [4Fe-4S] is covalently linked to the so-called 
proximal Fe or Ni atom by a bridging Cys thiolate ligand. The structure and function of the 
CODH/ACS A-cluster have been thoroughly reviewed65. The function of the A-cluster in 
CODH/ACS is to form the C—C bond responsible for acetylating CoA from CO generated at the 
CODH domain of the protein complex combined with a methyl group donated from the corrinoid 
iron-sulfur protein (CFeSP). The proximal Ni atom (NiP) is thought to be the sole site of catalysis, 
with both the [4Fe-4S] and NiD presumed to function mostly as elements to tune the reactivity of 
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NiP and provide a strongly electropositive environment. However, the [4Fe-4S] has been observed 
in both the [4Fe-4S]2+[NiP]
+ and [4Fe-4S]+[NiP]+ oxidation states, and the catalytically competent 
NiFeC (NiP
+—CO) species consists of [4Fe-4S]2+[NiP]
+ with CO-bound; redox activity of the 
auxiliary cluster is therefore not yet understood for the A-cluster. 
The role complex iron-sulfur clusters of the [FeFe] hydrogenase active center, the H-cluster, 
is better understood. Hydrogenase with a diiron catalyst generally exhibit higher turnover rates 
than [NiFe] hydrogenases68; though, they are highly susceptible to inactivation by oxidation. The 
H-cluster (Fig. 2.3) is composed of a ferredoxin-like cubane [4Fe-4S] ligated by four Cys, one of 
which is a thiolate bridging ligand to a [2Fe-2S] organometallic diiron center. The [4Fe-4S] cluster 
is bridged to the proximal iron (FeP), which is the only direct linkage of the diiron sub-cluster to 
the protein scaffold, HydA69–72. The proximal (FeP) and distal (FeD) iron atoms are bridged by an 
azadithiolate (ADT) amine cofactor that is well-positioned to donate a proton to FeD, the presumed 
active Fe site and a bridging CO ligand73,74. The irons in the diiron cluster are further tuned by two 
diatomic CO and CN- ligands each, providing strong metal-to-ligand π back-bonding that stabilizes 
low oxidation {Fe(I)/Fe(II)}Ox and {Fe(I)/Fe(I)}Red states and ensuring that the diiron sub-cluster 
is low-spin72. It was found that the first H+ atom in the H2 formation pathway likely binds to a so-
called “super-reduced” state (HSRed) in which the auxiliary iron-sulfur cluster is [4Fe-4S]
+ and the 
diiron sub-cluster is Fe(I)/Fe(I)75. Density functional theory (DFT) calculations suggest that ET 
occurs with or following transfer of the second H+ from ADT75,76. The HSRed state was initially 
observed only in HydA1, a minimal [FeFe]-hydrogenase from Chlamydomonas reinhardtii that 
lacks accessory ET iron-sulfur clusters that quickly quench the HSRed state in other HydA. The 
implication of these studies is that the auxiliary [4Fe-4S] plays a necessary role in hydrogen 
reduction by activating the diiron site and then quickly donating a poised electron. It was already 
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known that a pre-formed auxiliary cluster is necessary for maturation of the diiron sub-cluster77,72. 
It has even been demonstrated that a synthetically assembled diiron sub-cluster can be activated 
by azide linkage to a biologically formed [4Fe-4S] in the HydF subunit78. 
The final case of complex, auxiliary iron-sulfur clusters is the SiR/NiR siroheme-[4Fe-4S] 
cofactor, which is discussed in great detail elsewhere in this thesis. In every case so far described 
of an active metal center with a covalently linked auxiliary [4Fe-4S], there are commonalities. 
First, the auxiliary cluster is always connected to the active metal center by a Cys thiolate ligand. 
Second, the [4Fe-4S] is ferredoxin-like, accessing the [4Fe-4S]1+/2+ redox couple and with low 
reduction potentials (-400 to -450 mV). These low-potential iron-sulfur clusters are all poised to 
rapidly deliver one electron to a bound substrate at various stages of the reduction mechanism – 
and the exact points in the different mechanisms are at least somewhat unclear. Nature has reserved 
these complex iron-sulfur clusters for a select few reactions, indicating that they are either ancient 
relics for which nothing significantly better ever came along, supremely well-tuned to their 
respective reactions, or provide an important push to complete at least one crucial step that cannot 
be easily provided by other means. 
 
2.5. Hemoproteins 
Heme, a metal-chelating tetrapyrrole, is an ubiquitous cofactor in biology. Heme in various 
forms serves structural, ET, and catalytic roles; often, heme plays several of these roles within the 
same protein complex. The complex electronic structure of this metallocofactor means that its 
electronic properties can be extensively tuned by the protein matrix, and heme exhibits reduction 
potentials ranging ±450 mV in ET centers, but high-valent Fe(IV)=O species in (per)oxidases 
easily crest +700 mV. The various forms of heme and the general effects associated with heme 
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structural elements will be discussed in the sections below, followed by a discussion of the direct 
effects from heme structure thought to influence the catalysis observed in SiR/NiR. 
 
2.5.1. Heme types and structures 
The word “heme” specifically refers to the ferrous form of protoporphyrin IX, or “heme b,” 
which is the most common “heme,” but the name applies generally to a tetrapyrroline macrocycle 
with a chelated metal, usually Fe. Any molecule composed of four cyclic pyrroline rings joined by 
a meso-carbon (porphine) or nitrogen (tetraazaporphyrin) with unsaturated bonds is considered a 
porphyrin, a 16-member ring with 18 π electrons79. The organic ring of porphyrins is a fully 
delocalized π system that can be oxidized to a stable cation radical. The type of porphyrin (e.g. 
protoporphyrin IX) is determined by substitutions at pyrrole exo-hydrogens. The bulk of biological 
porphyrin variation occurs at positions 2 and 4, vinyl groups in heme b (ethyl groups and 
unsubstituted exo-hydrogens at these positions are mesoporphyrin and deuteroporphyrin, 
respectively), but other substitutions are made at positions 5, 6, and 8 in hemes a, d, and d1, making 
highly asymmetric molecules that are generally difficult to synthesize and require long synthesis 
pathways in cells. 
The 5 and 6 positions of heme d are both hydroxyl substituted, breaking the π delocalization, 
which makes heme d a chlorin instead of a pophyrin (20 π electrons), or a porphyrin for which one 
or more of the exo pyrrole double bonds has been hydrogenated. Other forms of chlorin that are 
important for ET and catalysis include bacteriochlorins and isobacteriochlorins, both of which 
contain two saturated pyrrole rings that are either trans (bacteriochlorin) or cis (isobacteriochlorin) 
with respect to the central metal atom. A characteristic feature of chlorin is a red-shift and 





Figure 2.4. Structures of common heme molecules in biology. Carbon numbering for substituents 
is provided for heme b. Figure reproduced with permission from reference20. 
 
The heme-like chromophore that was observed in early isolations of sulfite reductases from 
plants and bacteria was identified as an isobacteriochlorin possessing eight negatively charged 
carboxylate functional groups4. The chromophore was called “siroheme” (or, literally, the “heme” 
found in SiR), and it displays many properties characteristic of chlorin macrocycles. Eight 
carboxylate moieties are arranged with alternating propionate and acetate groups at every pyrrole 
exo carbon and methyl groups at positions 1 and 3 of the saturated rings. Siroheme assumes a 
profoundly saddle-shaped conformation in aSiR3, and this distortion may contribute to its 
relatively low reduction potential (-340 mV)80 as macrocycle distortion has been shown to increase 
localization of electrons on the porphyrin and to affect the metal reduction potential81–84. Chlorins 
are better electron donors than porphyrins, and the extra “push” effect from the electron-rich 
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macrocycle could further improve electron donation to a substrate bound to the central metal. 
Conversely, for siroheme in particular, the presence of eight weakly electron-withdrawing 
carboxylate groups should tend to increase the midpoint potential due to delocalization of d orbitals 
of the central Fe onto the ring system, making more electron-deficient Fe85. The unique structure 
of siroheme has been the underpinning of the long-held belief that it is an essential cofactor for the 
complete reduction of sulfite to sulfide, and isolated siroheme does incompletely reduce sulfite in 
solution at a low rate47. The π-cation radical form of siroheme is achieved at an oxidation potential 
500 mV lower than porphyrins86, allowing it to easily oxidize during turnover if siroheme ever 
enters an Fe(III) state. Extended MO calculations have shown that both siroheme and the 
demetallated form, sirohydrochlorin, are much more easily oxidized than they are reduced, having 
oxidation potentials of 0.13 V compared to 0.52 V for porphine, and should readily form a π-cation 
radical in the presence of a strong axial ligand4,86–89. This determination has led to the suggestion 
that siroheme may be able to inject more than one electron during a single catalytic step, possibly 
through a Compound I-like intermediate90. Studies of porphyrinoid models for NiR have suggested 
an alternative reason for selection of isobacteriochlorin over porphyrin: when the π-cation radical 
is preferred over Fe(III), bound NO becomes significantly less labile from siroheme than from a 
porphyrin, potentially facilitating reduction to hydroxylamine if the heme requires a ferric state 
during turnover89. Whether formation of a π-cation radical in siroheme is a physiologically relevant 
step in sulfite/nitrite reduction remains a point of contention, and no organic radical intermediate 





Figure 2.5. Structures of Fe-protoporphyrin IX (heme b) and Fe-sirohydrochlorin (siroheme). 
Rings 1 and 2 of siroheme have saturated pyrrole exo bonds with carboxylic acid moieties 
substituted at every pyrrole exo carbon. 
 
2.5.2. Heme proximal ligands 
Heme is ligated to its host protein primarily by at least one axial ligand coordinated to the 
central Fe (and also by post-translational Cys ligation in the case of heme c). The proximal axial 
ligand coordinates to the face of heme for which the Fe domes out-of-plane, and the most common 
proximal ligand is His. In cytochromes, the most common distal axial ligand is also His; however, 
there is a great variety in distal ligands including Met, Asn, and Lys20. The identity of the proximal 
ligand plays a defining role in the nature of 5-coordinate hemoproteins, for which the heme distal 
site is a substrate binding site. The proximal ligand of peroxidases, oxidases, and globins is His 
while in heme catalase it is Tyr, and Cys in chloroperoxidases and oxygenases such as cytochromes 
P45091,92. A simple principle is at play with respect to the function of the proximal ligand in 
catalytic hemoproteins: the so-called “push-pull” interaction between the proximal heme ligand, 
the central Fe atom, and the distal substrate coordinating ligands. Essentially, an electron-rich 
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proximal ligand weakens the substrate O-O bond (of H2O2, for instance) by increasing the strength 
of the Fe-O bond. A proximal ligand with negatively-charged character provides the most effective 
“push” (such as the thiolate character of the P450 proximal Cys), and the ability of the proximal 
ligand to carry a negative charge is supported by hydrogen bonding interactions within the 
proximal environment, such as hydrogen bonding to positively charged Arg in catalase that 
stabilizes phenolate character of the proximal Tyr, and even the dipole moment of the helix that 
bears the proximal ligand may play a role91. Additionally, a distal ligand—frequently proton-
donating or generally basic such as His, Glu/Asp, or Lys—“pulls” electron density up through the 
substrate either by hydrogen bonding or rapidly protonating the distal oxygen atom to facilitate 
heterolytic cleavage. This effect is well-documented for cytochromes P450 and heme catalases 
and depends strongly on the nature of the proximal ligand. However, mutational studies with yeast 
cytochrome c peroxidase (CcP) that have replaced the proximal His with Gln, Cys, and Glu have 
found that the distal His ligand (His52 in CcP) plays the defining role in the rate of O-O bond 
cleavage and formation of the high valent Fe4+=O species, Compound I93. The identity and charge 
state of the proximal ligand is also instrumental for electron transfer (ET) to heme: negatively 
charged proximal ligands can tip the balance in ET-limited reactions and is important for thiolate-
ligated heme enzymes. It is possible that, in addition to the electronic “push,” the position of 
proximal ligands provides a necessary steric push to the central heme Fe that keeps it more in-
plane with the heme, creating something of an entatic state that lowers the reorganization energy 






2.6. Siroheme-[4Fe-4S] sulfite reductase 
The complex step of sulfite reduction to sulfide in biology is accomplished completely by 
sulfite reductase, a single enzyme that catalyzes a 6-electron and 7-proton reduction of a small 
anionic substrate. The holoenzyme structure and function of both aSiR and dSiR were discussed 
in sections 2.1 and 2.2, and this section will discuss in detail the characteristics of the active site 
that contains the active heteronuclear metal center. The aSiR/dSiR cofactor is composed of 
siroheme covalently ligated to a cubane [4Fe-4S] by a bridging thiolate (Cys) ligand. The nature 
of this this coupled cofactor was elucidated from combined results of Mössbauer and EPR 
spectroscopies (vide infra) more than a decade before a high-resolution crystal structure of the E. 
coli aSiR hemoprotein (SiRHP) was available. Due to the covalent coupling of the two cofactors, 
the Fe atoms are exchange coupled. Beyond simple J-coupling, the prevailing theory is that 
significant magnetic exchange coupling between the siroheme central Fe and individual Fe atoms 
of the [4Fe-4S]. In the resting state, the total oxidation state of the cofactor is [+5] with Fe3+-
siroheme and [4Fe-4S]2+, but during turnover the total oxidation state is most likely [+3] with both 
cofactors reduced by one electron. The x-band EPR spectrum of SiRHP shows only a single S = 
5/2 species consistent with high-spin ferriheme, but gradual reduction by one and eventually two 
electrons shows the appearance of novel EPR signals at g = 2.29 and g ≈ 5. These anomalous EPR 
signals were found to be the product of weak magnetic exchange between the two cofactors such 
that all Fe atoms of the cofactor tend to behave like a single coupled 5-Fe system. The 
paramagnetic coupling can apparently be silenced only when the siroheme Fe is made rigorously 
low-spin hexacoordinate by a strong back-bonding ligand such as cyanide, and the cofactors 
remain coupled in all physiologically relevant oxidation and spin states with the native cofactors 
(see Chapter 4.1 for full detail). 
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Sulfite and nitrite reductases have been isolated from plants and bacteria, and the activity of 
these enzymes has been found to vary from ~20 to greater than 2500 single-electron turnovers per 
second. Strictly speaking, all siroheme-[4Fe-4S] SiR are also NiR (the reverse is also true). Vmax 
for nitrite reduction is always greater than for sulfite, but sulfite is the preferred substrate of SiR 
by, usually, 1-2 orders of magnitude. The sequence homology of these enzymes—in particular, 
between sulfite and nitrite reductases and between aSiR and dSiR—is low (<30%) while the 
structure of the active site is highly conserved. In SiRHP the siroheme distal pocket (relative to 
the [4Fe-4S] cluster) is highly positively charged and contains 8 Arg, 3 Lys, and 3 Asn/Gln 
residues within hydrogen bonding distance of siroheme. The positive charge of the SiR active site 
would be an attractive binding pocket for its small, anionic substrates, but the active site lacks a 
rigid internal network of hydrogen bonds to precisely position its flexible Lys and Arg residues, 
allowing them conformational flexibility during the course of catalysis. At least one charged 
residue, Arg83, is important for siroheme binding, and three highly conserved charged residues, 
Arg153, Lys215, and Lys217, are critically important catalytic residues that directly interact with 
bound substrate, position waters for proton donation, or both3,67. The numerous basic residues in 
the SiR distal site and the Cys proximal ligand with thiolate character stabilized by the positively 
charged [4Fe-4S] are prime examples of an active site that supports the push/pull mechanism to 
weaken S/N-O bonds. Electrons are presumed to enter the active site through the [4Fe-4S] cluster 
from which they are rapidly transferred to siroheme through the thiolate bond; the catalytic 
mechanism of SiR is discussed in detail in Chapter 5. 
Considering that the bare-bones components of sulfite reduction are three repetitive 
dehydration reactions, the complexity of the SiR active center is puzzling. Many questions remain 
unanswered regarding the precise role played by the coupled [4Fe-4S] in tuning the activity of 
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siroheme and, for that matter, why siroheme is the conserved catalytic heme with its structurally 
expensive set of carboxylates and intricately tuned electrostatic interactions. The following section 
will raise only further questions as to why nature has so rigorously preserved the siroheme-[4Fe-
4S] active site for the vast majority of sulfite reduction and, perhaps, begin to shed light on the 
essential components for efficient sulfite reduction. 
 
2.7. Heme-Cu sulfite reductase: Mcc SiRA 
To this point I have been careful to specify that the properties of SiR discussed so far applied 
specifically to siroheme-[4Fe-4S] SiR. This specificity is because there is one other known form 
of sulfite reductase that is not a classical siroheme-[4Fe-4S] SiR. Found commonly in sulfate and 
nitrate reducing bacteria is a structural gene, nrfA, that encodes a penta-heme nitrite reductase94,95. 
The gene product, NrfA, belongs to the class of multi-heme cytochrome c (Mcc) reductases that 
contain, generally, four to eight hemes c that are covalently ligated to the protein backbone96. The 
hemes are arranged in parallel, optimized for intraprotein ET, and all contain mostly bis-His axial 
ligands (but occasionally only one His; these hemes serve as catalytic centers). Sequence 
homology among Mcc proteins is low, but the heme arrangement is highly conserved, and many 
Mcc proteins are linked to the membrane quinol pool by ET chains and the peripheral membrane 
protein NrfH97,98. The active site of NrfA contains a His-ligated heme c and distal residues His, 
Arg, and conserved Tyr residues that may play a role in radical stabilization during catalysis97–99. 
The pentaheme NrfA has been reported to reduce sulfite with turnover rates similar to the rates of 
some dSiR despite lacking siroheme and any [4Fe-4S]99. Indeed, the only commonality between 
the two active sites is a heme of some sort. 
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Some classes of sulfate-reducing proteobacteria have been found not to express any form of 
siroheme-containing enzyme. Instead, the growth in the presence of sulfite induced the expression 
of heme c synthase and an octaheme Mcc enzyme (MccA) that reduces sulfite. These MccA are 
similar to other octaheme reductases involved in nitrogen and sulfur metabolism including 
tetrathionate reductase, hydroxylamine/hydrazine oxidoreductase, and the closely related 
pentaheme and octaheme cytochrome c nitrite reductases100–102. MccA isolated from Shewanella 
oneidensis MR-1 and Wolinella succinogenes have been found to reduce sulfite at rates that greatly 
exceed previously reported rates for siroheme-[4Fe-4S] SiR and have thus been termed Mcc 
SiRA102–105. A recently reported high-resolution x-ray crystal structure of the W. succinogenes 
SiRA revealed that the active site comprises a unique heme/non-heme Cu center, only the second 
such heme-Cu center so far observed in biology104. The non-heme Cu in SiRA is ligated in a linear 
fashion by two Cys residues at a heme Fe-Cu distance close to the Fe-Cu distance in heme copper 
oxidase (~4.5 Å) although the two classes of enzymes are structurally unrelated. The active site 
architecture and putative catalytic mechanism of SiRA are discussed in detail in Chapter 5. The 
function of SiRA almost certain arose from penta-/octaheme nitrite reductases, but there are 
surprising similarities between the active site architecture of SiRA and classical siroheme-[4Fe-
4S] aSiR/dSiR. While the conserved Tyr of Mcc nitrite reductase is preserved in SiRA, there are 
additional Lys and Arg residues in positions reminiscent of siroheme-[4Fe-4S] SiR/NiR, hinting 
toward a possible evolutionary convergence toward an optimal structure/function relationship. The 
presence of a non-heme Cu center is intriguing as well considering that this motif is only known 
to be essential for oxygen reduction, another multi-electron reduction reaction, but not for the 
electronically equivalent reduction of nitrite to ammonia (in Cu nitrite reductases, heme is not 
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present in the active site106–108). The possible cross-reactivity of the HCO and SiRA heme/non-
heme Cu centers is an interesting prospect that has never been explored. 
 
2.8. Importance of Modeling Siroheme-[4Fe-4S] and Heme-Cu SiR in a Common Protein Scaffold 
The low sequence and structural homology between siroheme-[4Fe-4S] and heme-Cu SiRs 
means that a large number of assumptions must be taken about the role of the protein scaffold in 
determining the activity and even the mechanism of each of these enzymes. For example, though 
both active sites contain at least three Lys/Arg residues in similar positions that are implicated in 
substrate coordination and/or proton donation, the relative arrangement of Lys and Arg residues is 
swapped in Mcc SiRA vs SiRHP; where Arg153 is a key residue oriented distal to the substrate 
that is thought to play a crucial role in maintaining substrate coordination as reduction proceeds in 
SiRHP, the analogous distal residue in Mcc SiRA is Lys393. Similarly, the active residue Lys215 
in SiRHP is replaced with an analogous Arg366 in Mcc SiRA. The presence of Tyr residues and 
the total 3D spatial arrangement of the substrate binding pocket in Mcc SiRA means that a simple 
Lys → Arg swap (and vice versa) in SiRHP to probe the effects of these substitutions cannot be 
the product of a single variable; many factors are surely involved. 
Considerable success at probing different active sites in a single biosynthetic model has been 
achieved for the two biosynthetic models CuBMb and FeBMb
109–113. In the case of these models, 
there was already significant structural homology between the native HCO and nitric oxide 
reductase (N2OR) enzymes, and the models differed by only a single glutamate substitution. A 
major takeaway from these studies, though, was that the subtle scaffold effects imparted by each 
of the native enzymes could be both (i) initially ignored and (ii) actively engineered to probe their 
effects on catalysis. The strategy can and should be applied to the two interesting variants of SiR 
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that share many but not all of their (presumably) key catalytic features. Only in a common scaffold 
can certain questions be unambiguously answered: does the presence of Tyr primarily affect ET 
or proton donation? Does the presence of a distal Lys instead of distal Arg favor rapid dehydration 
in the presence of a nearby Lewis acid? What effects do heme structure and redox potential have 
on catalysis? This last question of heme redox properties is particularly sensitive to protein scaffold 
effects, meaning that in a common scaffold many strong inferences can be drawn from 
electrochemical and enzyme activity experiments without need of a crystal structure for a direct 
structural comparison. The following chapters will describe the creation of a biosynthetic scaffold 
of both siroheme-[4Fe-4S] and Mcc type SiRs in a single hemoprotein scaffold, CcP, probing of 
the former scaffold design for catalytic activity and the factors that improve it, and some 
unexpected discoveries uncovered along the way. 
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DESIGN OF A [4FE-4S] CENTER IN CYTOCHROME C PEROXIDASE 
 
The characteristic features of a sulfite reductase active center are a combined (siro)heme-[4Fe-
4S] heteronuclear metal center situated in a largely solvent exposed, positively charged cofactor-
binding pocket with an abundance of Lys and Arg residues for charge stabilization and 
participation in catalysis. The iron-sulfur center in native siroheme SiR is structurally ferredoxin-
like with four Cys residues, one for each Fe atom, with one Cys serving as both a ligand to a [4Fe-
4S] Fe and as the proximal ligand to the siroheme Fe. This combination of Fe—Fe cofactors is, at 
the time of this writing, unique in biology, representing the only known heme-[4Fe-4S] center in 
which the two iron cofactors are covalently coupled. Each of the cofactors and their combination 
brings unique properties to the system: as discussed in Chapter 2, the saddled structure of siroheme 
plays a role in lowering its reduction potential and the orbital structure of the Fe and macrocycle; 
the [4Fe-4S] provides an excellent source of low-potential electrons; the coupling of these two 
cofactors, however, creates a distinct 5-Fe system with unique properties. Principally, while many 
enzymes and enzyme complexes in nature make use of heme and [4Fe-4S] in the same electron 
transfer chain and for catalysis, what is the benefit of covalently coupling the two cofactors toward 
sulfite reduction? We sought to mimic this unique catalytic center in a different hemeprotein to 
better understand how both its structural and electronic properties are required for its catalytic 
function. To accomplish this goal, we searched for hemoproteins whose folds allowed the 
incorporation of a [4Fe-4S]-binding motif adjacent to the heme by simple mutation and to 
eliminate the substantially more difficult task of engineering a heme-binding pocket ab initio. We 
selected cytochrome c peroxidase (CcP) as the scaffold protein and engineered a [4Fe-4S] binding 
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site proximal to the heme binding site by methods described in this Chapter. From this base 
scaffold, called SiRCcP, we have been able to explore the essential structural elements of the 
heme-[4Fe-4S] cofactor and its electronic and catalytic properties from a bottom-up perspective. 
 
3.1. Yeast cytochrome c peroxidase 
Cytochrome c peroxidase (CcP) is a yeast mitochondrial protein with a single heme-b cofactor. 
CcP is soluble, stable over a wide pH range (4-9), relatively small (33.7 kDa), and generally 
tolerant of multiple mutations1–8. Like other peroxidases, CcP follows a catalytic cycle, described 
by Equations 1-3, in which hydrogen peroxide binds to ferric heme iron to generate two oxidizing 
equivalents in the form of an Fe(IV)-oxo porphyrin π-cation radical called Compound I 
(Compound I’ in CcP due to the delocalization of the radical between the heme porphyrin and a 
nearby Trp residue) that becomes a ferryl oxo species (Compound II) upon one-electron reduction. 
Compound II serves as the second oxidizing equivalent that can be further reduced back to the 
ferric resting state. CcP is not natively reduced to the ferroheme oxidation state. CcP is known to 
oxidize ferrocytochrome c (Cc) in yeast mitochondria9; although, CcP is capable of oxidizing 
many small and macromolecular compounds.  
 
Fe(III)Heme + H2O2  {Fe(IV)Heme=O}Trp•+ + H2O  (1) 
{Fe(IV)Heme=O}Trp•+ + Fe(II)Cc  Fe(IV)Heme=O + Fe(III)Cc  (2) 
Fe(IV)Heme=O + Fe(II)Cc + 2H
+  Fe(III)Heme + Fe(III)Cc + H2O  (3) 
 
CcP contains 33 residues that can be self-oxidized during H2O2 turnover by hole-hopping through 
multiple pathways. Due to observations that certain residues, such as the heme proximal ligand 
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His175, are preferentially oxidized in the absence of physiological reductants, leading to the 
release of heme from CcP. It has been proposed that CcP and Cc serve as intermembrane H2O2 
scavengers, but that under highly oxidizing conditions the demetallation of CcP signals the 
maturation of catalase. Indeed, heme released by oxidized CcP is directly repurposed for catalase 
maturation while apoCcP is exported from the mitochondria10. 
The x-ray crystal structure of CcP was the first peroxidase structure to be solved11; thus, CcP 
has served as a model peroxidase in the ensuing decades. 
 
 
Figure 3.1. High resolution structure of yeast cytochrome c peroxidase (PDB: 2cyp)11  
 
The proximal residues of the heme pocket in peroxidases are conserved and are important to 
peroxide catalysis. In CcP, the hydrogen bond between Asp235 and His175 imparts a high degree 
of imidazolate character to the proximal His12 and, working together with the positioning of the 
proximal ligand by the protein backbone, promotes a “push” effect for O—O bond cleavage and 
to produce an entatic state that encourages the heme iron to remain more in-plane with the 
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porphyrin to stabilize rapid Fe(IV) formation13. This “push-pull” effect has been well documented 
in peroxidase and oxygenases14,15 with some notable differences in the mechanism. For 
cytochromes P450, the thiol ligation to the heme Fe from the proximal Cys residue situated in a 
hydrophobic environment delivers a sufficient “push” to generate Compound I without a distal 
basic residue to “pull.” In CcP, however, the distal Arg48 and His52 residues (Fig. 3.1) are 
relatively basic and provide the “pull” to facilitate rapid O—O bond cleavage. 
CcP has been repurposed into different functional roles through site directed mutagenesis. An 
early attempt to construct a functional P450-like enzyme in a non-P450 hemoprotein was 
conducted in CcP by creating a heme-thiolate ligation by mutating His175 to Cys and replacing its 
H-bonding partner Asp235 with Leu4. This model was determined to form a heme-thiolate bond 
to the mutant proximal Cys; however, the heme UV-vis absorption spectrum of this mutant did not 
display characteristic cytochrome P450 features. The 3-His CuB non-heme copper center from 
heme copper oxidase (HCO) was also engineered into CcP distal heme pocket5 (so-called 
CuBCcP). Though it was reported at the time that the mutant could bind Cu(II), our more recent 
investigations to revisit the construct have cast doubt on whether Cu was actually bound in the 
designed site or only adventitiously bound. Similar spectra were reported for titration with Zn2+ 
that undercut reports of paramagnetic coupling between the heme and non-heme metal in this 
system, and a recently obtained crystal structure of Cu(II)-bound CuBCcP apparently refutes this 
claim (see Chapter 8). The most successful biosynthetic model constructed in CcP to-date is the 
conversion of CcP to a lignin peroxidase by the design of a Mn2+ binding site adjacent to the heme 
similar to the Mn2+  binding site of Mn peroxidases (MnP)2,6–8. The model, MnCcP, was able to 
oxidize small molecule lignin model substrates such a veratryl alcohol by generating highly 
oxidizing Mn3+ chelated in malonic acid. Furthermore, MnCcP was used as a model system to 
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study the isolated impacts of secondary sphere interactions with a designed metal center, which 
were able to be quantitatively connected to impacts of kcat and KM in the Mn
3+ generation assay8. 
 
 
Figure 3.2. Reprinted with permission from reference8. (A) the designed Mn2+ (pink sphere) in the 
MnP model MnCcP; (B) structure of native MnP; and (C) a critical salt bridge interaction in the 
secondary coordination sphere of the designed Mn2+ center. 
 
The most crucial of the prior mutational studies conducted with CcP is the reported ability of 
the H175C mutation to form a thiolate bond to heme4. Thiolate bond formation, initially forbidden 
due to the nearby negative charge of Asp235, was achieved by mutation of this residue to an 
isostructural but uncharged Leu. Though not alone in the ability to replace the proximal His with 
Cys to achieve thiolate ligations, as such a substitution had been accomplished in myoglobin 
without the need for compensating mutations16, it is a helpful feature of CcP that allows it to form 





3.2.  [4Fe-4S] center in bacterial assimilatory SiR 
The catalytic center of assimilatory SiR contains a cofactor composed of a heme (siroheme) 
covalently coupled to a [4Fe-4S] through a shared Cys ligand. This Cys serves as the proximal 
thiolate ligand to the heme Fe while also serving as a ligand to one of the four Fe atoms that 
compose the [4Fe-4S] cluster. The structure and redox potential (E°ʹ under physiological and 
similar conditions) of the SiR [4Fe-4S]+/2+ are similar to the [4Fe-4S] found commonly in bacterial 
ferredoxins17. 
 
Figure 3.3. Structure of the E. coli SiR-HP cofactor binding site (PDB: 2gep18) 
 
Due to spin coupling between the closely linked iron centers, the E°ʹ of the [4Fe-4S] can be 
modulated by the spin state of the siroheme cofactor, which can be accomplished by the binding 
of small ligands such as CO, CN-, or sulfide19. The iron-sulfur center in SiR was initially 
characterized by Mössbauer and electron paramagnetic resonance (EPR) spectroscopy, which 
revealed the strong antiferromagnetic coupling between the iron-sulfur and siroheme cofactors20. 
The high-temperature Mössbauer parameters of the major quadrupole doublet of the fully oxidized 
enzyme were attributed to four equivalent Fe spins were characteristic of a [4Fe-4S]2+ with fully 
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delocalized {Fe2.5+—Fe2.5+} pairs, and a minor doublet of nearly identical parameters was observed 
for the S = 5/2 ferric heme. At low temperatures, magnetic features are present for both spin 
systems despite the lack of any EPR signal from the [4Fe-4S] (formally S = 0) when both iron 
centers are oxidized, leading to the conclusion that the two iron centers are coupled and share a 
single spin system by exchange coupling, the first indication that they are linked by a covalent 
bond before the structure of the active site had been determined. Correspondingly, when a single 
electron is added to the system, the heme is observed to enter a high-spin ferrous state of integer 
spin, but the spins of all five Fe atoms exhibit features of a non-Kramer’s system20; when a second 
electron is added, again, all five Fe atoms return to a Kramer’s state, indicating that the spins of 
all Fe atoms in both cofactors are coupled21. 
The solved crystal structure of the E. coli assimilatory SiR hemoprotein subunit22 definitively 
confirmed the existence of a bridging Cys ligand between the two iron cofactors (Fig. 3.3). The 
CX5C and CX3C loops that coordinate the cluster are the mostly highly conserved sequences in 
the family of siroheme enzymes, and they donate a total of eight hydrogen bonds (6 backbone and 
2 sidechain) to the cluster22. These hydrogen bonds and the relatively solvent-exposed location of 
the [4Fe-4S] likely establish its low E°ʹ. The structure of the (oxidized) cluster itself is mostly 
symmetrical (D2h) except where it interacts with the bridging Cys483. 
 
3.3. Selection of CcP as a Protein Scaffold to Engineer a [4Fe-4S]-Heme Cofactor 
The initial criteria for selecting an optimal protein scaffold into which to engineer the [4Fe-
4S] center were that (a) the protein natively contains a single heme and (b) that the fold on the 
heme proximal face contains a cavity described by the protein backbone that is sufficient to house 
a [4Fe-4S]. It was also important that the scaffold not be a close sequence homologue of any native 
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siroheme SiR, leaving a structural homology search as the best approach to find a suitable scaffold. 
However, all sequence homologues (that is, those structures that share >30% identity over the size 
of the search sequence) similarly well-matched structural homologues of known, small protein 
scaffolds are siroheme SiR and NiR from various organisms. We therefore devised a method to 
search through the library of hemoproteins while excluding SiR by selectively searching for 
homology against only the proximal cavity of SiR, which contains the binding site of the coupled 
[4Fe-4S] cluster. 
The input structure for the protein scaffold search contained the [4Fe-4S] center from E. coli 
SiR-HP generated from PDB: 2gep18. The search model contained all amino acids within a 10 Å 
radius of the [4Fe-4S] to describe the binding cavity. This structure was given as an initial query 
for the MarkUS server23. MarkUS is a collection of freely available tools designed for sequence 
and structural homology searches. It incorporates Skan24 and DALI25 as structural homology 
search tools and both SCREEN26, which searches for surface-accessible cavities, and VASP27, 
which compares the volumes of cavities between structures, to search the PDB for a set of 
hemoprotein structures with similar cavities. Results of native siroheme proteins (which made up 





Figure 3.4. (A) Iron-sulfur cluster binding cavity of the E. coli SiR hemoprotein subunit 
(PDB:2gep)18 and (B) the corresponding region in CcP (PDB:2cyp)11. (A) The sidechain and 
backbone atoms the form the nearest neighbor region around the [4Fe-4S] cofactor in the space 
below the proximal face of siroheme in SiR (pink and yellow spheres for iron and sulfur, 
respectively) are shown as green sticks and a space-filling surface representation. (B) The region 
comprising the cavity (MarkUS)23 created by the peroxidase fold in CcP (cyan) is depicted with 
the same surface representation. 
 
The peroxidase fold, including horseradish peroxidase, ascorbate peroxidase, and CcP, shared 
a high level of cavity homology with native SiR; that is, the volume and shapes of the regions 
proximal to heme as described by the protein backbone, were similar. Due to our familiarity with 
CcP as a recombinant protein, CcP was chosen for further design. A comparison of the heme 
proximal face cavities of CcP and E. coli SiR-HP is shown in Fig. 3.4. The apparent common 
feature among the peroxidases that matched well with our search criteria is the proximal His-Asp-
Trp hydrogen bonding triad (PDB: 2CYP, Fig. S1)11. This motif, a proximal His hydrogen bonded 
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by a Asp and the presence of an aromatic Trp or Phe in the heme proximal pocket, is conserved in 
peroxidases and is known to modulate the reactivity of high-valent Fe-heme species28. Importantly, 
due to the lengths of the hydrogen bonds, these residues are spaced and buried such that they form 
a cavity sufficiently large to accommodate a [4Fe-4S] while still in close proximity to the heme 
cofactor. This cavity-centered homology approach may, therefore, be generalizable to 
hemoproteins with proximal heme hydrogen bonding networks and/or buried charges, such as 
bacterial catalase29 and catalase-peroxidase30, despite their different heme proximal ligand sets. 
Importantly, CcP had already been the target of an attempt to engineer a cytochrome P450-like 
heme-thiolate linkage, which required the mutation of His175 to Cys4. It was found that a heme-
thiolate bond could be made between the native heme-b and H175C in CcP with the additional 
mutation Asp235 to Leu, which eliminated a negative charge nearby the new Cys residue. The 
siroheme-Cys483 bond in E. coli SiR-HP has thiolate character, making this bond an essential 





Figure 3.5. Crystal structure of WT-CcP (PDB: 2cyp)11 with selected residues in the heme 
proximal pocket illustrated as cyan ball-and-stick models. 
 
3.4. Design of [4Fe-4S] mutations with rosetta matcher/enzyme design and rational design 
To select the optimal residues to mutate to Cys to serve as [4Fe-4S] ligands, we used the 
Rosetta matcher algorithm31. The search process requires as input both a protein structure in the 
form of a PDB, for which we used a native CcP structure PDB: 2cyp11, and atomic coordinate and 
bond parameters for the target ligand to bind with the protein scaffold. We designed a [4Fe-4S] 
ligand based on charge and bond length parameters determined from reported density functional 
theory calculations32. We used a [4Fe-4S] ligand described in the parameters file (.params) 





Listing 1: File 4Fe4S.params containing the ligand structure for the [4Fe-4S] matching search. 
NAME F4O 
IO_STRING F4O Z 
TYPE LIGAND 
AA UNK 
ATOM FE1  Fe3p  X   1.83 
ATOM  S2  S     X   -1.33 
ATOM FE4  Fe3p  X   1.83 
ATOM FE2  Fe3p  X   1.83 
ATOM  S4  S     X   -1.33 
ATOM FE3  Fe3p  X   1.83 
ATOM  S3  S     X   -1.33 
ATOM  S1  S     X   -1.33 
BOND  S2  FE4  
BOND  S2  FE1  
BOND  S2  FE2  
BOND FE4  FE1  
BOND FE4  FE2  
BOND FE4   S3  
BOND FE4   S4  
BOND FE4  FE3  
BOND FE1  FE2  
BOND FE1   S3  
BOND FE1  FE3  
BOND FE1   S1  
BOND FE2   S4  
BOND FE2  FE3  
BOND FE2   S1  
BOND  S3  FE3  
BOND  S4  FE3  
BOND FE3   S1  
NBR_ATOM FE1  
NBR_RADIUS 3.967548 
ICOOR_INTERNAL   FE1     0.000000    0.000000    0.000000  FE1    S2   FE4  
ICOOR_INTERNAL    S2     0.000000  180.000000    2.335732  FE1    S2   FE4  
ICOOR_INTERNAL   FE4     0.000000  107.421730    2.343594   S2   FE1   FE4  
ICOOR_INTERNAL   FE2   -76.847206  126.420234    2.769515  FE4    S2   FE1  
ICOOR_INTERNAL    S4  -159.917952  126.420234    2.343594  FE2   FE4    S2  
ICOOR_INTERNAL   FE3   -76.847206  107.421730    2.335732   S4   FE2   FE4  
ICOOR_INTERNAL    S3    93.812278   75.246352    2.335732  FE3    S4   FE2  
ICOOR_INTERNAL    S1  -110.438908   74.935730    2.343594  FE3    S4    S 
 
A constraints file is required to define the type and number of protein-ligand interactions that 
are the target of the matcher search. In this case, all interactions are Cys—Fe bonds through the 
Sγ atom of Cys. Every required Cys in this model must be mutated into the protein scaffold, and 
all Fe atoms are members of the [4Fe-4S] ligand. The constraints file specifies a value for the bond 
length, bond angles, and dihedral angles between the specified atoms of the protein and ligand. 
The values are further subdivided into levels of tolerance and sampling levels (e.g. number of steps 
of 5 degrees that are allowed for a bond angle) for each protein-ligand interaction. The constraints 
(.cst file) used for the final search are given in Listing 2. 
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Listing 2: Constraint file applied for the [4Fe-4S] Matcher search. 
 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE1 S4 FE2 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_B:  106.00   6.00  50.00  360.00   1 
  CONSTRAINT::    angle_A:  180.00  10.00  25.00  360.00   2 
  CONSTRAINT::  torsion_B:  000.00  10.00  00.00   10.00   0 
  CONSTRAINT::  torsion_A:  000.00  60.00  00.00  360.00   6 
  CONSTRAINT:: torsion_AB:  000.00  10.00  00.00   10.00   0 
   
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
  ALGORITHM_INFO::END 




  TEMPLATE::   ATOM_MAP: 1 atom_name: FE2 S3 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_B:  106.00   6.00  50.00  360.00   1 
  CONSTRAINT::    angle_A:  180.00  10.00  25.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 




  TEMPLATE::   ATOM_MAP: 1 atom_name: FE3 S2 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_B:  106.00   6.00  50.00  360.00   1 
  CONSTRAINT::    angle_A:  180.00  10.00  25.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 




  TEMPLATE::   ATOM_MAP: 1 atom_name: FE CHD CHC 
  TEMPLATE::   ATOM_MAP: 1 residue3: HEM 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
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  CONSTRAINT::    angle_B:  106.50   6.00  50.00  360.00   1 
  CONSTRAINT::    angle_A:   99.01   8.00 100.00  360.00   2 
  CONSTRAINT::  torsion_A:   90.00   8.00  25.00  360.00   0 
  CONSTRAINT::  torsion_B:   80.00   3.00  75.00  360.00   0 
  CONSTRAINT:: torsion_AB:  -30.00   3.00 100.00  360.00   0 
 
  CST::END 
 
The Matcher algorithm can be applied to every residue in a protein structure; however, it 
is more efficient and to specify positions in the protein scaffold that fit known search criteria. From 
the cavity identification tools in MarkUS, we already had a fully-described cavity in CcP that was 
bounded by heme (Fig. 3.5), and by the requirements of the cofactor to share a Cys ligand between 
heme and the engineered [4Fe-4S], His175 was required to be mutated to Cys and serve as one of 
the four positions of the constraints. A “pose” file (.pos) specifies which residues to search with 
the Matcher algorithm and, further, can specify residues that receive specific constraints. Listing 
3 reproduces the entire pose file for the Matcher search in CcP. The first line of residue numbers 
specifies that the first constraint (Listing 2) be applied at residue 175 (His to Cys mutation), and 
the following lines identify possible residues with amenable orientations in the proximal pocket 
region for the other three Cys mutations. 
 
Listing 3: Residues, chosen for their orientation in the CcP heme proximal pocket, that were 
included in the pose (.pos) file to search for Cys mutations for [4Fe-4S] binding. 
N_CST 4 
1: 175 
2: 172 180 191 202 230 232 235 238 
3: 172 180 191 202 230 232 235 238 
4: 172 180 191 202 230 232 235 238 
 

















Options (flags) used in the Matcher run are given Listing 4, and the run was initiated via shell 
script on the School of Chemical Sciences “Triton” CPU cluster in Rosetta v3.5. Outputs of the 
matcher run are collections of semi-redundant mutant structures (cloud PDBs) containing all 
possible orientations, bond lengths, and angle conformations allowed by the constraints for a 
particular set of mutations (match group). All output cloud PDB structures were aligned with WT-
CcP, and match groups that produced significant overlap between the native heme and the [4Fe-
4S] were discarded. The remaining match groups were further optimized with the Rosetta enzyme 
design algorithm using the same constraints file that was used by the matcher. 
The enzyme design output contains a structure that is energy minimized by fast molecular 
mechanics modeling, and enzyme design may make sufficient compensating mutations to balance 
charge and optimize packing. The mutation Met230Ala was incorporated from enzyme design to 
optimize [4Fe-4S] packing. Additionally, the mutation Asp235Ala/Val was made rationally based 
on the insight gained from prior efforts to make a Cys-heme thiolate bond in CcP4. The final design 
contained six (6) total mutations: H175C/T180C/W191C/M230A/L232C/D235A, and we 
tentatively called the mutant “SiRCcP.” The mutation D235V-SiRCcP, an alternative to Ala to 
replace residue 235, we called “SiRCcP.1.” The designs were assessed for stability and 
conformational integrity by MD simulation as cofactor-free apo-protein with NAMD233 (Fig. 3.6) 
and as fully reconstituted heme-[4Fe-4S] proteins (Fig. 3.7) in the CHARMM22 force field34. 
Structure factor files for MD were generated with a built-in VMD35 psf-generating utility. A bond 
was patched from Cys175 to the heme Fe atom to form the Cys-bridged heme-[4Fe-4S] cofactor, 
for which the [4Fe-4S] parameters were the same as those given in Listing S1, and the heme 
parameters from the built-in CHARMM22 topology and parameters (revisions 22 and 27). 
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Equilibrations were conducted with protein molecules solvated in a periodic TIP3P water box (15 
Å buffer to the x-, y-, and z-axes maxima for the solvated molecules) that was charge neutralized 
by NaCl (0.1 M) and were run for a minimum of 2 ns to confirm scaffold stability. 
 
 
Figure 3.6. Overlay of the structure of WT-CcP (PDB: 2cyp, cyan)11 with the [4Fe-4S]-binding 






Figure 3.7. Computational model of the heme-[4Fe-4S] center in SiRCcP.1 compared to native 
SiR. (A) The designed heme-[4Fe-4S] center in SiRCcP.1. Residues mutated to Cys to ligate a 
[4Fe-4S] are drawn in magenta. Residue His175 was mutated to Cys as a required ligand for the 
model and is designed to act as a ligand to both heme and the [4Fe-4S]. (B) The metal centers of 
native E. coli SiR-HP (green, PDB: 2gep18) overlaid with the designed heme-[4Fe-4S] site in 
SiRCcP.1 (magenta). Iron and sulfur atoms in the [4Fe-4S] of native SiR-HP are made transparent 
for clarity. Images were generated with VMD35. 
 
3.5. Purification of SiRCcP 
Mutations designed through Rosetta and by visual inspection were accomplished 
simultaneously via Gibson assembly36 (New England Biolabs). Gibson assembly is a method that 
allows the rapid and efficient ligation of a DNA fragment up to several kilobases in length into a 
linearized plasmid vector. This method can also replace a gene fragment by using primers to 
generate a linear vector that excludes the target region, which is the approach that we employed. 
An insert fragment (240 bp) containing the mutant sequence for His175Cys, Thr180Cys, 
Trp191Cys, Met230Ala, Leu232Cys, and Asp235Ala (sequence provided in Listing 5) was 
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designed for an E. coli codon optimized yeast CcP gene cloned into a pET17b expression vector2 
(Listing 6). The vector was first linearized using Phusion high-fidelity DNA polymerase 
(ThermoFisher) using the primers given in Listing 7. 
 
Listing 5: Sequence of the pET17b high-copy expression vector with ampicillin resistance gene 












Listing 6: Insert sequence. Grey shading indicates primer overlap regions. Underlined codons 







Listing 7: Primers for Gibson assembly vector: 
Forward primer: 5’-TTGATTCAGGATCCCAAGTAC-3’ 




Subsequent mutation to D235V (SiRCcP.1) was accomplished through quick-change 
mutagenesis. All mutants of CcP were expressed and purified by methods our lab has developed 
over many years and which have been extensively described previously7. Briefly, mutant CcP was 
transformed into chemically competent E. coli BL21-DE3* high-efficiency expression cells (New 
England Biolabs), grown from colonies in 5 mL and subsequently 2 L cultures (LB) under 
ampicillin selection, and recombinant protein expression was induced by addition of 0.1-1.0 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were lysed by sonication, and the soluble 
lysate fraction was batch-bound overnight at 4°C to DEAE Sepharose anion exchange beads (GE 
Healthcare). Soluble proteins were eluted on a gradient from 40-500 mM KCl in phosphate buffer 
(50 mM, pH = 7.0, EDTA 1 mM). The highest absorbing fractions at 280 nm and 410 nm from the 
linear gradient were collected, concentrated on an Amicon ultrafiltration unit (10 kDa cutoff) to a 
volume of 6-8 mL, and then passed through a gel filtration column (Sephedex S-100, GE 
Healthcare) equilibrated with phosphate buffer (100 mM, pH = 7.0). Fractions of the appropriate 
molecular weight were collected and analyzed by electrospray ionization mass spectrometry (ESI-
MS) for purity and accurate expression of the target protein (Fig. 3.8). These fractions were further 
purified on an additional DEAE or QFF column to separate apo-protein from the hemoprotein 
fraction when hemoprotein content exceeded 5% of the total protein. Purified mutant apo-CcP was 
concentrated, flash-frozen in liquid nitrogen, and stored at -80°C.  
To prepare protein samples for ESI-MS, a small aliquot (typically 0.2 mL, 50 µM) of protein 
solution was rigorously exchanged into ammonium acetate buffer (50 mM, pH = 5.0) by double 
passage through a PD10 column and 3-5 buffer exchanges by micro-centrifuge concentration. The 
calculated mass for SiRCcP is 33501 Da, and for SiRCcP.1 the theoretical mass is 33530 Da (Fig 
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3.8). Typical mass spectra for purified apo-protein contained a single prominent peak within ±5 
Da, which is within the typical error for the instrument (Waters ZMD Quadrupole). 
 
 
Figure. 3.8. ESI-MS for apo-SiRCcP.1. The theoretical mass of SiRCcP.1 is 33529.6, and the 
measured mass of 33524.0 is within the error routinely observed for this instrument (Waters ZMD 
Quadrupole). 
 
3.6. [4Fe-4S] reconstitution in SiRCcP 
Reconstitution of the iron-sulfur cofactor was attempted first with apo-SiRCcP because the 
Soret band of the hemoprotein would completely obscure the broad and substantially weaker 
absorbance at around 400 nm that is indicative of an iron-sulfur center37. All iron-sulfur 
reconstitution and subsequent manipulation was carried out under strictly anaerobic conditions in 
a vinyl anaerobic chamber (Coy) equilibrated with a nitrogen-hydrogen mixture maintained at less 
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than 1 ppm molecular oxygen. All buffers were made anaerobic by rigorous degassing on a 
Schlenk line with vacuum/argon replacement cycles or by stirring overnight in the anaerobic 
chamber. Protein samples were first exchanged to HEPES buffer (50 mM, pH = 8.0) by passage 
through a PD10 desalting column (GE Healthcare) and thoroughly degassed by repeated freeze-
pump-thaw under nitrogen on a vacuum manifold or by stirring for at least one hour in the 
anaerobic chamber followed by a second desalting with degassed buffer. 
To reconstitute an FeS-cluster in degassed apo-SiRCcP, the protein was diluted to 50-100 µM 
in oxygen-free HEPES buffer and equilibrated for 1 hour in 2-5 mM dithiothreitol (DTT) or 2-5% 
(v/v%) β-mercaptoethanol (BME). Iron-sulfur reconstitution was accomplished by first adding, 
slowly, 8 molar equivalents of a 20 mM solution of either FeCl3 or ammonium ferrous sulfate, 
after which the solution was allowed to equilibrate for approximately 10 min while faint red color 
developed. Typically, more intense color was obtained from FeCl3; however, at pH 8.0 Fe(OH)2 
forms over time as a green precipitate. Ferrous ammonium sulfate, however, remains stable under 
these conditions. Following equilibration with iron, an equimolar quantity of a freshly prepared 20 
mM solution of Na2S (dissolved in pH = 8 HEPES buffer) was added slowly (over the course of 
1-2 hours) while brown color developed. The brown solution was allowed to equilibrate at ambient 
temperature until absorbance at 400 nm saturated (typically 90 minutes). Excess soluble iron-sulfur 
species were removed by passage through a PD10 column, and amorphous ferrous sulfide (often 
present as a black precipitate) was removed by a small DEAE column equilibrated in oxygen-free 
HEPES buffer and eluted with HEPES buffer plus 250 mM KCl followed by desalting on a PD10 
column. 
Because the addition of Na2S frequently results in significant formation of amorphous ferrous 
sulfide and because the process of removing ferrous sulfide can result in lower yield of iron-sulfur 
75 
 
reconstituted protein, we also employed an alternate in vitro method of iron-sulfur reconstitution 
using the E. coli cysteine desulfurase, IscS38,39. A cell stock containing the IscS plasmid for 
overexpression in BL21-DE3* cells was generously gifted to us by Prof. James Imlay (UIUC). In 
the presence of a reductant (5 mM DTT), IscS slowly generates labile sulfide from L-cysteine (L-
Cys) and usually does not result in significant ferrous sulfide formation. The equilibration period, 
however, is typically longer than ~8 hours when stirred at a controlled temperature of 20°C 
(maintained by water back circulation). After equilibration with excess ferrous ammonium sulfate, 
L-Cys IscS (2.5-5 mM) is added, and IscS is added in catalytic amounts (~0.5% of total protein) 
without subsequent removal40. The method of in vitro reconstitution used for a given sample 
preparation was, in general, the Na2S method unless otherwise indicated. 
The first attempts to reconstitute an iron-sulfur cluster in SiRCcP were not successful, resulting 
only in black (ferrous sulfide) precipitation. Subsequent iron-sulfur reconstitution of SiRCcP.1, 
however, resulted in the gradual development of brown color and the appearance of a broad UV-
visible (UV-vis) absorbance feature around 400 nm that is typical of native iron-sulfur proteins 
(Fig. 3.9). An in-depth discussion of the spectroscopic properties of FeS-reconstituted SiRCcP.1 
is provided in the following section. Color development began quickly after the first sub-
equivalent of sulfide was added and continued to develop gradually for 60-90 minutes following 





Figure 3.9. Iron-sulfur reconstitution of apo-SiRCcP.1 by addition of ferrous ammonium sulfate 
and gradual addition of Na2S. Panel A shows a time course of additions of the reconstitution 
starting from apo-protein. Panel B shows the saturation curve resulting from gradual addition of 
sulfide every 10 minutes unless otherwise indicated in Panel A. Samples were allowed to 
equilibrate for an additional 90 min before excess Fe and ferrous sulfide were removed by anion 
chromatography with (DEAE Sephadex). 
 
3.7. UV-vis, EPR, and X-ray Absorption Spectroscopy of FeS-Reconstituted SiRCcP.1 
The UV-vis absorbance features of FeS-reconstituted SiRCcP.1 are shown in Fig. 3.10. These 
features remain following cleanup by either DEAE anion exchange or gel filtration 
chromatography, and the typical 400:280 nm absorption ratio is 0.22-0.26 following cleanup. The 
appearance of the 400 nm absorbance feature, however, is not sufficient to determine whether the 
species formed in SiRCcP.1 is indeed a [4Fe-4S] cluster and not a [2Fe-2S] or some other iron-
sulfur species because the 400 nm feature lacks characteristic features for a specific iron-sulfur 
species and is sensitive to the protein environment. We added sodium dithionite (DT) to reduce 
the resulting FeS-reconstituted protein (hereafter referred to as EHeme-FeS-SiRCcP.1 to indicate 
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that the heme site of SiRCcP.1 is “empty” while its FeS site is occupied), resulting in a loss of 
intensity of the 400 nm feature, which is the expected outcome of reducing an iron-sulfur cluster. 
We then attempted to recover the initial absorption features by gradually adding potassium 
ferricyanide to the reduced EHeme-FeS-SiRCcP.1, resulting in some recovery of the initial 
absorptive intensity but not the original spectrum (Fig. 3.11, blue and magenta traces). The re-
oxidized species resembles an oxidatively damaged [4Fe-4S] species, a [3Fe-4S]+ product that 
results from oxidation of a [4Fe-4S], but—again—the UV-vis spectrum alone is not a definitive 
assignment of these species. 
 
 
Figure 3.10. UV-vis spectra of iron-sulfur reconstituted SiRCcP.1 (EHeme-FeS-SiRCcP.1) as 
prepared (black), reduced with sodium dithionite (blue), and subsequently re-oxidized by addition 
of potassium ferricyanide (magenta). Reduced FeS-protein undergoes a broad loss of absorptivity. 
Addition of ferricyanide results in some recovery of absorption, but the initial spectrum is not  
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Figure 3.10 (cont.) recovered. We attribute the weak peak at 420 nm in all spectra to a small 
amount (<5%) of ferrous hemoprotein that remains after purification of apo-SiRCcP.1. 
 
3.7.1.Electron Paramagnetic Resonance Spectroscopy of EHeme-FeS-SiRCcP.1 
In order to characterize the nature of the iron-sulfur species formed in SiRCcP.1, electron 
paramagnetic resonance (EPR) spectra (Fig. 3.11) were collected for each of the three samples 
described in Fig. 3.10. The EPR first derivative spectra of [4Fe-4S]+ have characteristic S = ½ 
signals comprised of mostly axial gy and gx, giving rise to the so-called g⊥ = 1.94 signature. The 
oxidized species, [4Fe-4S]2+, is diamagnetic and, therefore, EPR silent. The four Fe atoms of a 
[4Fe-4S] are always high-spin due to the strong covalency Fe—S covalency. Sulfur, generally a 
weak ligand, has negligible nuclear charge while occupying Fe 3d orbitals, allowing the Fe atoms 
to remain high-spin as S = 5/2 for formal Fe3+ atoms and S = 2 for formal Fe2+ atoms41,42. 
Mössbauer studies have further shown that oxidized [4Fe-4S] may be considered to be fully 
delocalized {Fe2.5+—Fe2.5+} pairs that are antiferromagnetically coupled (thus, S = 0 in the [4Fe-
4S]2+ state)43. Other iron-sulfur species, such as [2Fe-2S] and [3Fe-4S], have more rhombic and 
isotropic EPR signals, respectively, than is common for [4Fe-4S] species. X-band EPR spectra 
were collected on a Varian E-122 spectrometer fitted with a liquid He cryostat at the University of 
Illinois School of Chemical Sciences Electron Paramagnetic Resonance Laboratory. The typical 
microwave power applied was 10 mW, and spectra were collected with a 100 kHz modulation 
frequency and 10 G modulation amplitude at a temperature of 10-20 K. The sample temperature 
could only be approximated within this range due to limitations of the cryostat control. Samples 
were prepared under anaerobic conditions by concentrating EHeme-FeS-SiRCcP.1 to 0.8-1.2 mM in 
HEPES buffer and mixing with 20-30% (v/v%) of glycerol. The EPR tube was capped with a 
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rubber septum, removed from the glove bag, and rapidly frozen by plunging into liquid nitrogen. 
Identical spectra were obtained at similar protein concentrations when snap frozen in dry-ice 
cooled isopentane or acetone without the addition of glycerol. 
 
 
Figure 3.11. X-band EPR spectra of EHeme-FeS-SiRCcP.1 corresponding to the species shown in 
Fig. 3.10. (A) The freshly reconstituted species (black) is EPR silent, but reducing the sample with 
an excess of sodium dithionite gives a “g⊥ = 1.94”-type species (blue). Addition of potassium 
ferricyanide (~5 equivalents) produces an isotropic species indicative of a 3Fe-species resulting 
from the oxidative loss of one iron atom. The putative structures of each [4Fe-4S] form and their 
oxidation states are drawn on the right. EPR spectra shown were measured at 18 K with a 
microwave power of 10 mW at a frequency of 9.24 GHz. (B) Typical EPR spectrum of [4Fe-4S] 
reconstituted EHeme-FeS
+-SiRCcP.1 reduced with an excess of dithionite (black) and simulation of 
the spectrum (red). The small feature at g ~ 2 is attributed to the quartz cuvette and is present in 
most samples. Simulations were performed in Simpow6 and gave the following g values:  
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Figure 3.11 (cont.) gx = 1.8907, gy = 1.9185, gz = 2.0354; linewidths (MHz) Ax = 117.09, Ay = 
77.01, Az = 69.77. Spectra were collected at 9.17 GHz frequency and a temperature of 15 K. 
 
The EPR spectra of samples of EHeme-FeS-SiRCcP.1 as-prepared, reduced, and re-oxidized 
with potassium ferricyanide are given in Fig. 3.11. As-prepared, EHeme-FeS-SiRCcP.1 is apparently 
diamagnetic, exhibiting no EPR signal in the g = 2 region. When reduced with DT, however, EHeme-
FeS-SiRCcP.1 displays a slightly rhombic EPR spectrum (gx = 1.89, gy = 1.92, gz = 2.04) indicative 
of a S = ½ iron-sulfur species. From this result, we tentatively assigned the EPR-silent iron-sulfur 
species to be S = 0, which strongly suggests a [4Fe-4S]2+ species as-prepared. Furthermore, adding 
an excess of ferricyanide to the reduced species resulted in a weak isotropic EPR spectrum with g 
~ 2. This type of isotropic spectrum has been observed in native [3Fe-4S]+ proteins and [4Fe-4S]2+ 
that have lost an Fe due to oxidative damage44–48. The emergence of a signal characteristic of a 
[3Fe-4S]+ species as a result of chemical oxidation precludes the possibility of a [2Fe-2S] cluster 
constituting the major species in EHeme-FeS-SiRCcP.1 as such a 3Fe species could only result from 
the loss of an Fe ion under oxidizing conditions. Increasing the cryostat temperature to greater than 
30 K caused the spectra of the DT-reduced sample to diminish until no longer detectable without 
the emergence of additional features. This strict temperature dependence indicates that there are 
no [2Fe-2S] species present in the sample or that they make up a negligible portion of the total 
paramagnetic species. Therefore, we were able to determine that the iron-sulfur species in EHeme-
FeS-SiRCcP.1 was indeed a [4Fe-4S]2+/+ cluster and gave rise to the anticipated paramagnetic 





3.7.2.Mössbauer spectroscopy of SiRCcP.1 
Mössbauer spectroscopy is a useful method to describe the spin states of both paramagnetic 
and diamagnetic iron species. The technique is sensitive only to the stable iron isotope 57Fe, 
requiring isotopic enrichment of biological samples to produce sufficient signal. A sample of 
EHeme-FeS
2+-SiRCcP.1 was prepared by reconstituting the apo-protein with ammonium 57-iron 
sulfate. The salt was prepared from 57Fe powder by stirring a few mg of the labeled iron in 1 M 
sulfuric acid under Ar gas. A solution of two-fold excess ammonium sulfate was added under low-
oxygen conditions and allowed to evaporate until pale green crystals grew. Solutions of the 
isotopically labeled salt were made by mass, and the concentration of soluble ferrous iron was 
verified spectrophotometrically by FerroZine complexation49. The Mössbauer sample was made 
by concentrating the reconstituted protein to 0.8 mM (ostensibly 1.6-3.2 mM of 57Fe based on 
typical incorporation efficiencies for ammonium ferrous sulfate [4Fe-4S] reconstitutions) and a 
volume of 0.4 mL, transferred to a Teflon Mössbauer cup, and frozen by slowly dipping the cup 





Figure 3.12. Mössbauer spectrum of EHeme-
57FeS2+-SiRCcP.1 collected at 4.2 K and a field of 0.45 
kG (approx. zero-field spectrum). Red trace: simulation of two iron species, Site I and Site II, in a 
1:1 abundance. For Site I, δFe = 0.46 mm/s, and Site II was simulated as δFe = 1.28 mm/s, which is 
unusually large for [4Fe-4S]. 
 
The zero-field spectrum of the iron-sulfur cluster (Fig. 3.12) could be simulated with a single 
quadrupole doublet with an isomer shift of δ = 0.46 mm/s and quadrupolar splitting of ΔEq = 0.98 
mm/s. These values are quite typical of [4Fe-4S]2+ with valence delocalized {Fe2.5+} pairs 
sufficiently large to rule out a [2Fe-2S]50. Mössbauer spectra of the SiRCcP.1 hemoprotein are 





Figure 3.13. Iron K-edge XANES of EHeme-FeS
2+-SiRCcP.1 (oxidized) and EHeme-FeS
+-SiRCcP.1 
(reduced by addition of excess sodium dithionite). The spectra shown were measured from samples 
that had been already characterized by EPR to ensure that their oxidation states were known. Data 
were collected at 8 K. 
 
3.7.3.X-ray Absorption Spectroscopy of SiRCcP.1 
To gain more structural information on the [4Fe-4S] in EHeme-FeS-SiRCcP.1, the near-edge 
(XANES) and extended x-ray absorption fine structure (EXAFS) x-ray absorption spectra were 
collected of both oxidized and reduced samples. The oxidation states of XAS samples (EXAFS) 
were verified by their EPR spectra prior to data collection. These samples were recollected from 
their sealed EPR tubes under anaerobic conditions, further concentrated to 1-3 mM, and transferred 
to XAS sample holders that were rapidly frozen in liquid nitrogen in the anaerobic environment. 
Data were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) operating at 3 GeV 
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with a 500 mA current on beamline 9-3 (Si monochrometer, ϕ = 90°, energy cutoff 10 keV). Data 
were collected in fluorescence mode on a Canberra 100-element Ge array detector with maximum 
count rates below 120 kHz. Soller slits and a 3 μm Z-1 (Mn oxide) filter were placed between the 
samples and the detector array to reduce Compton and elastic scattering. Edge energy was 
calibrated against an Fe foil reference that was scanned simultaneously with all samples. Samples 
were scanned 6-9 times at a temperature maintained at 8-10 K and were averaged for analysis. 
Data analysis, including background subtraction and normalization, and EXAFS simulations were 
performed using Athena and Artemis from the Demeter software suite51. First, there is no 
difference in the XANES pre-edge peaks (7112.9 eV) between the oxidized and reduced samples 
(Fig. 3.13). The edge energy of both samples is 7118.4 eV, and reducing EHeme-FeS
2+-SiRCcP.1 to 
EHeme-FeS
+-SiRCcP.1 with dithionite results only in a small change in the line shape of the reduced 
sample relative to the oxidized sample. The white line intensity of EHeme-FeS
2+-SiRCcP.1 is less 
than EHeme-FeS
+-SiRCcP.1, but the magnitude of the change is smaller than is typically observed 
for an iron-sulfur species displaying similar edge behavior. The near-edge transformations of [4Fe-
4S] are not as well understood as [2Fe-2S] centers, and the specific interactions that modulate the 
white line intensity of [4Fe-4S] have not been characterized or unambiguously modeled. 
Nevertheless, Debeer and coworkers have shown that edge shifts from the reduction of [2Fe-2S] 
centers can become less intense when the absorption contributions from localized {Fe3+—Fe2+} 
pairs increase52. This effect should reasonably apply to the XANES spectra of EHeme-FeS
2+-
SiRCcP.1 and EHeme-FeS
+-SiRCcP.1. The observed minor edge shift and change in near-edge 
features could result from structural changes in the [4Fe-4S] that occur upon oxidation/reduction 
that give rise to a redistribution of Fe charge localization. The small changes in XANES pre-edge 
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and edge features suggest that there is likely some contribution from localized {Fe3+—Fe2+} pairs 
mixed with fully delocalized “Fe2.5+” iron pairs upon reduction.  
 
Table 3.1 - Parameters for EXAFS best-fit simulations of EHeme-FeS-SiRCcP.1 for both 
[2Fe-2S] and [4Fe-4S] models 
 
Simulation of the best-fit model of reduced [4Fe-4S] required two unique Fe—Fe scattering paths while 
only one type of Fe—Fe path was required to fit the oxidized [4Fe-4S] spectrum. 
 
The EXAFS region of the EHeme-FeS-SiRCcP.1 were also collected, and the R-space 
Fourier transform of the EXAFS are shown in Fig. 3.14. The Fe—Fe scattering peak in the reduced 
sample is less intense than in the oxidized sample, a change that is frequently observed for iron-
sulfur species relative to their Fe—Fe scattering intensities at higher oxidation states. The best fit 
of the EXAFS spectrum of the oxidized protein is a cubane species in EHeme-FeS
2+-SiRCcP.1 (three 
scattering Fe atoms per absorber Fe and four scattering S atoms in the first coordination shell) that 
assumes a symmetrical structure with 3 equivalent inorganic scattering S atoms, 3 equivalent 
scattering Fe atoms, and one SCys scattering atom per Fe absorber. The reduced species modeled 
well as a slightly more tetrahedrally distorted [4Fe-4S] with a shorter separation between [2Fe-2S] 
planes and longer paired Fe—Fe distances than the oxidized species. The fit statistics and 
parameters for each species are given in Table 3.1 for fits of [2Fe-2S] and [4Fe-4S] models. In the 
cases of both the oxidized and reduced species, the 2Fe and 4Fe models both gave reasonable fits, 
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and the reduced species was less well-defined; however, the 4Fe models gave significantly 
improved fits versus the 2Fe models. 
It is notable that the fit of the reduced species is tetrahedrally distorted relative to the best 
fit of the oxidized species, which was treated symmetrically to obtain its best fit. The EXAFS 
modeling supports a structural difference between the oxidized and reduced species that 
corresponds to a lengthening of the inter-plane distances of [2Fe-2S] diamond-core pairs, which 
could give rise to a greater contribution of Fe3+/Fe2+ charge localization in the reduced species 
relative to the oxidized species, as suggested by the XANES spectra. This effect has not as of yet 
been intentionally studied in biological [4Fe-4S] clusters, but the XAS behavior of cubane [4Fe-
4S] centers is likely to resemble the behavior of [2Fe-2S] centers. The combination of EPR, 
Mössbauer, and XAS spectra of EHeme-FeS-SiRCcP.1 strongly support the assignment of the iron-






Figure. 3.14. The magnitude of the phase-uncorrected, k3-weighted Fourier transform and EXAFS 
(upper inset) of the Fe K-edge spectra for EHeme-FeS
2+-SiRCcP.1 (A, black trace) and for EHeme-
FeS+-SiRCcP.1 (B, blue trace). Simulated fits are shown as solid red lines. The best fit for the 
oxidized species (A) was obtained from a symmetrical first-shell model for each absorber Fe atom 
with three inorganic sulfur scattering atoms at 2.302 Å, one Cys sulfur atom at 2.214 Å, and three 
scattering Fe atoms at 2.700 Å (R-factor of 0.0056, R-range 1.35 - 3.3 Å). The best fit for the 
reduced species (B) was obtained from a first-shell model with three inorganic sulfurs at 2.305 Å, 
one Cys sulfur at 2.194 Å, two scattering Fe atoms at 2.641 Å, and a third scattering Fe at 2.756 
Å per Fe-absorber (R-factor of 0.0076, R-range 1.2 - 3.0 Å). Fits to either [2Fe-2S] or FeS4 models 
were less robust. A three-dimensional model (lower inset) of bond lengths determined for the [4Fe-




3.8. Determination of Iron and Sulfur content in Fe-S reconstituted SiRCcP.1 
The spectroscopic characterization techniques described above in Section 3.7 are not 
quantitative in the absence of suitable standards or known extinction constants, and the 
concentrations that were given, where necessary, had been best-guess estimates based on UV-vis 
absorption extinction coefficients calculated from the sequence of SiRCcP.1 (45 mM-1cm-1 at 280 
nm). The protein concentrations in the instances are likely to be overestimations given that in 
native CcP the corresponding coefficient is ~80 mM-1cm-1 while the value calculated identically 
from its sequence is only 60  mM-1cm-1. To accurately determine the iron-sulfur content of the 
reconstituted proteins, the protein matrix can be used as an internal standard by its sulfur content 
through inductively coupled plasma mass spectrometry (ICP-MS). The mutant protein SiRCcP.1 
contains 10 S atoms in the form of Met and Cys residues, allowing for a maximum of 14 S atoms 
per monomer when fully reconstituted with [4Fe-4S], which would contain a corresponding 4 Fe 
atoms (+~5% of bound heme). Iron and sulfur content of FeS-reconstituted protein samples were 
determined by ICP-MS on a NexION 350D instrument at the UIUC Microanalysis Laboratory. 
Protein samples (3 mL sample volume) were exchanged anaerobically into phosphate buffer, and 
sample concentrations were estimated by their absorbance at 280 nm (for apo- and FeS-
reconstituted protein) prior to sample submission to ensure sufficient sample was delivered for 
unambiguous determination, approx. 100 ppm of Fe. A sample that is 100% reconstituted would 
be expected to have a Fe:S ratio of 4:14 (0.286). The Fe content such a sample was determined to 
be 333 ppm Fe, and the sulfur content of the same sample was 1166 ppm S, giving a ratio of 0.286, 
which taken as the mass fraction of the sample gives a Fe:S ratio of 0.163, or approx. 57% 
saturation with [4Fe-4S] per protein monomer under the preparation conditions described. It is 
possible that, due to generally less resolution of S at ppm concentrations than Fe by ICP-MS, the 
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amount of S in the sample could have been overestimated. However, FerroZine quantification of 
Fe in prepared EHeme-FeS-SiRCcP.1 subsequently found similar saturation values. The most likely 
reason for low cofactor loading into SiRCcP.1 is significant Fe loss during reconstitution in the 
form of ferrous sulfide, leaving soluble iron and sulfur in concentrations lower than one [4Fe-4S] 
equivalent or at concentrations near the KD of [4Fe-4S] binding in SiRCcP.1. Interpreting the mass 
fraction of Fe in EHeme-FeS-SiRCcP.1 as evidence of [2Fe-2S] at high concentration is plausible, 
but the presence of [2Fe-2S] species is conclusively refuted by the spectroscopic characterization 
described above. The method of FeS reconstitution by IscS + L-Cys generally produced a more 
fully reconstituted protein, giving Fe2+ content consistently greater than ~80% as determined by 
the FerroZine colorimetric assay. 
 
3.9. Redox chemistry of [4Fe-4S]-SiRCcP.1 
In addition to being structurally similar to bacterial ferredoxin [4Fe-4S], the [4Fe-4S] in SiR 
has a reduction potential (E°ʹ) for the [4Fe-4S]2+/+ pair that falls within typical low-potential 
ferredoxin E°ʹ values53. The measured E°ʹ for E. coli SiR [4Fe-4S] in the absence of exogenous 
ligands, determined by potentiometric titration coupled with EPR spectroscopy, is -405 mV (SHE), 
and the E°ʹ of siroheme was determined to be -340 mV under the same conditions17. In the presence 
of strong ligands such as CN- and CO, the siroheme E°ʹ was found to increase to -155 mV while 
the [4Fe-4S] E°ʹ decreased by about 15 and 70 mV, respectively19, increasing the driving potential 
for the [4Fe-4S]+ to reduce ferric siroheme. 
Though the E°ʹ of the native protein cofactors were determined by potentiometric titration and 
subsequent quantification of the paramagnetic species, this process requires a large protein sample, 
and because SiRCcP.1 is a recombinant protein with in vitro reconstitution of the [4Fe-4S] 
90 
 
cofactor, the method is prone to being non-quantitative. CcP, however, generally gives strong 
signals on pyrolytic edge graphite (PEG) electrodes, making electrochemical measurements 
potentially straightforward. To measure the E°ʹ of the [4Fe-4S]2+/+ pair (presumably the accessible 
redox pair based on prior characterization described above), we deposited EHeme-FeS-SiRCcP.1 
onto PEG electrodes and performed electrochemical sweeps. Cyclic voltammetry (CV) was 
attempted first, but this method yielded signals too weak to be conclusive. We then attempted 
differential pulse voltammetry (DPV), which can produce much greater signal amplitude relative 
to background Faradaic current than CV. DPV measurements were performed with a standard 3-
electrode setup: a Ag/AgCl reference electrode, Pt wire counter, and a PEG working electrode 
polished with alumina powder and sonicated in an acetone/water mixture and cycled repeatedly 
until a clean and stable baseline was obtained. Protein films were deposited on the electrodes under 
anaerobic conditions by dropping 5-10 µL of 0.100 mM protein solution directly onto the electrode 
surface and incubating for 15 min without allowing the film to dry. The protein-treated electrode 
was sealed in a glass vial, removed from the anaerobic chamber, and quickly immersed in 100 mM 
Tris buffer (pH = 7.4) that had been degassed by rigorous sparging with argon. DPV sweeps were 
collected at room temperature with the following parameters: voltage increment = 0.002 V, 





Figure 3.15. DPV of EHeme-FeS-SiRCcP.1 deposited on a PEG electrode. (A) Unprocessed 
measurements showing the working electrode background signal (black) and the protein-
functionalized electrode signals before (red) and after background subtraction (blue). (B) Rescaled 
and background subtracted protein signal. The black arrow indicates the presence of a minor redox 
active species at approx. -0.20 V (NHE). Reported peaks were determined from the 1st derivative 
of the curve. The applied potential is given in terms of an Ag/AgCl reference electrode (+200 mV 
correction to NHE, standardized against ferrocene). 
 
Two redox active species are present in EHeme-FeS-SiRCcP.1 with a major species at -0.474 V 
and a minor species with E°´ = -0.200 V (Fig. 3.15). The potential values are given in terms of the 
normal hydrogen electrode (NHE). The major species is consistent with a low-potential ferredoxin-
like iron-sulfur cluster. The minor species is attributed to [4Fe-4S] decomposition caused by 
exposure to oxygen at the electrode surface. Frequently, a broad peak is present near 0.0 V that is 
attributable to ferrous sulfide; though, this feature was not present in the measurement shown (Fig. 
3.15A). The measured E°ʹ for EHeme-FeS-SiRCcP.1 is 69 mV lower than the E°ʹ of the [4Fe-4S] in 
native SiR. The low E°ʹ of the iron-sulfur cofactor in the SiRCcP.1 model has implications for the 
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effects of E°ʹ on reductase activity for the heme-[4Fe-4S] holo-protein (discussed in further detail 
in Chapters 4 and 7). The effects of secondary sphere mutations on the E°ʹ of [4Fe-4S] in native 
proteins and in SiRCcP are discussed in Chapter 7. As it relates to the initial model SiRCcP.1, 
however, the E°ʹ of the [4Fe-4S] is not only similar to native SiR (being in the range of -0.4 to -
0.5 V), but it is surprisingly of lower midpoint potential. Lowering E°ʹ to less than -0.5 V or raising 
E°ʹ to higher than -0.4 V in SiRCcP, therefore, offers an opportunity to directly study the impact 
on [4Fe-4S] E°ʹ on the reductase activity of SiR from a bottom-up perspective. 
 
3.10. Secondary sphere mutations in the designed [4Fe-4S] binding site 
A critical difference between biosynthetic model scaffolds and their native enzyme 
counterparts is the identity of the residues (and backbone contributions) in the secondary 
coordination sphere (SCS). The latter, while often critical in the case of iron-sulfur species (see 
Chapter 2), are difficult to engineer precisely. The former may be addressed by site directed 
mutagenesis. In the case of SiR, there are two polar sidechains in the SCS that are clearly within 
hydrogen bonding distance of S atoms in the [4Fe-4S]: Thr477 and Asn481 at distances of 3.18 Å 
and 3.54 Å, respectively. Of particular interest in early design phases was N481 due to the similar 
positioning of two residues in CcP, Met172 and Asp235, the latter of which had already been 
flagged for mutation in the design of SiRCcP.1. To address this potentially important SCS 
interaction, Met172Gln (M172Q-SiRCcP.1) and Asp235Asn (SiRCcP.2) mutants were designed 
and purified as with SiRCcP.1. The mutation of Asp235 to more than a single alternate residue led 
to the notation …1 and …2 for the SiRCcP mutants in which the predicating number always 
denotes a change in identity of residue 235. Other mutations are given as an antecedent list 
preceding “SiRCcP”: N1/N2/N3-SiRCcP.j for the j





Figure 3.16. Results of molecular dynamics simulations of two mutations (M172Q and D235N) 
to the [4Fe-4S] second coordination sphere in SiRCcP that were inspired by the 3.54 Å hydrogen 
bonding interaction between residue N481 and the [4Fe-4S] in native SiR. 
 
3.11. Summary 
Mutations were made to yeast hemoprotein cytochrome c peroxidase to create a [4Fe-4S] 
binding site proximal to the native heme binding pocket in an effort to create a structural and 
functional biosynthetic model of the siroheme-[4Fe-4S] catalytic cofactor present in assimilatory 
sulfite reductases. Mutations were designed through a combination of computational and rational 
methods including the Rosetta matcher and enzyme design algorithms, molecular dynamics, and 
visual inspection. The designed mutations were accomplished through Gibson assembly and 
quick-change mutagenesis in a recombinant plasmid, and the mutant proteins were expressed and 
subsequently purified from E. coli. One of the designed models, SiRCcP.1, distinguished from the 
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base model (SiRCcP) by replacing Asp235 with Val, was found to bind an iron-sulfur species that 
was subsequently determined to be a [4Fe-4S] cubane cluster by the combined and concurrent 
results of UV-vis, EPR, Mössbauer, and x-ray absorption spectroscopies. The [4Fe-4S] 
reconstituted SiRCcP.1 has a redox potential that is similar to native [4Fe-4S] ferredoxins while 
being somewhat more negative than the native SiR from E. coli. 
 
3.12. Conclusions 
The biosynthetic model SiRCcP.1 is a viable scaffold for a fully structural and functional 
model of SiR. Every characteristic method of spectroscopy applied from UV-vis and x-ray 
absorption to EPR and Mössbauer spectroscopies support the formation of a [4Fe-4S] cluster in 
SiRCcP.1. The geometry of the cluster determined by EXAFS indicates that all four Fe atoms are 
ligated by a Cys residue, which could only be derived from the designed [4Fe-4S] binding site. It 
is interesting to note that both in native SiR and in the designed SiRCcP.1 model only loosely 
adhere to the classical Cys sequence “C x2 C” motif. In SiR, pairs of Cys residues are separated by 
5 and 12 intervening residues, respectively, with each pair located on different loops separated by 
30 residues. In SiRCcP the sequence is C175 x4 C180 x10 C191 x40 C232, following no obvious pattern 
beyond spatial arrangement. Nevertheless, though this C x2 C motif has been applied successfully 
to engineer [4Fe-4S] into helical maquettes, native ferredoxins typically employ this motif in a 
series of loops, turns, and short helices, so the ability to recapitulate the binding properties of this 
motif in a rigid helical structure imply that either the motif, the protein backbone properties, or 
both are somewhat flexible with respect to their function. The successful creation of a [4Fe-4S] 
binding site in SiRCcP.1 is the first and most crucial step toward engineering a complete structural 
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HEME RECONSTITUTION IN SIRCCP.1: A COMPLETE SIR STRUCTURAL MODEL 
 
The active site of sulfite reductase (SiR) is found in the hemoprotein subunit. In the 
assimilatory SiR (aSiR), there is a single active site composed of two iron-containing prosthetic 
groups: a [4Fe-4S] cluster that is covalently bound to siroheme, an Fe isobacteriochlorin that bears 
eight negatively charged carboxylic acid moieties, by a shared cysteine ligand. While heme and 
iron-sulfur cofactors are found commonly throughout biology, frequently acting together in the 
same electron transport chain, there are very few examples in biology of iron-sulfur clusters that 
are covalently attached to other metal cofactors. The topics of heme and iron-sulfur species in 
biology was discussed in Chapter 2. As a consequence of being covalently coupled together, the 
siroheme and [4Fe-4S] cluster are exchanged coupled, sharing a single electron spin system across 
all five iron atoms, a fact that on its face is clearly important for catalysis, but precisely why such 
a cofactor was selected by nature for a multi-electron reduction reaction and how the coupling of 
the two cofactors (as opposed to simply placing them within electron transfer distance) plays a role 
in that reaction remains to be fully understood. The previous chapter described the design and 
characterization of a [4Fe-4S] binding site in cytochrome c peroxidase (CcP), called SiRCcP.1, 
and this chapter will describe the incorporation of heme into FeS-reconstituted SiRCcP.1 (FeS-
SiRCcP.1) to form a holoprotein with a covalently conjugated heme-[4Fe-4S] cofactor, thereby 






4.1. Features of a thiolate proximal ligand in the sulfite reductase hemoprotein 
The diversity of function in hemoproteins, aside from the structural differences in heme 
environments provided by the protein architecture, is derived in large part by the identity of the 
proximal ligand. The proximal ligand of globins, cytochromes, heme oxygenases, and most 
peroxidases while a Cys thiolate proximal ligand is found in C—H bond cleaving enzymes, such 
as cytochromes P450, for which the heterolytic cleavage of an O—O bond is necessary to generate 
a high-valent iron-oxo species that can abstract a proton from the substrate. The effectiveness of 
the thiolate bond for this mechanism is attributed to the sulfur “push” effect. The electron rich SCys 
pushes additional electron density onto the heme Fe, which in turn creates a more basic oxygen 
that “pulls” at the substrate proton. Discussion of the nature of heme proximal ligands is provided 
in greater depth in Chapter 2. The strong nature of the sulfur “push” comes from the short SCys—
FeHeme bond length (~2.2 Å) that allows a large amount of orbital mixing from the thiolate ligand 
to the heme, as evidenced by the short heme-thiolate bond in cytochrome P450cam1 (Fig. 4.1A). 
The catalytic hemoprotein subunits of sulfite reductase (SiR) also have a proximal Cys thiolate 
ligand on their heme prosthetic groups (siroheme), but this Cys is also a direct ligand to an Fe atom 
of a covalently conjugated [4Fe-4S] cluster. By contrast to the short S—Fe bond in P450cam, the 
heme-thiolate bond between siroheme Fe and Cys483 in SiRHP is significantly longer and weaker 
(Fig. 4.1B), meaning that there is a weaker “push” effect from the proximal ligand in SiR than 
most thiolate ligated hemoproteins, but this weakened push may be compensated for by other 
facets of the siroheme-[4Fe-4S] cofactor that still allow for substantial donation of electron density 
into the bound substrate to weaken the S—O bond. A significant push is thought to be provided 
by the proximal [4Fe-4S], which has a complex influence on the catalytic heme. The immediate 
impact of a second Fe atom ligated to Cys483 is to withdraw electron density from SCys483; 
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however, the Fe atoms of an iron-sulfur cluster are quite electron rich, and particularly in the 
reduced state ([4Fe-4S]+) there is a driving force from the cluster to donate an electron to siroheme. 
The overall effect is at least some degree of weakening of the S—O bond in bound sulfite. 
 
 
Figure 4.1. Heme proximal ligand sites of (A) cytochrome P450cam and (B) SiRHP. The short 
heme-thiolate bond in P450cam provides a strong push of electron density from the sulfur atom, 
and in the ferric form (shown) there is obvious doming of the electron-rich heme Fe. The thiolate 
bond in SiRHP is 0.2 Å longer than P450cam while the SCys483—Fe[4Fe-4S] bond is similar to the 
other cluster-ligating Cys residues. The saddled geometry of siroheme enforced by the SiRHP 
scaffold and siroheme structure keeps the siroheme Fe in-plane with the macrocycle in both the 
ferrous and ferric states. 
 
The functionality of the siroheme-[4Fe-4S] cofactor is more complex than the heme thiolate 
interaction. A large body of evidence has been collected on both plant and bacterial SiR that 
definitively demonstrated exchange coupling between the siroheme and [4Fe-4S] iron centers such 
that the spin states of the two cofactors behave as a single 5-Fe center. Analysis of low-
temperature, zero-field Mössbauer spectra of fully oxidized, one-electron reduced, and two-
electron fully reduced SiRHP found that, while the first electron is essentially accommodated by 
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siroheme and the second essentially by the [4Fe-4S], the spin states of all 5 Fe atoms are found to 
change. In the ligand-free ferric state, siroheme is a high-spin S=5/2 system and becomes a high-
spin (S = 1 or S = 2) system with the addition of one electron. Addition of a second electron 
changed the S = 0 [4Fe-4S]2+ species to as classically S = ½ [4Fe-4S]+ species, all of which have 
been observed in the EPR spectra of purified SiRHP2. In addition to these classical species, 
additional species centered at g ~ 5 and g = 2.29 appear as the enzyme acquires the first electron2–
4. Though initially these spectra seemed to correspond to S = 3/2 species arising from anti-
ferromagnetic spin coupling between the high-spin ferrous siroheme and S = ½ [4Fe-4S]+, this 
interpretation was inconsistent with Mössbauer spectra of the enzyme in all three oxidation states, 
for which the magnetic hyperfine coupling interactions are all the same. What was observed as 
electrons entered the enzyme was a bizarre interaction between the two irons systems: acquisition 
of one electron caused a shift from paramagnetic siroheme and diamagnetic [4Fe-4S]2+ to a fully 
diamagnetic siroheme-[4Fe-4S] cofactor (from a Kramer’s to a non-Kramer’s system with no 
unpaired electrons), but addition of a second electron to create the fully reduced enzyme results in 
a transition for all five Fe atoms back to a Kramer’s system despite EPR and optical evidence of a 
S = 1 or S = 2 ferrous siroheme5–7. This observation along with experiments with strong-field 
ligands added to siroheme (CN-, CO, and S2-) confirmed that the two cofactors are exchanged 
coupled. Janick and Siegel postulated that the source of the coupling is not a dipolar interaction 
(supported by the observation that spin exchange persists even when the [4Fe-4S] is oxidized, S = 
0) but born of weak interactions between individual iron sites in the [4Fe-4S] cluster and siroheme 
Fe beside the normal, strong antiferromagnetic exchange interactions between the Fe sites within 
the [4Fe-4S]5. In the ground state, this is an antiferromagnetic interaction, but the siroheme-[4Fe-
4S] interaction can be switched to ferromagnetic coupling in the presence of an S2- ligand bound 
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to siroheme, changing the Fe configuration to low-spin, leaving the siroheme Fe with fewer 
unpaired electrons8. Furthermore, it was concluded from analysis of Mössbauer data collected on 
SiRHP in the presence of guanidinium sulfate (which stabilizes the g = 2.29 species of fully 
reduced SiRHP) that the siroheme Fe is in a high spin (S = 2) state when both cofactors are fully 
reduced but that it most likely adopts an “intermediate” high spin ferrous state (S = 1) when only 
one electron enters the system. The g = 2.29 and g ~ 5 species are purely results of weak exchange 
coupling between the siroheme and [4Fe-4S] cofactors and not S = 3/2 species8. The thorough 
work of spectroscopists to identify the nature of the siroheme-[4Fe-4S] ten years before a crystal 
structure became available is evidence of the unique nature of this cofactor: the siroheme-[4Fe-
4S] cofactor behaves like a 5-Fe system, and the properties of the ligand bound to siroheme affect 
the properties of the iron-sulfur cluster, such as the redox potential difference between the two 





Figure 4.2. Characteristic spectra of the E. coli aSiR hemoprotein (SiRHP). Upper left panel: UV-
visible absorption spectra of SiRHP photoreduced by deazaflavin and EDTA. Two sets of 
isosbestic points (A, B) are associated with the first and second electron reduction, respectively. 
The peak at 628 nm is characteristic of an isobacteriochlorin (reprinted with permission from 
reference2). Lower left panel: X-band CW EPR spectra of photoreduced samples of SiRHP. The 
lower inset shows the emergence of a “g ~ 5” species associated with weak exchange coupling 
between high-spin ferrous siroheme and the [4Fe-4S] cluster (reprinted with permission from 
reference2). Upper and lower right panels: high temperature zero-field (140 K, upper panel) and 
low-temperature (4.2 K, lower panel) Mössbauer spectra of the one-electron reduced SiRHP 
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Figure 4.2 (cont.) (upper panel) and the two-electron reduced SiRHP with (A) weak transverse 
field (60 mT), (B) weak parallel field (60 mT), and (C) strong parallel field (6 T) (lower panel7). 
The siroheme isomer shift between the 1- and 2- electron reduced states is essentially the same, 
but the quadrupolar splitting increases from 0.72 mm/s to 0.9 mm/s, indicating a change in the 
bonding characteristics of the siroheme Fe when the [4Fe-4S] acquires an electron. Reprinted with 
permission from7. 
 
The hemoprotein characteristics of CcP are typical of heme peroxidases. CcP binds the most 
commonly utilized heme in biology, protoporphyrin IX (PPIX), or heme b. In the ferric state at 
neutral pH, the Soret maximum is 408 nm, and CcP exhibits optical and electron paramagnetic 
features associated with high-spin ferriheme when freshly prepared and gradually taking on more 
low-spin characteristics over time, presumably by the acquisition of an endogenous sixth ligand in 
the heme distal site10. CcP in the ferrous state undergoes a neutral/high-pH transition of the Soret 
maximum from ~440 nm at pH < 6.5 to a 425 nm Soret maximum above neutral pH11. Like most 
other peroxidases, CcP (and SiRCcP mutants) is obtained primarily as heme-free apo-protein that 
can be reconstituted to the hemoprotein by addition of excess hemin (3-5 molar equivalents) 
dissolved in a minimal volume of hydroxide or dimethyl sulfoxide (DMSO). The excess hemin 
may be removed by binding and elution of CcP to an anion exchange column packed with DEAE 
Sephadex resin, to which the excess hemin remains irreversibly bound. The methods have been 
described extensively previously and modified slightly for use in the Lu lab12. A variant of CcP 
was designed that replaced the heme proximal ligand (His175) with a Cys, and it was also found 
that a replacement of the nearby charged residue Asp235 with Leu was necessary to achieve a 
heme-thiolate bond. With a heme-thiolate Cys175, the Soret maximum of H175C-CcP shifted 
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higher in energy to 392 nm, indicating the formation of a high-spin, ferric thiolate-ligated heme, 
and the g-values of the ferric heme-CN- complex were nearly identical to the closely-spaced low-
spin features of native cyanide-bound P450cam as well as reduced cyanide binding affinity in the 
ferric state associated with thiolate ligation13. These studies demonstrated that, with suitable 
modifications, CcP could be made to accommodate a heme thiolate linkage. The following sections 
will detail the reconstitution and characterization of the SiRCcP.1 hemoprotein as well as its 
relevance as a biosynthetic model of SiR. 
 
4.2. Heme-b binding in SiRCcP.1 by in vitro reconstitution and spectral characterization 
Hemoprotein and holo-protein were reconstituted by adding to FeS- or apo-protein, 
respectively, sub-equivalents of hemin (10 mM, prepared anaerobically by first dissolving in a 
minimal volume of 0.100 M KOH and subsequent dilution with water). Heme was added slowly 
in sub-equivalents until saturation of the Soret peak (approx. 3.5 molar equivalents). Excess heme 
was removed by passage through a thin layer of DEAE beads and elution with 250 mM KCl 
followed by passage through a PD10 column to lower the concentration of KCl. The heme Soret 
peak extinction coefficient was determined by the pyridine hemochrome assay14 to yield ε382 nm = 
108.1 mM-1 cm-1 for SiRCcP.1. The Soret extinction coefficient (98 mM-1 cm-1 at 408 nm)10 of in 
vitro heme-reconstituted native CcP was referenced as a control. Reconstituted metalloproteins 
were concentrated and temporarily stored anaerobically at 4°C. Photoreduced samples were 
prepared anaerobically and sealed with a Teflon cap inside a 0.1 cm path length quartz cuvette or 
by a stop-cock in a glass kinetics cuvette (5 mL) with a small magnetic stir bar for even light 
exposure. Photoreduction was achieved by exposure for 30-60s intervals to a broad-spectrum 
xenon arc lamp at a power of 100 W. Samples were prepared in phosphate buffer (100 mM, pH = 
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7.0) with 10-20 µM proflavine (Pfl) as a photosensitizer and 10 mM ethylenediaminetetraacetic 
acid (EDTA), triethanolamine (TEOA), or reduced nicotinamide adenine dinucleotide (NADH) as 
the sacrificial reductant. Samples were protected from ambient light before exposure to the xenon 
lamp. The absorption spectrum of the sample was measured immediately following light exposure 
at the specified time intervals. 
The heme absorption spectrum completely obscures the broad absorption from the [4Fe-4S]; 
therefore, to monitor the reconstitution of the FeS protein, hemoprotein reconstitution was always 
performed following FeS reconstitution and clean up. Attempts to reconstitute the [4Fe-4S] in 
hemoprotein routine led to significant heme loss on the anion exchange column, likely due to 
proximal bond destabilization by the high concentration of sulfide. Excess heme was not 
effectively removed by gel filtration chromatography only. Elemental analysis of Heme-FeS-
SiRCcP.1 by ion-coupled plasma mass spectrometry yielded 5.54 Fe per heme, confirming that 
the [4Fe-4S] remains intact following heme reconstitution. The various features of heme 
reconstituted FeS-SiRCcP.1 (hereafter Heme-FeS-SiRCcP.1) are shown in Figure 4.3. The Soret 
band of Heme-FeS-SiRCcP.1 is substantially blue-shifted to 382 nm relative to the 408 nm of WT-
CcP, an additional 10 nm blue shift compared to H175C-CcP, but remarkably close to the blue-
shifted Soret band of SiRHP (384-388 nm)2,3. Reduction by titration with sodium dithionite could 
only achieve a split Soret spectrum comprising a mixture of oxidized and reduced enzyme as well 
as a visible spectrum consistent with the ferrous enzyme in the presence of an excess of sulfite. 
Generation of the ferrous enzyme by photoreduction, however, gave a single reduced species that 
with isosbestic points associated with the heme transition from the ferric to ferrous oxidation state 





Figure 4.3. Electronic absorption spectra of Heme-FeS-SiRCcP.1. (A) Spectra and estimated 
extinction coefficients for the apo-protein (black trace), FeS-protein (magenta trace), and heme-
FeS-protein (cyan trace) in the fully oxidized states, as prepared. (B) Reduction of the fully 
oxidized heme-FeS protein by sodium dithionite yields an increase in absorption at 418 nm (red 
arrow) but does not saturate until far greater than 100 equivalents of dithionite have been added. 
Only a few equivalents of dithionite are required to reduce the FeS-protein, and WT-CcP requires 
only 1-2 equivalents. As with native SiRHP, the mixed oxidation state may be attributable to a 
partial turnover complex with bound sulfite as a result of dithionite decomposition. (C) Fully 
reduced protein may be obtained by time-dependent photoreduction with a proflavine 
photosensitizer. Isosbestic points are indicated by black horizontal arrows, and blue and red arrows 
denote the decrease in ferric heme absorption and decrease in ferrous heme absorption, 
respectively. 
 
The behavior of the electronic absorption spectra of Heme-FeS-SiRCcP.1in the presence of 
various ligands is shown in Figure 4.4. Notably, Heme3+-FeS2+-SiRCcP.1 has low affinity for 
cyanide anion (CN-), requiring ~2000 equivalents, which is expected (though to a lesser degree) 
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from thiolate ligated heme, whereas 1e- reduced Heme2+-FeS2+-SiRCcP.1 rapidly binds ~1 
equivalent of CN-. This behavior has been reported for SiR9 but not most other hemoproteins, 
including CcP, suggesting that our designed SiRCcP.1 substantially alters the heme character of 
the native scaffold protein without altering heme chemical structure. Several explanations are 
plausible for this effect as seen in both SiRHP and SiRCcP.1: the presence of the positively charged 
[4Fe-4S] could screen the increased negative charge in ferrous heme that tends to weaken the 
CN—Fe2+ interaction in hemoproteins, but high CN- affinity only in the ferrous protein was also 
encountered in Heme2+-SiRCcP.1 with no reconstituted [4Fe-4S]. Therefore, local electrostatic 
effects, perhaps related to removal of the proximal His-Asp-Trp peroxidase triad in SiRCcP.1 or 
changes in heme conformation that impact σ acceptance and π back-donation must also play a 
role15–17 in ligand affinity. 
A high concentration of sulfite produces a spectrum identical to the spectrum obtained from 
reduction of the hemoprotein with sodium dithionite. Both cyanide anion and sulfide were capable 
of displacing sulfite from the dithionite reduced protein in quantities of only a few equivalents, 
yielding the spectra for the CN-- and S2--bound species in Figure 4.4. Both cyanide and sulfide 
could be easily removed from the hemoprotein by first oxidizing the protein back to the heme 
ferric state followed by passage through a small (PD-10) gel filtration column. Taken together, the 






Figure 4.4. Ferrous heme-FeS-SiRCcP.1 in the presence of various small ligands. 
 
Samples of Heme-FeS-SiRCcP in the fully-oxidized and fully reduced states were examined 
by EPR spectroscopy (samples prepared as described in Chapter 3), but the samples universally 
displayed EPR spectra of multiple low-spin species and a minority of high-spin heme instead of 
the high-spin state suggested by the electronic absorption spectra. Freezing and aging-induced 
conformational changes reported for WT-CcP as described above likely play some role in the 
transition to low-spin in the EPR spectra; however, it is also probable that the protein can assume 
multiple conformations. Though SiRCcP.1 is stable both as apo-protein and with both of its 
cofactors reconstituted, six mutations in a small region is a large number for most proteins. With 
the set of residues responsible for a conserved hydrogen bonding network in the proximal heme 
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cavity (His175, Trp191, and Asp235) all mutated in SiRCcP.1, even ligated heme may be free to 
assume multiple conformations in the binding pocket, leading to line broadening and multiple 
observed low-spin states. When the samples were prepared with an excess of cyanide (1-5 mM), 
heme homogeneity was largely overcome, indicating that the heterogeneity is probably largely 
determined by multiple 6th ligands or conformations in a weakly hexacoordinate state. 
The X-band CW EPR spectra of Heme-FeS-SiRCcP.1-CN are given in Figure 4.5. The EPR 
spectra of the cyanide-bound holoprotein contain features that are consistent with both thiolate 
ligation and a fully reconstituted heme-[4Fe-4S] cofactor. The g-values of the ferric hemoprotein 
(Heme3+-FeS2+-SiRCcP.1-CN, gx = 2.45, gy = 2.26, gz = 1.87) are closely spaced and similar to the 
ferric-cyano low-spin EPR spectra cytochromes P450. Two electron reduction yields only the “g 
= 1.94” spectrum of the [4Fe-4S]+ cluster; though, in this case gy = 1.94 precisely, a slight 
downfield shift from the FeS-SiRCcP.1 without heme reconstitution, indicating a perturbation to 
the [4Fe-4S] environment. Presence of the characteristic [4Fe-4S]+ feature is a reaffirmation of the 
retention of the iron-sulfur cluster following heme reconstitution. The peculiar g = 2.29 and g = 
4.88 features of native SiRHP are absent in the cyanide-bound form, and the behavior of the native 
SiR is identical to the behavior of SiRCcP.1, which is not surprising as both proteins are forced 
into the S = ½ low-spin ferric state in the presence of the strong-field ligand, and then to the S = 0 
EPR-silent state upon addition of one electron. Only upon addition of the second electron do the 





Figure 4.5. X-band CW EPR and Mössbauer spectra of Heme-FeS-SiRCcP.1. The EPR spectra 
(left) were obtained in a homogenous low-spin state by addition of ~5 mM potassium cyanide. The 
ferric hemoprotein (Heme3+-FeS-SiRCcP.1-CN) (cyan) shows features of a S = ½ low-spin heme-
cyano complex that upon reduction (orange) is completely silenced to an S = 0 spin state. The g = 
1.94 spectrum of the reduced [4Fe-4S]+ cluster emerges simultaneously with heme reduction. EPR 
spectra were measured at 18 K with a microwave power of 10 mW at a frequency of 9.24 GHz. 
Low-temperature Mössbauer spectra at various applied field strength collected on 57Fe-
reconstituted Heme-FeS-SiRCcP.1 (center and right panels) prepared by photoreduction show a 
mixture of ferric and ferrous heme species. The spectra in (A) is 50% composed of ferric heme, 
simulated in the red trace, with the remained being a 4:1 ratio of two indistinguishable [4Fe-4S]2+ 
states and ferrous heme (S = 2). Panel (B) shows the spectrum, composed of three sites, with the 
ferric component subtracted. 
 
Mössbauer spectra were collected on Heme-FeS-SiRCcP.1 prepared by photoreduction until 
no further changes to the hemoprotein were observed. Isotopically enriched 57Fe heme and 
ammonium ferrous sulfate (prepared from 57Fe powder dissolved in < 1 M sulfuric acid and slowly 
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diluted with an equimolar quantity of ammonium sulfate under continuous Ar flow; the resulting 
pale yellow/green solution was cooled and allowed to rest until large, translucent green crystals 
formed) was used so that both cofactors were Mössbauer active. Unlike the EPR spectra, the 
Mössbauer spectra definitively contained only high-spin heme Fe; however, the majority species 
was found to be ferric heme with broad features. The ferric heme, which was completely absent 
from the spectrum of the photoreduced sample, could have developed during sample shipment or 
otherwise as a result of excess heme loosely associated with the protein. The remainder of the 
sample was composed of ferrous heme (Site I), simulated as S = 2, but whether the species is S = 
1 or S = 2 could not be definitively assigned, and two indistinguishable iron sites (Site II and Site 
III) associated with an oxidized [4Fe-4S]2+. The isomer shift (δ) of Site I (δFe = 0.95 mm/s) is on 
the higher end of typical for ferrous high-spin heme species and much larger than for siroheme in 
SiRHP, but the δFe = 0.45-65 mm/s reported for siroheme in SiRHP is much smaller than is typical 
of porphyrins and is likely characteristic of isobacteriochlorins. Both Sites II and III had isomer 
shifts of δFe = 0.55 mm/s and quadrupolar splitting of ΔEQ = -1.45 mm/s, both of which are 
somewhat larger than usual for [4Fe-4S]2+ and both larger than in SiRHP. 
Importantly, the isomer shifts for the two indistinguishable Fe Sites in Heme-FeS-SiRCcP.1 
differ from the two sites identified in the [4Fe-4S]2+ of FeS-SiRCcP.1 (lacking heme), indicating 
that though heme binding and reduction does not change the oxidation state of the [4Fe-4S], as 
with native SiRHP, heme binding does change ligand environment such that the two Fe Sites unify 
into a single species. This effect is consistent with conformational stability induced by heme 
binding, as might be expected for a native heme-binding protein. What the state of the [4Fe-4S] is 
in native SiR without siroheme is unknown and, as of yet, has not been investigated. Despite the 
overabundance of inexplicable ferric heme, the remainder of the heme:[4Fe-4S] species were 
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present in an essentially 1:4 ratio, the ideal for a heme-[4Fe-4S] system, and a reaffirmation of the 
ICP-MS and EPR data. The degree of coupling between the two cofactors could not be determined 
from these experiments due to broadening from multiple heme species, but with the ferric heme 
component subtracted, the remaining Heme2+-[4Fe-4S]2+ species most likely corresponds to the 
one-electron reduced state of SiRHP. The mysterious presence of ferric hemoprotein as well as 
other samples examined simultaneous that contained a large proportion of ferric iron suggest that 
many of the samples may have become oxidized either in transport or during freezing, at least 
partially oxidizing any of the two-electron reduced species, if present. 
 
4.3. Reconstitution of SiRCcP.1 with siroheme analogues 
The structure of the “heme” prosthetic group in SiR differs from heme b, the native Fe 
macrocycle of CcP, in several respects. Every edge carbon of the pyrroline rings has either a 
propionic or acetic acid group, six more negative charges than PPIX, and two pyrroline rings are 
saturated with the addition of a methyl group at the base of the propionic acid and hydrogen at the 
base of the acetic acid moieties, the ring structure of an isobacteriochlorin. The close structural 
relative, bacteriochlorin, differs only in that the rings are trans with respect to the central Fe atom 
instead of cis, and chlorins have a single saturated pyrrole ring. Like PPIX, the electronic properties 
of chlorins are strongly influenced by the geometric structure of the macrocycle. Both 
bacteriochlorin and isobacteriochlorin can distort significantly from planarity, and 
isobacteriochlorin in particular prefers a saddled geometry while bacteriochlorin prefers a bent 
geometry. Additionally, isobacteriochlorins are considerably easier to oxidize than porphyrins and 
chlorins, in that order, but more difficult to oxidize than bacteriochlorins18. The ease of oxidation 
of isobacteriochlorins led to a proposed hypothesis that a ring-abstracted π-cation radical may be 
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involved in the catalytic cycle of SiR, but no direct evidence of this mechanism has been observed. 
Considering the abundance of porphyrin and chlorin derivatives found in nature, it remains an 
open question why Fe-sirohydrochlorin (siroheme) was selected as the active catalyst in such a 
unique cofactor as the 5-Fe cofactor in SiR. If heme ring oxidation is not required for the 
mechanism (and the associated higher energy HOMO), why select a heme for which the ring is 
potentially more easily oxidized than the Fe2+/3+ transition? The saddled geometry of siroheme is 
clearly supported by the protein scaffold through strategically located hydrogen bonds, yet heme 
saddling has an ensemble effect that is difficult to tease apart: saddling affects the degree of Fe in-
plane and out-of-plane positioning, which in turn affects the SCys—Fe proximal bond length and 
the electron density on the heme Fe. 
 
 
Figure 4.6. Structures of heme macrocycles 
 
Due to the eight negative charges of siroheme and the finely-tuned charge balance in the native 
SiR active site, replacement of siroheme with other chlorins would be quite disruptive to the active 
site, potentially perturbing more than just the ring structure. The biosynthetic model SiRCcP.1, 
however, can easily accommodate siroheme mimics that are structurally similar to PPIX with 
115 
 
minimal perturbation to the active site with the ultimate goal of using SiRCcP directly to study the 
role of heme ring structure, position, and saturation on SiR catalysis. Toward this goal, a simple 
chlorin analogue of PPIX was reconstituted in SiRCcP.1 instead of heme b, chlorin e4 (Figs. 4.6 
and 4.7). Iron was inserted into chlorin e4 (Fe-Ce4), and the heme analogue was titrated into 
SiRCcP.1 by the same method as heme b, and Fe-Ce4 incorporation was completed with the 
addition of two molar equivalents, yielding a vividly green species (Fig. 4.7D, inset). Removal of 
excess Fe-Ce4 was easily accomplished by using a small gel-filtration column. Incorporation of 
Fe-Ce4 into the protein matrix was easily tracked spectroscopically by the distinct absorption peak 
at 640 nm, a stark contrast from the two peaks present in the free Fe-Ce4 at 590 nm and 690 nm, 
and a red shift in the Soret maximum from 393 nm in the free Fe-Ce4 to the protein-ligated peak 
at 417 nm. Reconstitution of SiRCcP.1 with Fe-Ce4, a chlorin whose structure differs from heme 
b only by the location of one carbon atom, demonstrates the facile nature of heme substitution in 
the SiRCcP model, allowing for the iterative and individual investigation of specific aspects of 
heme structure on the electronic and functional properties of SiR. 
 
Figure 4.7. Electronic absorption spectra associated with reconstitution of SiRCcP.1 with Fe(III)-
chlorin e4 (Fe-Ce4). (A) Reconstitution of apo-SiRCcP.1 with sub-equivalents of Fe-Ce4, 
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Figure 4.7 (cont.) beginning from the black trace toward the final bright green trace after removal 
of excess Fe-Ce4 by a mini gel filtration column. (B) Scatter plot of the increase in the Soret band 
vs 280 absorption of the solution as Fe-Ce4 was added. Black lines indicate the two rates at which 
the ratio changed, and their intersection was taken to be the saturation point (~1.8 equivalents). 
(C) Absorption spectrum of free Fe-Ce4. (D) Comparison of the absorption spectra of SiRCcP.1 
reconstituted with heme b (red) and Fe-Ce4 (green). The visual difference between the two species 
is shown in the inset photograph. 
 
4.4. Summary 
The native heme cofactor of CcP, heme b was reconstituted SiRCcP.1 that had previously been 
reconstituted with a [4Fe-4S] cluster to create a heme-[4Fe-4S] model of sulfite reductase. 
Electronic absorption, EPR, and Mössbauer spectra all describe a metalloprotein with two Fe 
cofactors with the heme:[4Fe-4S] abundance found in the ideal 1:4 ratio. The optical absorption 
spectra indicate a thiolate ligated heme, and the EPR spectra of the cyanide-bound heme-[4Fe-4S] 
protein demonstrate that the [4Fe-4S] is retained following heme reconstitution. Mössbauer isomer 
shifts of one-electron reduced holoprotein are consistent with high-spin ferrous heme and an 
oxidized [4Fe-4S], similar to the state of native SiRHP reduced by one electron. Though SiRCcP.1 
can be reconstituted to the heme-[4Fe-4S] cofactor using the native heme b of CcP, it is possible 
to reconstitute SiRCcP.1 with siroheme analogues such as chlorin e4 to systematically examine the 







It has long been assumed, reasonably, that siroheme—an isobacteriochlorin with electronic 
structure that differs significantly from protoporphyrin—is necessary for efficient sulfite reduction 
in a protein by a heme macrocycle since siroheme has been rigorously conserved in aSiR. 
However, this paradigm has been challenged by the recent characterization of the heme/non-heme 
Cu multi-cytochrome c SiR (see Chapter 6) that accomplishes extremely efficient dissimilatory 
sulfite reduction with heme c, a protoporphyrin heme instead of an isobacteriochlorin. With the 
aid of a biosynthetic model, it is possible to test this paradigm in a modular protein scaffold to 
determine which specific factors surrounding the catalytic heme and even the structure of the heme 
itself are necessary and sufficient to impart sulfite reduction catalysis. Toward this goal, SiRCcP.1 
has been shown to be an appropriate structural model of classical siroheme-[4Fe-4S] SiR by the 
full reconstitution of the heme-[4Fe-4S] cofactor of the native SiR active site. It was unclear at the 
outset, purely from a design perspective, whether simply depositing an iron-sulfur cluster 
proximate to heme in protein scaffold would elicit characteristic features of a native SiR. In part, 
the success of this process is due directly to the careful selection of the peroxidase scaffold as a 
reasonable spatial analogue of the SiR cofactor cavity. However, it is never clear that structural 
mimicry of a protein will yield a similar model due to the large number of subtle structural features 
that can combine to influence the binding and geometry of a metal center. It is fortuitous that, in 
this case, it would seem that association between the two cofactors may be largely due to 
proximity, an observation that hints at the possible path followed by the ancient SiR enzyme from 
disparate heme and iron-sulfur binding sites toward the finely tuned, uniquely coupled cofactor at 
the center of sulfate metabolism. The following chapter will discuss the prospect of transforming 
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the SiRCcP.1 structural model into a functional model and begin to explore the minimally 
necessary structural elements to achieve catalysis in this highly complex metallocofactor. 
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SULFITE REDUCTION ACTIVITY IN SIRCCP 
 
The most important milestone for any biosynthetic model of a natural enzyme is the 
demonstration of native activity. Successful biosynthetic models of heme copper oxidase in sperm 
whale myoglobin (Mb) such as CuBMb
1 have shown that a bottom-up design to recreate a 
metalloprotein active center combined with fine-grained investigations of the nature of the metal 
cofactors can dramatically improve native activity and provide in-depth mechanistic insights2–5 
and even explore the metallocofactor space beyond the native enzyme by substitution of non-native 
metals6. The CuBMb model was able to achieve activity comparable to one form of native terminal 
oxidase and even exceed the activity of native oxidases when conjugated to a gold electrode7. 
These engineering successes were not achieved merely by recapitulating the basic structure of the 
metallocofactor binding site; indeed, in all initial models where the structural modeling reached 
only so far as to achieve metal binding, the models were essentially non-functional. The path to a 
functional model in these cases required the inclusion of certain amino acid residues from the 
native protein that modulate activity. In the case of CuBMb, it was necessary to include an active 
site Tyr residue (F33Y or G65Y) to dramatically increase oxidase activity and product conversion 
efficiency to within two orders of magnitude of a native oxidase8. In the case of biosynthetic 
models in cytochrome c peroxidase (CcP), it was found that oxidation activity of a model 
manganese peroxidase (MnP) designed in CcP (called MnCcP) could be directly influenced by the 
presence of specific hydrogen bonds or hydrophobic sidechains that modulated both substrate 
affinity and the rate of catalysis9,10. This chapter will describe the engineering efforts and successes 
toward generating a CcP mutant capable of significant sulfite reduction activity through rational 
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design of residues that coordinate the substrate (sulfite) and by rational tuning of the second 
coordination sphere of the iron cofactors. 
 
5.1 Sulfite reduction activity in native sulfite reductase 
Though multiple biological and artificial systems are capable of reducing oxyanions including 
nitrate, arsenate, and perchlorate, the only enzymes in nature known to reduce sulfite are two 
classes of sulfite reductase (SiR): the siroheme-[4Fe-4S] sulfite reductases, which are further 
subdivided into assimilatory and dissimilatory subclasses, and the recently characterized heme-
copper octaheme sulfite reductase.11,12 The assimilatory SiR (aSiR), which belong to pathways in 
bacteria and plants that incorporate sulfur into biomolecules such as L-cysteine from sulfate, are 
distinguished from dissimilatory SiR by their capacity for nearly perfect conversion of substrate, 
sulfite (HSO3
- under physiological conditions), to product, sulfide (HS- under physiological 
conditions). Dissimilatory SiR (dSiR) are part of the sulfate respiration pathway in anaerobic 
bacteria, wherein sulfate serves as the terminal electron acceptor instead of molecular oxygen. The 
energetics of bacteria sulfate respiration are discussed at greater length in Chapter 2. The dSiR 
have been observed to expend a significant portion of their electron flux in vitro on the production 
of side products including trithionate (S3O4
2-) and thiosulfate (S2O3
2-) by reaction of soluble sulfite 
with presumed SII and S0 heme-bound reduced intermediates13–16 (see Chapter 2). These side 
products, however, may be physiologically productive as well because they also provide free 
energy for ATP production in their own cyclic redox pathway (see Fig 2.1), bolstered by the 






Figure 5.1.  Proposed mechanism of sulfite reduction performed by SiRHP from E. coli (Reprinted 
with permission from reference18). Many of the proposed steps in this mechanism are inferred from 
crystal structures obtained of SiRHP bound to various substrates that potentially mimic the 
geometry of presumed intermediates in the reduction pathway as well as the positions of 
crystallographic waters18,19. 
 
As was discussed extensively in Chapter 2, the reduction potential, electronic, and magnetic 
properties of [4Fe-4S] centers are modulated in ferredoxin-like domains mainly by NH‧‧‧S 
hydrogen bonding that controls the degree of electron density localized to sulfur atoms; however, 
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polarity of the binding cavity, solvent accessibility, and geometric distortion can all play parts in 
tuning the redox potential (and thereby the driving force for electron transfer) of a [4Fe-4S] center. 
The unique case of the coupled siroheme-[4Fe-4S] cofactor in SiR (see Chapter 2) makes the 
assessment of electron localization—whether on [4Fe-4S] iron and sulfur atoms, the siroheme Fe 
atom, or the siroheme ring—significantly more complex to assign and interpret. However, as with 
any protein for which the three-dimensional structure has been determined, the positions of 
residues in the primary and secondary coordination spheres are a good place to begin when 
determining which components constitute the minimal interacting residues and which are involved 
in fine-tuning reactivity and substrate selectivity; vide infra. 
The reductase activity of SiR has been measured by a variety of techniques but always—and 
by necessity—under anaerobic conditions. The most detailed reaction mechanism yet proposed is 
based on crystallographic evidence of substrate-, intermediate-, and inhibitor-bound aSiR (Fig. 
5.1)18–20. A loop closure event is also hypothesized to take place following substrate binding and 
may explain the role of the conserved Asn149 in aSiR18,19. The generally accepted mechanism 
involves sequential transfer of two electrons to the substrate through siroheme that is coupled to 
protonation and dehydration of the substrate. Some evidence exists, however, of the possibility of 
single electron transfer at certain stages of the mechanism from the presence of a trapped NO 
intermediate, and at least one stable SO2
x intermediate of indeterminate oxidation state has been 
observed in the case of an electron-limited reaction19,21,22. Protonation is presumed to be mediated 
by the basic residues that line the substrate binding pocket and/or by water molecules that are 
positioned within hydrogen bonding distance of the substrate. Three residues in particular, R153, 
K215, and K217, severely reduce activity or the proportion of sulfide generated as the final 
product19; the nearby R83 is important for siroheme binding18. A series of crystal structures of 
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SiRHP obtained with siroheme-bound sulfite, a sulfur species that is partially oxidized (SX), and 
analogues of potential intermediates revealed that residues K215 and R153 undergo 
conformational changes that depend on the substrate geometry while K217 is relatively static19 
(Fig. 5.2). The number and position of waters trapped in the active site also rearrange based on 
substrate geometry. It is these structures and the stable position of a buried water molecule near 
K217 that have supported the inclusion of water as a direct proton source and the possibility of 
single proton/electron transfer events. 
 
 
Figure 5.2. X-ray crystal structures of SiRHP in with different substrates and inhibitors bound to 
siroheme in the enzyme active site obtained by soaking crystals in high concentrations of the 
respective chemicals. (A, PDB: 2gep) sulfite binds to siroheme by its sulfur atom and is 
coordinated by K215, K217, and R153. Two water molecules are coordinated by K215 and K217, 
respectively. The latter water molecule persists regardless of the substrate with the K215- 
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Figure 5.2 (cont.) -associated water is lost. (B, PDB: 3geo) with bound nitrite, both R153 and 
K215 reorient, but with bound NO (C, PDB: 6gep) two conformers of R153 are observed. Similar 
conformations for K215 were observed for both the partially reduced SX species (D, PDB: 7gep) 
and sulfite while similar conformations of R153 were observed for nitrite, SX, and the 
perpendicularly bound CN- (E, PDB: 7gep). 
 
The most widely adopted assay to measure SiR activity in vitro is to monitor the rate of 
oxidation of the small molecule electron donor methyl viologen in its mono-cation reduced state 
(MV•+). The reduced mediator has been generated by exposure to Pt/asbestos, by bulk electrolysis, 
photoreduction mediated by flavin and a sacrificial electron donor such as ethylenediamine-
tetraacetic acid (EDTA), or by chemical reduction by compounds such as Cr(II)-EDTA or 
dithionite (H2S2O4). SiR can be completely reduced by dithionite directly; however, the generation 
of the actively reducing radical species is slow, and a biproduct of dithionite decomposition is 
sulfite (SO3
2-). While the use of MV•+ as a mediator does dramatically increase the rate of electron 
transfer to the enzyme, assays using dithionite as an initial electron source can only be conducted 
under conditions of substrate saturation (typical as 1 mM of sodium sulfite). Activity at saturation 
for various aSiR and dSiR is given in Table 5.123–27. 
Product analysis of SiR has typically been performed either through quantification of HS- by 
nucleophilic attack against N,N-dimethyl-p-phenylenediamine (DMPD) in the presence of ferric 
iron to form methylene blue, an assay that is relatively insensitive to the less nucleophilic sulfur 
oxyanions28. Alternatively, because the methylene blue assay is known to suffer from interference 
by decomposition products of the commonly used reductant dithionite, radio labeling with 35S has 
been used to quantify sulfide produced by SiR in end-point assays24. For assays of dSiR, side 
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products of incomplete reduction such as trithionate and thiosulfate may be quantified through 
cold cyanolysis of sulfur to generate thiocyanate29. 
 
Table 5.1.  Saturation activity for sulfite reduction of representative sulfite reductases. 
Enzyme Activity Reference 
E. coli SiRHP 2600a, 1320±70a 
 
24, 19 
Spinach SiR 10.3b 
 
23 






D. desulfuricans dSiR 7d 
 
26 
D. vulgaris (Hildenborough) 18.6c 
 
27 




5.2 Sulfite reduction activity in SiRCcP.1 
Measurements of sulfite reduction activity in the engineered SiRCcP models were conducted 
by the method of MV•+ oxidation described above under conditions of substrate saturation25. 
Assays were conducted in phosphate buffer (100 mM, pH = 7.0) in the presence of 0.2-1.0 mM 
sodium sulfite and 0.2 mM or 2 mM methyl viologen dichloride (MV2+) to a final volume of 1 mL. 
The MV2+, acting as an electron donor, was first reduced by rapid addition of a 100 mM solution 
of sodium dithionite to achieve a final concentration of MV•+ of either 0.1 mM or 1 mM, verified 
by the absorption peak at 604 nm (ε604 = 13,000 M


































Measured activity did not differ, within error, from the rate of 
background MV
+
 oxidation in the absence of enzyme 
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MV2+/dithionite mediated system introduces an unknown quantity of sulfite to the solution from 
the reaction byproducts of dithionite; thus, conditions of substrate saturation were chosen to 
eliminate variability between mutants related to individual KM values. Assays were initiated by 
addition of the specified enzyme to a final concentration of 5-10 μM. Reductase activity was 
monitored by the decrease in absorption at 604 nm due to MV•+ oxidation to MV2+. Spectra were 
first monitored for 100s prior to addition of the enzyme in order to establish a background re-
oxidation rate for MV•+ under the assay conditions; the slope of this background rate was 
subtracted from the slope of the initial rates determined for each assay. 
Sulfide quantification of the assay solution was accomplished by generation of methylene blue 
by methods previously reported28,30,31 using solutions of N,N-dimethyl-p-phenylenediamine 
(DMPD, 20 mM) dissolved in 7.2 M HCl and FeCl3 (30 mM) dissolved in 1.2 M HCl. Samples 
were reacted for 15 min, protected from light, under anaerobic conditions before centrifugation to 
pellet precipitated protein, and the methylene blue produced was quantified by UV-vis absorbance 
at 670 nm (ε670 = 29 mM
-1cm-1) with correction for dilution and standardized against sodium 
sulfide under the assay conditions. Reactions without substrate were performed for durations 
equivalent to a standard assay before methylene blue determination to correct for sulfide liberated 
from protein [4Fe-4S] clusters. Product analysis for thiosulfate (S2O3
2-) and trithionate (S3O6
2-), 
known side-products of dissimilatory sulfite reductases, was also conducted. Determinations of 
thiosulfate and trithionate from assays that were allowed to continue to completion were 
accomplished by the cyanolysis method of Kelly, et al with minimal modifications29: the total 
reaction volume was reduced to 1 mL, and the spectrophotometer blanking buffer was the buffer 
used for MV•+ photoreduction. Solutions of sodium sulfite used in the assays were assessed for 
thiosulfate and trithionate contamination and were found to contain negligible quantities of both. 
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The product conversion efficiency of sulfite to hydrogen sulfide was quantified from assays that 
were allowed to reach complete consumption of MV•+, and the product conversion efficiency was 
determined as has been previously reported for dissimilatory SiR32 using the proportion of the total 
moles of MV•+ consumed against the moles of trithionate, thiosulfate, and sulfide generated 
assuming a 2-electron, 4-electron, and 6-electron process for each product, respectively (in which 





As a control, WT-CcP was assayed for sulfite reductase activity. Within error and accounting 
for the background rate of MV•+ oxidation, no reductase activity was detectable in WT-CcP, 
indicating that CcP has no endogenous activity toward sulfite under the standard assay conditions. 
CcP is, therefore, a good orthogonal scaffold for building SiR activity in a biosynthetic model. 
SiRCcP.1 holoprotein was assayed under the same conditions and did result in measurable activity 
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(0.348 ±0.15 min-1, measured as activity per unit heme) in the presence of 1 mM or 5 mM sodium 
sulfite; no HS- was detectable as a final product, however. A typical assay is given in Fig. 5.3, 
showing the relative activity of the native dSiR from Mycobacterium tuberculosis and SiRCcP.1. 
The presence of low sulfite reduction activity was encouraging and was a major improvement over 
the synthetic models created by Holm and colleagues, which did not display sulfite reduction 
activity under physiological conditions33,34. Surprisingly, it seems that the presence of the [4Fe-
4S] cluster proximal to the native CcP heme b is sufficient to impart at least minimal activity when 
combined in a protein scaffold. Two broad routes were available to attempt to increase activity 
rationally while simultaneously increasing the similarity of the model to native aSiR: incorporation 
of active site basic residues and probing of the [4Fe-4S] environment, each of which is covered in 
a separate section below. 
 
 
Figure 5.3. Relative activities of a native dSiR and the model SiRCcP.1. The steep drop in 
absorbance for SiRCcP.1 is the point at which enzyme was added and shows the rapid reduction  
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Figure 5.3 (cont.) of the SiRCcP.1 cofactors. The dashed line indicates the projected background 
rate of MV•+ over time. 
 
5.3 Improving SiRCcP activity with aSiR-inspired distal catalytic residues 
The initial design that incorporated the heme-[4Fe-4S] cofactor (SiRCcP.1) showed notable 
sulfite reduction activity over its native scaffold protein but far less than a native SiR, indicating 
that a heme-[4Fe-4S] cofactor alone is sufficient to impart some reductase activity not exhibited 
by the starting hemoprotein but insufficient to promote rapid sulfite reduction to sulfide. To 
improve activity, key features of native aSiR active sites were incorporated to improve catalysis. 
The conserved Lys and Arg residues considered important for catalysis (Fig. 5.2) are K215, K217, 
and R153. This motif of three positively charged residues, always two Lys and one Arg, is 
conserved among aSiR and dSiR (and, interestingly, in a recently characterized new class of non-
siroheme dSiR, see Chapter 6). Several permutations of this “2Lys-1Arg” motif were investigated 
to determine the optimal ligand arrangement. Based on structural homology between the heme b 
site in CcP and the siroheme site in aSiR as well as the availability of positions amenable to the 
long, flexible Lys and Arg residues, it was determined that the set of possible mutations was 
W51K, H52A (to remove a His ligand from the active site), H52K, or P145K for the Lys residues 
and H52R and S81R for the Arg residue. The position of the native CcP residue Arg48 is similar 
to the position of the aSiR residue Arg83, which is not thought to be catalytic but, rather, that it is 
important for siroheme binding18. Residue Arg48 in CcP plays a similar role in heme stabilization 
and catalysis. The following permutations were constructed on the SiRCcP.1 scaffold and 
expressed as described in Chapters 3 and 4: the double mutants W51K/H52A and W51K/H52K; 
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and the triple mutants W51K/H52K/S81R, W51K/H52A/P145K, and W51K/H52R/P145K. The 
reductase activity of these mutants is given in Table 5.2.  
 
 
Figure 5.4. Comparison between the native substrate binding site SiRHP (green) (PDB: 2gep)19 
and the computational model of W51K/H52R/P145K-SiRCcP.1 (magenta) following a 20 ns 
thermal equilibration with sulfite bound to heme (not drawn for clarity). (A) The active site of 
SiRHP has three positively charged residues (Lys and Arg) that are oriented to coordinate sulfite 
(Lys215, Lys217, and Arg153), and Arg83 that plays a role in siroheme incorporation. (B) The 
mutations P145K and W51K in SiRCcP.1 align closely with the SiRHP residues Lys215 and 
Lys217, respectively. The mutation H52R aligns well with SiRHP Arg153, while the native CcP 
residue Arg48, a conserved Arg in many peroxidases involved in heme coordination, is in a similar 
position to SiRHP Arg83. 
 
All SiRCcP.1 mutants were assayed for sulfite reductase activity as described above from pH 
5.0 to pH 9.0, but the activity at pH 7.0 was found to be 2-3 fold greater than at higher or lower 
pH values for every mutant; only the pH 7.0 values are given in Table 5.2. The activity of the 
W51K/H52K- and W51K/H52K/S81R-SiRCcP.1 mutants increased 1.4-fold relative to SiRCcP.1, 
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but the activities of both mutants were within error of each other, suggesting that inclusion of the 
S81R mutation has little to no effect on turnover rate or may simply not interact with the substrate. 
Close inspection of residue S81 suggests that it may preferentially orient a polar or charged 
functional group toward the bulk solvent. The position of the His in the S81H mutation of CuBCcP 
confirmed this conformation; it is likely that S81R would assume a similar solvent-oriented 
conformation (see Chapter 6, in which the three-dimensional structure of CuBCcP is discussed). 
Rearrangement of the pair of Lys residues to W51K and P145K mutations (including H52A to 
remove a His ligand from the active site) was found to increase activity 1.6-fold over the 
W51K/H52K double mutant, a total 2.25-fold increase over SiRCcP.1 lacking any modification of 
the native CcP distal heme pocket. It could not be determined whether this modest increase was 
related more to a reduction in KM or by an increase in turnover rate. Due to the constraints of the 
dithionite-activated MV assay, activity is measured at a constant substrate concentration of 1 mM 
SO3
2- due to the variable contribution to sulfite concentration from decomposing dithionite. 
However, since the arrangement of Lys in the active site is important for activity, it seems likely 
that the increase in activity from inclusion of the P145K mutation is at least partially attributable 
to substrate coordination or protonation. 
Adding a second active site Arg in a “hangman” configuration (Figs. 5.2 and 5.4B), H52R, 
creates the closest structural match to native aSiR that is possible in CcP. The activity of the triple 
mutant W51K/H52R/P145K-SiRCcP.1 (hereafter abbreviated to KRK.1) was measured to be 
1.26±0.20 min-1, 5.3-fold greater than SiRCcP.1, and nearly double the activity of the best double-
Lys mutant. Unfortunately, it was not possible to crystallize any of the distal pocket mutants and 
solve their three-dimensional structures, so the positions and exact roles of each Lys and Arg 
mutant is not known. The positions of all three residues can be inferred from molecular dynamics 
133 
 
simulations (Fig. 5.4B), and all three positively charged mutations were found to be stable in the 
active site pocket of SiRCcP in both the presence or absence of substrate. An important differences 
between the native state of SiRHP and the SiRCcP model is the openness of the active site: in 
native SiR, a loop closure is hypothesized to occur upon substrate binding, helping to block 
invasion of additional substrate molecules that could react with partially reduced intermediates18. 
The substrate binding site is probably also at least partially occluded by the binding of the SiR-
FMN/FAD subunits, such as in the case of native dSiR complexes. All that can be measured by 
the MV oxidation assay is the rate of single-electron turnover. Assays for the formation of sulfide 
as a final product by the methylene blue assay were inconsistent for these mutants of relatively 
low activity, and the presence of any MV•+ or dithionite interferes with the accuracy of the assay30. 
Nevertheless, inclusion of positively charged residues in the SiRCcP active site increased the 
turnover rate by at least 5-fold. 
 
5.4 Improving SiRCcP activity by modification of the second coordination sphere 
With the successful increase of activity from including Lys and Arg residues in the substrate 
binding site that mimicked the positions of the conserved Lys and Arg residues in native aSiR, 
questions remained about the extent to which second-sphere interactions influence SiR catalysis. 
The roles of the conserved catalytic residues have been thoroughly examined through inspection 
of SiRHP crystal structures in the presence of substrates, intermediates, and several structural 
homologues of difficult to capture intermediates18,20. The role of hydrogen bonding and weak 
second-sphere interactions on the catalytic properties of the SiR cofactors has not been examined. 
In particular, the effects of second-sphere interactions with iron-sulfur clusters is not as well 
understood as for mono-nuclear metal centers, and the effects are certainly not quantitative. The 
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crystal structure of SiRHP shows 6 backbone donated and 2 sidechain donated hydrogen bonds to 
inorganic sulfur atoms of the [4Fe-4S]. The backbone hydrogen bonds are all amid NH‧‧‧S 
interactions20, which generally lower the reduction potential of iron-sulfur clusters by reducing the 
withdrawing electron density. The [4F-4S] is also only ~5 Å from the surface of the protein, 
leaving it open to solvent invasion, which has also been found to lower the redox potentials of 
[4Fe-4S] clusters (see Chapter 2). However, the two sidechain hydrogen bond donors, Thr477 and 
Asn481, could play potentially antagonistic roles. The OH‧‧‧S hydrogen bond from Thr477 could 
increase electron density while the amide hydrogen bond from Asn481 would act similarly to the 
backbone amides. Alternatively, Asn481 could impose a local dipole moment on the [4Fe-4S], 
creating a relatively positive charge near the [4Fe-4S]1+/2+ cluster that would destabilize the 
oxidized state, thereby increasing redox potential. The [4Fe-4S] cluster is also bounded on opposite 
sides by Val and Leu residues, hydrophobic residues that in mono-nuclear metal centers tend to 
increase redox potential by modulating solvent access to the metal center. Interestingly, there are 
no direct hydrogen bonds to the proximal Cys483 that joins siroheme and the [4Fe-4S]. Like in 
cytochromes p450, the absence of hydrogen bonding may protect the Cys from protonation, 
protecting the negatively charged thiolate nature of the Cys ligand. However, electron donating or 
withdrawing groups that act on the proximal Cys in particular could have a dramatic impact on 





Figure 5.5. Comparison of the hydrogen bond donor residue N481 in SiRHP (A) to mutations of 
the D235 position in SiRCcP (B). The amino group of N481 is oriented toward an inorganic Si 
atom of the SiRHP [4Fe-4S] in the SiRHP crystal structure (PDB: 2gep)19 and may interact with 
the cluster in a similar way to backbone amides, which are known to be important for tuning the 
reduction potentials of [4Fe-4S]. The D235 position in SiRCcP was initially mutated to Val 
(SiRCcP.1) for charge balance35; however, the position of the carboxylate O atoms of D235 is a 
close match to the position of the amino group on N481 in SiRHP, leading us to make the D235N 
(SiRCcP.2) and the D235C (SiRCcP.3) mutations, with the latter being chosen due to the 
propensity of iron-sulfur redox potentials to use a Cys—Si hydrogen bond to modulate iron-sulfur 
cluster redox properties. 
 
To explore whether secondary sphere interactions at the [4Fe-4S] site are in important 
influence on the rate of turnover in SiR, three mutations were engineered at two sites in SiRCcP.1 
in positions that resemble the position of Asn481 in SiRHP. Two of these mutations, M172Q 
(M172Q-SiRCcP.1) and D235N (SiRCcP.2), either added the polar Gln residue in a position that 
my hydrogen bond with the [4Fe-4S] or replaced the non-polar Val235 of SiRCcP.1 with a polar 
residue whose functional group is in a similar position. Activity assays conducted with these 
mutants are given in Table 5.2, and both were found to have similarly large impacts on activity 
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above SiRCcP.1 and even above W51K/H52R/P145K-SiRCcP.1, the Lys/Arg mutation with the 
highest recorded activity. The mutation M172Q increased activity by 12.3-fold over SiRCcP.1 
(3.4-fold over the KRK.1 mutant), and SiRCcP.2 was found to have activity 17-fold greater than 
SiRCcP.1 (4.7-fold greater than KRK.1). The inclusion of the polar residues near the iron-sulfur 
cluster may have had one of several potential effects on the site: if a dipole moment is induced or 
if the carbonyl oxygen is oriented toward the [4Fe-4S], then the redox potential of the cluster is 
likely to increase slightly; if an NH‧‧‧S hydrogen bond is created, it likely reduces the redox 
potential of the cluster. In these cases, the apparent increase in activity could be attributable either 
to an increased rate of [4Fe-4S] reduction by the small molecule electron donor or to faster electron 
transfer to heme. Alternatively, the presence of the polar residue may have a stabilizing effect on 
the [4Fe-4S] binding pocket or cause a change in the symmetry of the cubane cluster, which was 
suggested to be quite symmetrical in the oxidized form (D2h) by EXAFS. These latter effects are 
difficult to quantify and are not well-explored in iron-sulfur clusters, or heteronuclear metal centers 
in general. The larger increase in activity found for the D235N mutation over the M172Q residue 
may be related to removal and replacement of the closely packed Val residue with a polar Asn, 
which suggests a direct interaction with the cluster. 
Given the success of the M172Q and D235N mutations, a third mutation was made that was 
not directly inspired by native SiR but by the secondary sphere interactions of [4Fe-4S] 
ferredoxins. In some low-potential [4Fe-4S] ferredoxins, notably the lowest potential [4Fe-4S]+1/+2 
cluster from Azotobacter vinelandii (-647 mV), one or more non-coordinating Cys residues is 
present near the [4Fe-4S] that does not perturb the structure. The S atoms are generally hydrogen 
bond acceptors, and the SH‧‧‧S hydrogen bond of a Cys donor generally has strong effects on redox 
potential in the realm of +60 mV36–40. The mutation D235C (referred to as SiRCcP.3 in reference, 
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as with D235N, to the change in residue identity at position 235) was made to the construct KRK.1, 
hereafter KRK.3, and it was found to increase the activity of the SiRCcP model by the largest 
degree of any individual mutation (Fig. 5.5). The full KRK.3 construct exhibited a single-electron 
turnover rate of 21.8 (±2.4) mol MV•+-1 min-1 heme-1, a rate that is 3.7-fold greater than with the 
D235N alone, 17.3-fold greater than KRK.1, and 62.6-fold greater than the initial SiRCcP.1 model. 
The activity of the KRK.3 model was sufficiently large (nearly 20% of a native dSiR25)to allow 
reliable measurement of  product formation (Fig. 5.6) 
 
Figure 5.6. Activity assays for methyl viologen oxidation by W51K/H52R/P145K-SiRCcP.3 
(KRK.3) and product analysis. (A) Triplicate assay of MV•+ oxidation by in the presence of 
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Figure 5.6 (cont.) 0.2 mM sodium sulfite. The black arrow indicates the time at which the enzyme 
was added. (B) Sulfite reduction assay by KRK.3 with excess MV•+: A pool of 1 mM MV•+ was 
generated by addition of sodium dithionite prior to addition of the enzyme (absorbance of 1 mM 
MV•+ greatly exceeded the dynamic range of the spectrometer until its concentration was reduced 
to ~ 0.150 mM) in the presence of 1mM sodium sulfite. The assay was allowed to continue to 
completion. Analysis of the products formed by this assay are given in panels (C) and (D). (C) 
Enzymatically produced hydrogen sulfide (HS-) was determined by the formation of methylene 
blue, and (D) thiosulfate (S2O3
2-) and trithionate (S3O6
2-) were estimated by the CuSO4 catalyzed 
cyanolysis method of Kelly, et al29. The major product was found to be S3O6
2- (66.35 ±15.6 µM, 
accounting for 66.3% of MV•+ consumed during the assay), the outcome of a 2 e- sulfite reduction, 
followed by S2O3
2- (10.37±6.0 µM 20.7%), the result of a 4 e- reduction, and finally HS- (3.59±0.55 
µM 10.8%), the result of a 6 e- reduction. The estimated yields of these products account for 98% 
of the MV+ consumed. The product distribution from sulfite reduction by SiRCcP is similar to the 
product distributions of dissimilatory SiR32,41. Product analysis assays were conducted in 
phosphate buffer (pH = 6) with MV•+ that had been photoreduced by proflavine (20 µM) and 
sodium oxalate (40 mM) in phosphate buffer (pH = 7) to a concentration of 1.2 mM as determined 
by absorbance at 604 nm (ε604 = 13,000 M
-1cm-1). Photoreduction was used in place of sodium 
dithionite to generate MV•+ to prevent interference from the products of dithionite decomposition. 
 
Product analysis was performed by both the methylene blue assay for HS- and by 
cyanolysis quantification of multi-sulfur compounds produced as a consequence of side 
reactions with partially reduced intermediates, most probably by invasion of additional 
substrate into the active site or by early release of intermediates. Thiosulfate and trithionate 
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have been found as side-products of sulfite reduction in dSiR under in vitro conditions; 
though, it is unclear whether these reactions occur in solution or whether they are merely 
artifacts of the laboratory conditions (though most likely)42. Nevertheless, the accumulated 
products can give some insight into the reaction mechanism of the SiRCcP model. 
Equations S1-S3 describe the reduction process required to generate each of the side 





As with native dSiR, the dominant product is trithionate, suggesting that early invasion of 
sulfite into the active site interrupts the reaction after two electrons are transferred to the substrate 
or that two equivalents of sulfite are released after a single electron transfer step. Thiosulfate, a 4e- 
reduced product, is found much less abundantly than trithionate and accounts for between 1/3 and 
½ of the total electron flux that generated trithionate, and HS-, the 6e- reduced final product of the 
native activity of dSiR and aSiR, accounts for ~11% of the total electron flux. Each of the products’ 
abundance decreases more or less in accordance to the number of reduction steps in the SiRCcP 
active site required to generate them. Due to the reactivity of the theorized intermediates, it should 
not be expected that any other products would be found other than the three quantified above, and 
indeed they account for essentially all of the MV•+ consumed in the assay (80%-110%). What these 
data show is that not only does KRK.3 transport electrons to sulfite at a rate approaching native 
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dSiR (which do tend to be 1-2 orders of magnitude slower than aSiR) but that at least some of the 
substrate is retained and protected in the active site long enough to be reduced completely to HS-. 
Final absorption spectra taken after completion assays show enzyme in the oxidized form, not the 
sulfite bound, dithionite reduced form or the sulfide-bound form, indicating that all products are 
released from the active site (as is suggested by the side-product activity). Product release, as in 
native aSiR, is probably related to lowered affinity for sulfite and sulfide in the oxidized form after 
the final electron transfer form heme to substrate. Given the ability of KRK.3 to convert a small 
portion of substrate to the fully reduced product, it may be possible to shift the product distribution 
toward a higher proportion of 4e- and 6e- reduced products by narrowing the substrate binding 
cavity to accommodate only a single sulfite anion, increasing the rate of electron transfer from the 
metallocofactors to the substrate, or by decreasing the KM of substrate binding so that the total 
concentration of sulfite could be lowered, slowing the rate of competitive reactions. 
It is unclear what the precise effect(s) of the D235C mutation are that so dramatically increase 
activity. Reliable redox potential measurements for KRK.3 have not been obtained, but 
preliminary results suggest that the heme Fe2+/3+ potential is very close to WT-CcP. When KRK.3 
is purified, the “apo” form is often faintly colored red and has weak absorption bands from 300-
450 nm suggestive of a [2Fe-2S] cluster or other iron-sulfur species; however, following reduction 
with dithiothreitol and reconstitution with iron and sulfur, a [4Fe-4S] is always detected with Fe 
abundance consistent with 4 bound Fe at 80-100% occupancy. 
 
5.5 Native CcP is an efficient nitrite reductase 
All aSiR display higher kcat for NO2
- as a substrate over SO3
2- at saturation. The preference for 
sulfite over nitrite is determined by KM over reactivity, a selectivity that may be in large part 
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determined by a loop closer mediated by Asn14918,19,24. With the intention of testing the SiRCcP 
models for nitrite reductase activity, first WT-CcP was tested for nitrite and hydroxylamine 
(NH2OH) reduction activity, yielding a surprising result. Not only was CcP capable of reducing 
nitrite, it did so much more rapidly than even the native dSiR from M. tuberculosis. In the absence 
of any enzyme, nitrite also consumes MV•+, presumably in a single electron reduction, but the 
reduction is far more rapid than background when CcP is added (Fig. 5.7). A recent report detailing 
the likely physiological role for CcP as a low-level peroxide scavenger and recruiter of catalase in 
yeast mitochondria43, which does little to explain the anomalous activity against nitrite that 
requires a heme redox state (Fe2+-PPIX) that is not accessed by CcP in its native function (and 




Figure 5.7. Reactivity of WT-CcP with nitrite and hydroxylamine. (A) rates of reaction of CcP 
with the specified concentrations (both at saturating concentrations) for nitrite (black trace) and  
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Figure 5.7 (cont.) hydroxylamine (red trace) with MV•+ as an electron donor. (B) Michaelis-
Menten parameters were determined for nitrite (inset table), and the concentration dependence of 
CcP reductase activity against hydroxyl amine (C) is similar to native ccNiR. 
 
Reaction with hydroxylamine was slower than nitrite; however, reductase activity implies that 
CcP can reduce hydroxylamine to ammonia, which is the terminal step in the nitrite reduction 
reaction. At the very least, a single electron reduction would result in an amino radical (•NH2)
44, 
but the radical species is unlikely to persist in the presence of MV•+ at micromolar concentrations. 
There have been reports of plant and cyanobacterial hemoglobins capable of hydroxylamine 
reduction to ammonia45, and also for myoglobin electrocatalytically46, in addition to the three 
native hemoprotein nitrite reductases (one of which is a siroheme-[4Fe-4S] enzyme, vide supra. 
Even though the apparent rates for CcP for nitrite reduction (4.32 μmol min-1 mg-1) and 
hydroxylamine reduction (51.3 μmol min-1 mg-1) are 2-3 orders of magnitude slower than native 
cytochrome c nitrite reductase (ccNiR)47,48, the KM values (3.22 ±0.6 μM for nitrite and ~30 mM 
for hydroxylamine) are similar. These rates, however, are comparable to the nitrite reduction rates 
for many dSiR. Due to the high native activity, CcP and mutant SiRCcP derivatives may not be 
well-suited as biosynthetic models for substrate selectivity between nitrite and sulfite for native 
aSiR; however, this activity may warrant further study and could have implications for a 
physiological role of CcP as a NO sensor in addition to its major role in hydrogen peroxide 







SiRCcP has proven to be both a structural and functional model of sulfite reductase. The initial 
stable design, SiRCcP.1, displayed minimal sulfite reductase activity while the parent scaffold, 
CcP, had no such activity. The activity of the SiRCcP models was dramatically increased by 
building in features that are present in native aSiR. A significant increase in activity was achieved 
by adding positively charged residues to the substrate binding site in positions that are close to the 
arrangement of the conserved Lys and Arg residues in native aSiR. Much larger increases in 
activity were achieved by making mutations within hydrogen bonding distance of the designed 
[4Fe-4S] binding site: a dramatic increase in activity of at least one order of magnitude was 
achieved by making either the M172Q or D235N mutations, replacing nonpolar residues with the 
polar carboxamide functional group similar to residue Asn481 in SiRHP. An even more dramatic 
increase in activity was achieved from the mutation D235C, which when combined when the most 
successful “2Lys+1Arg” construct, created a model enzyme (KRK.3) with activity up to 20% of a 
native dSiR. The product distribution of KRK.3 tracked closely with the product distribution 
commonly detected from dSiR with small molecule redox mediators, suggesting a similar 
mechanism. All native siroheme-[4Fe-4S] SiR display nitrite reduction activity that is greater than 
sulfite reduction activity at substrate saturation; however, ideally a biosynthetic model scaffold 
should be orthogonal with respect to the activity of a target native enzyme. When assayed for 
nitrite and hydroxylamine reduction activity, it was found that WT-CcP could reduce nitrite and 







A major goal of biosynthetic modeling is to design an enzyme that is not merely a structural 
model of an interesting and/or difficult to study target enzyme, but it is to create a functional 
enzyme that can be used to probe specific structural elements of a target enzyme without perturbing 
the finely-tuned native structure of an evolved natural enzyme. Though the initial stable sulfite 
reductase model, much like CuBMb and MnCcP developed previously in the Lu lab, SiRCcP.1 
barely qualified as a functional model with activity 2-3 orders of magnitude slower than the slowest 
characterized dSiR. However, the composition of this initial model also barely qualified as a 
structural model. The conserved active site residues in aSiR and dSiR severely attenuate activity 
when removed, and the [4Fe-4S] binding site, like ferredoxins that share a similar fold, is evolved 
to provide a finely-tuned cradle for the cofactor and maintain a specific redox potential and cluster 
geometry. SiRCcP.1 had none of these features built-in—not even the eponymous siroheme—yet 
it still managed to squeeze out a little activity. Iterative addition of native-mimicking residues did 
build up the minimal starting activity, but the surprisingly strong effect on activity imparted by 
single residue mutations in the [4Fe-4S] binding site have not been explored at all in native SiR. 
The unique coupled nature of the heme-[4Fe-4S] in SiR means that, in principle, any change 
to the environment of one cofactor will have at least some effect on the cofactor connected to it, 
even if it is minor. Whether in the case of SiRCcP it is primarily an issue of cluster stability or 
something more subtle like local polarity, the positioning of a solvent molecule, or redistribution 
of electron density from the [4Fe-4S] that expands to the ability of the heme to donate electrons to 
the substrate, the precise nature of the effect remains to be seen and would be aided greatly by a 
crystal structure. Additional mutations, such as to introduce a hydroxyl functional group such as 
with Thr477 in SiRHP, warrant exploration to determine the extent to which catalysis is 
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determined by weak interactions at the iron-sulfur cluster, which—if found to be a major 
determining factor—would provide direct insight into the natural selection of a covalently coupled 
heme-[4Fe-4S] cofactor for this reaction, and to what extent other structural elements, such as the 
macrocyclic structure of the catalytic siroheme, determine reactivity. 
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DESIGN OF A MCC SULFITE REDUCTASE HEME-COPPER CENTER IN CYTOCHROME 
C PEROXIDASE 
 
6.1 The multi-heme cytochrome c sulfite reductase SiRA: a new heme-Cu center in biology 
The central aim of this section is to create a model system for the recently characterized active 
site of the heme-copper sulfite reductase (SiRA), a homotrimeric protein with 8-hemes per 
monomer, only one of which serves as the catalytic site for sulfite reduction1,2. Relatively little 
literature exists on the nature of Mcc enzymes, but the most important is the solution of the three-
dimensional structure of SiRA. The unique aspect of the SiRA active site—aside from its structural 
disparity from all other characterized sulfite reductases—is the bent linear coordination of a Cu(I) 
atom in the between two Cys residues (Cys399 and Cys495) at a metal-metal distance of 4.4 Å to 
the Fe of the catalytic heme c2. The identity of SiRA as an octaheme cytochrome c enzyme (Mcc) 
variety was uncovered by genetic analysis of Shewanella oneidensis MR-1 where it was 
determined to be part of the sirABIGCDJKLM locus in which sirA encodes the reductase. The gene 
form sirG resembles a heme lyase similar to what is required for the NrfA nitrite reductase and is 
necessary for SiRA maturation, and a Cu chaperon was also predicted to be found in this locus1. 
SiRA functions as a dissimilatory sulfite reductase and is thought to function in the periplasm with 
a ferredoxin-like redox partner that exchanges electrons with the quinol pool. There are roughly 
40 known examples of MccA enzymes, but so far only the enzymes from S. oneidensis and 
Wolinella succinogenes have been characterized3. At least the W. succinogenes SiRA can reduce 
sulfite to sulfide at 1-2 orders of magnitude the catalytic rate of the E. coli SiRHP, an aSiR; dSiR 
are typically 1-2 orders of magnitude slower than aSiR under laboratory conditions. It is clear that 





Figure 6.1. Space-filling models of the multi-cytochrome c sulfite reductase (SiRA) from W. 
succinogenes (PDB: 4rkn)2. The active form of the enzyme is a homotrimer (left) with a central 
substrate channel. Each monomer (right) contains eight heme c prosthetic groups, seven of which 
are bis-His coordinated for electron transfer (drawn as violet stick models) with a single heme-
Cu(I) active site per monomer. The active site heme and Cu(I) are colored red and depicted as a 
green sphere, respectively. 
 
The crystal structure of W. succinogenes SiRA was solved in 2015 with sulfite and sulfoxide 
in the active site2, revealing the nature of the heme-Cu active site and the key similarities and 
differences between the active sites of heme-Cu MccA and siroheme-[4Fe-4S] sulfite reductases. 
Present in the active sites of both classes of enzymes are basic residues, Lys and Arg, within 
hydrogen bonding distance of bound substrate. The spatial arrangements of these residues differ, 
however, owing largely to the very different structures of heme c and siroheme. In the well-studied 
aSiR from E. coli, SiRHP, K215, K217, and R153 are critical catalytic residues that likely undergo 
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dynamic conformational changes during the course of one turnover from sulfite to sulfide4,5. 
Lys393 in SiRA occupies an analogous position to R153 in SiRHP, and R366 is positioned 
essentially between the relative location of the two catalytic Lys residues in SiRHP with a second 
Lys, K208, positioned directly opposite the heme from R366. Here, however, the similarity ends: 
the active site of SiRA is largely ordered by a triad of Tyr residues (Y123, Y285, and Y301) that 
hydrogen bond with R366 and K393, sulfite, and a number of water molecules poised to supply 
protons. All of the residues mentioned above are conserved across MccA, and all appear 
structurally important for catalysis. The role of Cu in the active site is less well understood. SiRA 
represents only the second identified heme-Cu reductase after heme copper oxidase (HCO), or 
terminal oxidase. Several elements of the two active sites are strikingly reminiscent: though the 
orientation of the Cu atoms in SiRA and HCO differ, the distance from Cu to heme Fe is similar, 
and the positioning of the active site Tyr in HCO overlays with the positions of Tyr285 and Tyr301 
in SiRA. The Cu in HCO undergoes a redox transition during catalysis, but the Lewis acidity of 
Cu is critical for weakening the O—O bond in molecular oxygen to allow heterolytic cleavage and 
minimize the production of reactive oxygen species6,7. Given the structural similarity between the 
heme-Cu centers in SiRA and HCO and that both enzymes catalyze multi-electron reduction 






Figure. 6.2. Comparison between the heme-copper active centers of the W. succinogenes Mcc 
SiRA and bovine heart cytochrome c oxidase. (A) Reprinted with permission from reference2; 
heme-Cu(I) active center of SiRA. One Cu atom is coordinated by a pair of Cys residues (C399, 
C495), and the substrate, sulfite—shown here in the first dehydrated form—is coordinated by 
conserved basic residues K208, R366, and K393 such that R366 and K393 orient the substrate by 
fixing the position of one Osulfite atom. Three Tyr residues (Y123, Y285, and Y301) are present in 
the active site and exposed to solvent. The latter two Tyr coordinate the substrate and a water 
molecule, and Y123 is well positioned to be a proton donor. (B) Overlay of the structures of SiRA 
(cyan) with bovine heart CcO (orange) with the SiRA Cu(I) atom and the CcO CuB atom shown 
as green and violet spheres, respectively. With the heme macrocycles aligned, the Fe—Cu 
distances are similar in both enzymes while the position of the Cu atoms is offset. The His 
crosslinked Tyr residue in CcO is positioned between SiRA residues Y285 and Y301 in this 
orientation, but it overlaps with Y285 when the Cu atoms are aligned. 
 
A reaction mechanism has been inferred from the crystal structure that postulates the function 




- in this mechanism), allowing an immediate dehydration to SIVO2 without reduction. The 
first step of this proposed mechanism is depicted in Scheme 6.1. The remaining oxygen atoms 
point away from the Cu atom crystal structure, both in the presumed SIVO2 form and in a S
xO form 
generated from reduction by the x-ray beam, seemingly in support of this hypothesis. It is also 
unlikely that Cu(II) would remain stable in bidentate coordination. However, when sulfite is added 
to fully reduced SiRA, only 4 electrons are extracted from each subunit, leaving open the 
possibility that either Cu redox chemistry is involved or that only two equivalents of sulfite are 





The presence of seven catalytically inactive hemes (21 hemes in the native trimer) makes 
spectroscopic isolation of the active site all but impossible, necessitating a simpler model to fully 
study catalysis in this interesting “new” enzyme. Constructing such an active site in CcP has the 
added benefit of providing a platform for direct comparison between the SiRCcP model of the 
siroheme-[4Fe-4S] aSiR, with which SiRA shares a highly similar substrate binding pocket while 





Figure 6.3. Simulated model of H64C/V68C-Mb (cyan), the superior of the two double-Cys Mb 
mutants designed to mimic SiRA, overlaid with the active site of native SiRA (green). Cu is shown 
as a sphere in both models, red and bronze, respectively. The Cu-Fe distances and relative positions 
of the Cu atoms do not overlay well in the two models, and the shallow O2 binding pocket of Mb 
does not have many residues that significantly overlap with the Tyr and basic residues of the SiRA 
active site. 
 
6.2 Designing a Cu(SCys)2-heme binding site in CcP 
To make a biosynthetic model of SiRA, a mono-heme protein with a suitable scaffold is 
required. Since myoglobin (Mb) has been an extremely successful scaffold for developing 
biosynthetic models of the Cu-heme center in HCO and the heme-nonheme Fe center in NOR, 
sperm whale Mb was the first choice to design a new model of SiRA. Several computational 
models were constructed and subjected to thermal equilibration simulations. The best models 
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devised by visual inspection and comparison to the target SiRA structure were H64C/T67C-Mb 
and T67C/V68C-Mb; however, the Cu-Fe distances in the resulting simulated structures were 
significantly more distant (6.6 Å and 5.8 Å, respectively) than in native SiRA (4.9 Å ) and did not 
overlay well with the target structure (Fig. 6.3), the position of the Cu(I) atom being too centrally 
located above the heme. Given that the standing hypothesis for the functional role of Cu(I) is as a 
Lewis acid to weaken the S-O bond, beginning with a structure in which the Cu-Fe distance is 
quite long was non-ideal. 
Given that the globin scaffold that was successful for one type of heme-Cu center was not 
successful for another, there was an opportunity to achieve a design goal similar to what had been 
accomplished in the FeBMb and CuBMb systems. Rather than investigate how the choice of a 
specific metal ion leads to the selection of oxygen reduction over NO reduction, cytochrome c 
peroxidase could be used to study how two very different heme-nonheme metal centers—the 
heme-[4Fe-4S] center of siroheme SiR and the heme-Cu(I) center of Mcc-SiR—can accomplish 
the same reaction with very little structural homology. In either case, the protein scaffold is 
removed as a variable when comparing systems (once a functional model has been achieved); 
whereas, scaffold-related effects from mutation or metal-substitution (effects that are certainly 
adaptive to retain certain activity) cannot be ignored in native enzymes. Therefore, CcP was chosen 
as a scaffold into which to engineer the Cu(SCys)2-heme active site of the Mcc-SiR. 
The number of mutations required to design the Cu(I) binding site was minimal: in SiRA, only 
a single pair of Cys residues on opposing loops coordinate Cu(I) in an approximately linear 
geometry and with a total coordination number of two. To select the optimal location for the Cu(I) 
binding site, WT-CcP was overlaid with the catalytic heme of SiRA. The closest match could be 
achieved by mutating two residues on the major distal helix in the CcP heme binding pocket, Arg48 
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and Trp51, to Cys and the distal His52 to Ala to remove what would likely be a third ligand. 
Mutating both of these residues in CcP would have the added benefit of abolishing most of the 
native peroxidase activity of CcP because mutation of the distal Arg in peroxidases where it is 
present severely lowers activity, but prior studies have shown that mutation of Trp51 to Phe can 
increase catalytic efficiency8. Due to the relatively open distal substrate binding cavity in CcP, no 
loops are present to mimic the Cys orientation. In order for the two Cu binding sites to align, the 
CcP heme is rotated ~90° relative to the catalytic heme in SiRA, in which Cu(I) is situated between 
the two propionic acid moieties of heme c, so that the designed Cu(I) binding site would be over 
the first heme edge anti-clockwise to the propionate moieties. 
To check the stability of the proposed model, the mutant protein (R48C/W51C/H52A-CcP) 
was simulated by thermal equilibration in a water box for 5 ns. The resulting structure varied little 
from the native CcP and still aligned well with the active site of SiRA (Fig. 6.4). Rigid bond and 
angle parameters were applied to the Cu(SCys)2 center to preserve the nearly linear binding 
configuration. A sufficient number of residues with Cα in similar positions to residues in SiRA are 
also present in CcP to make it possible to model the Tyr and basic residues of the SiRA substrate 






Figure 6.4. Images from molecular dynamics simulations of the heme-Cu(I) centers of native 
SiRA and the designed Cu(I) binding site in CcP. Left, overlay of the native SiRA active site heme 
c (blue) with the thermally equilibrated simulated structure of R48C/W51C/H52A-CcP. The 
positions of the Fe and Cu atoms of the respective proteins overlay very closely despite a ~90° 
anti-clockwise rotation of the Cu(I) binding site in CcP relative to SiRA. Right, the residues in CcP 
whose Cα align closely with corresponding basic or Tyr residues in the SiRA active site. 
 
The three mutations (R48C/W51C/H52A) were made simultaneously by Gibson assembly. 
The resultant triple mutant was expressed and purified as heme-free apo-protein as described in 
detail in Chapter 3. The identity of the protein was confirmed by ESI-TOF mass spectrometry (Fig. 
6.5). Hemoprotein was reconstituted in a manner similar to as described in Chapter 4 with slight 
modifications: hemin solution was added in a stepwise manner by 0.5 molar equivalents with 
intervening incubation of 15-20 minutes until saturation (~3 molar equivalents). Excess heme was 
removed by salt gradient elution on a DEAE Sephadex column. Fractions with maximal 410:280 
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nm and minimal 360:410 nm ratios were retained. Protein concentration was determined to be 
(84.5 mM-1 cm-1) by the pyridine hemochrome assay9. The final construct was called “CuICcP.” 
 
 
Figure 6.5. Mass spectrum by ESI-TOF for purified R48C/W51C/H52A-CcP. Experimentally 
determined mass: 33530 Da; mass calculated from sequence: 33528.5. 
 
6.3 Cu(I) binding in CuICcP 
To determine whether the designed Cu(I) binding site could bind Cu(I), a solution of CuICcP 
was made anaerobic by freeze/pump/thaw gas replacement with Ar or by transfer of a frozen 
aliquot of protein directly into the anaerobic chamber where it was allowed to equilibrate for at 
least one hour. Initially the hemoprotein was treated with dithiothreitol (DTT) to reduce any 
disulfide bonds formed from the mutant Cys residues; however, this was later found to make no 
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difference in the Cu binding profile. Initial titrations of Cu(I) were performed by adding sub-molar 
equivalents of Cu(I) prepared from the tetrakis(acetonitrile)-Cu(I) hexafluorophosphate salt in 1 
M acetonitrile to a concentration of 10-20 mM with the exact concentration determined by 
bathocuproine (BCS) binding assay. The BCS assay is performed by making a sample of 0.2 mL 
solution containing Cu(I) to a final concentration of 1 mM BCS, allowing the solution to incubate 
5 min with mixing, and then measuring the UV-visible absorbance spectrum of the BCS-Cu(I) 
complex (ε482 nm = 12 mM
-1 cm-1). Samples containing protein are always centrifuged prior to 
measurement to pellet any precipitated or solid material. 
 
 
Figure 6.6. Reconstitution of Cu(I)-CuICcP by gradual addition of Cu(I). (A) Change in UV-
visible absorption spectra of CuICcP upon Cu(I) binding. (B) Plot of Cu(I) binding saturation and 
representative BCS assay for Cu(I) quantification after desalting. 
 
CuICcP was found to bind Cu(I) as predicted by the design. A typical binding saturation curve 
is shown in Fig. 6.6 and can be monitored by the change in the heme visible absorption spectrum 
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in a manner like the previously reported effect of Cu(I) binding in CuBMb
6. In the case of CuICcP, 
in the presence of Cu(I) the intense heme Soret absorption band increases slightly in intensity, 
undergoes a ~2 nm red shift, and loses a small shoulder present at ~415 nm. In the visible 
absorption region, the 530 nm peak broadens, decreases in intensity, and blue shifts by ~25 nm 
(Fig. 6.6A, blue trace). Copper binding saturates at 3-4 molar equivalents. Though this may 
indicate adventitious Cu-binding sites (vide infra), isosbestic points for all of the spectral shifts 
indicate that there are only two distinct absorbing species, meaning only a single Cu(I) binding 
site—presumably the designed site—is acting on the heme. Subsequently, samples of Cu(I)- 
CuICcP were usually prepared by slow addition of Cu(I) up to 3.5 equivalents. Excess Cu was 
removed by passage through a PD-10 desalting column, and the amount of bound Cu(I) was 
quantified by BCS assay (Fig. 6.6B, inset) and again by ion-coupled plasma mass spectrometry 
(ICP-MS). The amount of Cu(I) present as determined by the BCS assay is 1.3 Cu per heme. By 
ICP-MS 1.021 Cu per heme were found. Both values are in relative agreement that only ca 1 
equivalent of Cu(I) is tightly bound to CuICcP after the desalting column. It is notable that if the 
ICP-MS quantification of heme Fe is correct, then the heme extinction coefficient should be 
revised upward to 115.8 mM-1 cm-1. CuICcP was therefore found to bind one equivalent of Cu(I) 
as predicted by the rationally designed model. Due to the general spectroscopic silence of Cu(I), 
however, it a three-dimensional structure of the Cu(I)-bound protein was necessary to determine 
the mode of binding and whether it matched with the intended Cu(I)-(SCys)2 design. 
 
6.4 X-ray crystal structure of CuICcP with Cu(I) and Ag(I) 
Unlike SiRCcP, CuICcP could be readily crystallized using conditions similar to WT-CcP to 
yield high-quality crystals without reseeding in a matter of hours. Though crystals could be 
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obtained in PEG/iodide buffers, the highest quality crystals were obtained by the following 
conditions: protein exchanged by desalting on a PD-10 column in Tris buffer (50 mM, pH 7) and 
concentrated to 0.5 mM was mixed 1:1 with a 1.5 μL drop of well buffer (polyethylene glycol, 
average MW 2000, 10-15% w/v and sodium acetate, 50 mM pH 5.5) at 4°C in a hanging-drop 
vapor diffusion cell. Crystals of protein with metal bound in the non-heme site could be obtained 
either by adding 0.5 μL of a 40 mM solution of Cu(I) solution (prepared as above) directly to the 
edge of the drop in an anaerobic chamber (final concentration 5 mM Cu) and allowed to soak. 
Cu(I)-bound structures were obtained with partial metalation after 60 min incubation; however, 
longer incubation times caused crystal decomposition in the wells. Harvested crystals were mixed 
in cryoprotectant solution (30% ethylene glycol, w/v% in mother liquor) for 10-30 s before snap 
freezing on a nylon mounting loop. Proteins metallated with Ag(I) as an air-stable Cu(I) analogue 
were obtained by a similar procedure by adding a stock solution of AgNO3 directly to the edge of 
the crystal drop and protecting the drop from light during incubation. Slightly longer incubation 
times (60-120 minutes) yielded better results for the Ag(I) soaked crystals. The harvested protein 
crystals were diffracted at Brookhaven National Laboratory National Synchrotron Light Source II 
(NSLS-II) on the highly automated macromolecular crystallography (AMX) beamline 17-ID-1. 
Diffraction data were solved by molecular replacement against the WT-CcP structure PDB: 2cyp10 
and refined with Phenix. Refinement statistics for all protein structures discussed in this chapter 






The highest quality structure was obtained for CuICcP hemoprotein in the absence of non-
heme metal (hereafter E-CuICcP), which diffracted to 1.40 Å. The structure clearly shows the 
positions of the two mutant Cys residues (Fig. 6.7) in positions close to the positions predicted by 
computational modeling. Indeed, the structure of the triple mutant hardly deviates from the 
structure of native CcP at all; so little in fact that the Cβ of the mutant and native residues overlap 
(Fig. 6.7C). Furthermore, the crystal structure shows no evidence of a native disulfide bond 
between the two mutant Cys or of Cys-heme ligation (though, no spectroscopic evidence of 
sulfheme had been observed prior). The position of R48C seems likely to accommodate a metal 
ion; however, W51C is rotated away from R48C, requiring a change in conformation for the 
second Cys to participate in metal binding. This Cys rotamer, and indeed the position of the Cβ 
that so closely matches the native Trp residue, could be a result of the central position of W51C in 
the distal heme binding helix; there is no evidence of an alternate conformation in the structure. 
While this rigidity clearly aides in preventing disulfide bond formation, it may well impede metal 
binding. Mutation of the distal Trp and Arg residues in E-CuICcP also modified the pattern of 
crystal waters relative to the WT enzyme. In E-CuICcP, there are two additional buried waters, 
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one where the Trp51 phenyl ring stacks with heme in WT and another deeply buried behind R48C, 
as well as a water that occupies the position of the guanidinium moiety of the native R48. Other 
water molecules are conserved, such as the most solvent exposed water and the heme aquo ligand. 
 
 
Figure. 6.7. High-resolution (1.40 Å) crystal structure of E-CuICcP. (A) 2Fc-Fo map of the 
substrate binding site containing the three mutations made to mimic the SiRA Cu(I)-binding site. 
(B) Cartoon model of the E-CuICcP structure illustrating the position of the mutant residues in the 
distal heme binding helix. (C) Overlay of the structure of E-CuICcP (green) with WT-CcP (orange, 
PDB: 2cyp10). Waters present in the WT structure are drawn as red spheres and as purple spheres 
in E-CuICcP. 
 
A structure of a partially metallated Cu(I)-CuICcP was obtained at 2.07 Å resolution. This 
structure, while not entirely clear with respect to the bound Cu atom, suggested that Cu may not 
bind in the manner predicted by the computational model. Figure 6.8 of the electron density map 
shows two important features of bound Cu: first, while it is clear that R48C participates in metal 
binding, W51C does not. The Cu-SCys distances to R48C and to W51C are 2.67 Å and 3.73 Å, 
respectively, which are quite long for Cu-S bond length, which typically range from 2.2-2.4 Å. 
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Second, the backbone carbonyl of R48C forms a long bond (2.45 Å) with the Cu atom, raising the 
possibility that the intended 2-coordinate Cu(SCys)2 site may actually be 3-coordinate. 
Additionally, there are 2 water molecules, one positioned over the heme Fe that is likely a weak 
heme ligand, and two others at similar distances to the Cu atom as the backbone carbonyl. The 
water closest to R48C is in low occupancy (0.62). 
 
 
Figure 6.8. X-ray crystal structure of Cu(I)-CuICcP to a resolution of 2.07 Å obtained by Cu(I) 
soaking. (A) The 2Fc-Fo map shows the low occupancy of the bound Cu atom and at least one of 
the surrounding waters. There is no electron density overlap between the Cu atom and W51C while 
the Cu atom and the backbone carbonyl of R48C clearly share density. (B) cartoon drawing 
showing the possible 3(-4)-coordinate Cu(I) bound form with a labile water near R48C. 
 
As with all crystal structures—and especially those obtained by soaking a ligand into pre-
formed crystals—it is certainly possible that the crystal structure of Cu(I)-CuICcP is not the 
solution form. The positions of R48C and W51C hardly change at all upon Cu binding relative to 
their positions in E-CuICcP. This could be due to dynamic motion being restricted in the solid 
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state. It is also possible that during soaking or storage after harvest, the Cu(I) in the crystal was 
oxidized to Cu(II), causing a distortion of the metal binding site and, perhaps, an intermediate 
structure between the preferred geometry to Cu(I) and Cu(II), hence the low-occupancy water 
positioned so as to promote a distorted tetrahedral geometry. In addition to the active site Cu atom, 
Cu was found to bind in two other sites on the surface of CuICcP, shown in Fig. 6.9. The presence 
of two surface sites is consistent with the Cu(I) reconstitution data that required >3 molar 
equivalents of Cu(I) to saturate the tight-binding site. Additionally, the two surface sites contained 
Cu in higher abundance than the active site located in the protein interior, indicating that soaking 
time is a critical limiting factor both in crystal stability and Cu access to the more buried designed 
Cu(I) binding site. 
One adventitious Cu atom could be clearly identified in bidentate coordination by Asp34 and 
held in place weakly by water oriented in a hydrogen bond with Asp35. An additional Cu atom 
was bound at the protein-protein interface of the crystal (between residues His60 and Asp135) 
such that only one Cu atom and one of the two ligating residues was present per unit cell. Both of 
these surface Cu atoms were found in bidentate or weakly tridentate coordination, suggesting that 
the Cu present in the crystal is mostly Cu(I). 
Crystals grown in the presence of ZnCl2 did not diffract, and crystals could not be grown in 
the presence of either AgNO3 or tetrakis(acetonitrile) Cu(I), so it was not possible to determine by 
crystallography if a different “native” form of Cu(I)-CuICcP could exist. Therefore, samples of 
Cu(I)-CuICcP were prepared for x-ray absorbance spectroscopy (XAS) to obtain the solution form 
of Cu(I)-CuICcP. The results of the XAS experiments will be described in section 7.6; however, 
first the Ag(I) soaked form of CuICcP warrants discussion for the presence of two highly unusual 





Figure 6.9. Positions of two adventitiously bound Cu atoms in the crystal structure of Cu(I)-
CuICcP, obtained by soaking with tetrakis(acetonitrile) Cu(I). A surface site is shown in (A, B). 
The 2Fc-Fo map indicates that the Asp-Cu coordination is bidentate and either 3- or weakly 4-
coordinate Cu. Parts (C, D) show a Cu-binding at the protein-protein interface of the crystal lattice. 
Only a single Cu atom is present per unit cell. The bound Cu atom is apparently 2- or weakly 3-
coordinate, suggesting that most of the Cu(I) remained in the reduced form in the crystal or was 







6.5 CuICcP binds Ag(I) with an unusually small Ag-Ag bond and metallocene configurations 
CuICcP that was co-crystallized in the presence of AgNO3 displayed a set of unusual Ag(I) 
binding sites. In total, there were 4-5 Ag atoms present in the structure, all in high occupancy. The 
resolved structures are shown in Figures 6.8-6.9. In the designed Cu(I) binding site, there are 
apparently two Ag atoms with a Ag—Ag distance (2.68 Å) close enough for a Ag—Ag bond11. 
Due to the energy cutoff of the collection beamline, anomalous data above the Ag absorption K-
edge (25.5 keV) were not collected, and the large radius of the “soft” silver ion makes it difficult 
to find the true center of the atom in the 2Fc-Fo map, particularly in the active site due to the close 
proximity of the heme molecule. Two Ag ions were modeled in this binding site in a Ag2(SCys)2 
arrangement similar to the diamond core of CuA (see Chapter 7). The Ag (Ag2 in Fig. 6.10) closest 
to the heme is well modeled as 100% occupied, and the other Ag (Ag1) is nearly 90% occupied. 
The first obvious alternative is some combination of oxidized Cys compound and/or disulfide 
bond. The bond angles are extremely unfavorable for a disulfide bond, however; the bond length 
would be too great, and a significant amount of unmodeled density in the Fc-Fo map is apparently 
a high-mass atom similar to the nearby heme Fe. Astoundingly, if this structure is correct, the Ag—
Ag bond in CuICcP is the shortest Ag—Ag bond ever reported. The shortest Ag—Ag bond in a 
thiol complex is 2.93 Å, characterized in a cysteine-penicillamine-glutathione complex, and the 
shortest Ag—Ag bond reported is metallic silver, 2.89Å. Both of these Ag—Ag bonds are already 
shorter than the van der Waals contact distance for two Ag atoms (3.44 Å)11. On the basis of a 2.21 
Å crystal structure alone, it is impossible to definitely support the claim that a new Ag—Ag bond 
that is 0.21 Å shorter than metallic Ag is formed in a recombinant protein. Nevertheless, no other 
reasonable models of Ag bound in the site provide better fits to the data. The Ag-SCys bond lengths 
(2.50-2.67 Å) are all consistent with other Ag-thiol compounds, as is the Ag-OBB carbonyl bond 
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length (2.69 Å). A number of water molecules were also included in the model, some of which are 
clear, while others appear merely as outgrowths of the Ag density. It appears that there is one water 
molecule associated directly with each Ag atom such that Ag1 appears to have two axial ligands at 
similar distances (a water molecule and the backbone carbonyl of R48C) and Ag2 has a similar 
pair of axial ligand: another water molecule and, curiously, a pyrroline nitrogen atom of heme. Of 
note also is the position of W51C, which moves closer to R48C so that the S—S distance is only 
4.20 Å, while R48C is more or less in the same position as in E-CuICcP or Cu(I)-CuICcP. It is 
unclear whether two silver atoms would assume a similar conformation in apo-CuICcP without 
heme. It is possible that the presence of heme enforces the (putative) close Ag—Ag bond and even 
supports the complex by donation of a π-ligand from a pyrroline nitrogen. 
 
 
Figure 6.10. Putative structure of a binuclear Ag(I) center in CuICcP crystals obtained by soaking 
in AgNO3 to a resolution of 2.21 Å. 
 
In addition to the exciting potential Ag—Ag bond in the CuICcP active site, there were two 
additional Ag binding sites: one buried in the heme proximal cavity and a second pair of Ag atoms 
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at the solvent-accessible native Cys128 (Fig. 6.11). The buried binding site houses one Ag(I) atom 
between residues Trp191 and Met230 (Fig. 6.11A) with a very short Ag—SMet bond length (2.29 
Å) as well as a backbone carbonyl at 2.61 Å provided by the Met residue. The unusual aspect of 
this binding site is that the Ag atom forms an apparent metallocene complex with the indole ring 
of Trp191 (Fig. 6.11B). The centroid of the metallocene bond is located toward the center of the 
ring between C2 and C3 of the indole ring, not the phenyl ring. As with the Ag—Ag bond in the 
heme distal site, an Ag bound to the indole ring of Trp would be the first of its kind reported. Based 
on the apparent centroid and the distribution of Ag—Trpindole bond distances (2.52-3.05 Å), Ag(I) 
forms a πoff(η
2) or πoff(η
3) complex12. Modeling of Ag—phenyl metallocenes suggest that a πcen 
geometry is preferred, but the indole N1 likely changes the energy landscape of the π-delocalized 
ring. The Ag-to-ring bond distances are consistent with these computations; the only Ag-Trp 
complex that has been reported, however, is Ag(I) bound to the free acid and amino termini of a 
free Trp residue13. It is surprising that such a Ag(I)-Trp complex has never been observed (or at 
least not reported if it has) because, from an energetic standpoint Trp has the greatest binding 
potential to Ag(I) of the aromatic amino acids; Met follows closely behind with similar ΔΔG°. Of 
the aromatic amino acids, only a Ag(I)-His complex is more stable; though His would be far more 
likely to coordinate by Nδ or Nε
14. A Met-Trp-Ag(I) site, therefore, is only of the most stable 






Figure 6.11. Two Ag(I) metallocene binding sites in CuICcP, crystal structure obtained at 2.21 Å 
resolution by soaking in AgNO3. The buried mono-Ag(I) site (A, B) depicts the first reported Ag-
Trpindole metallocene complex with short bond distances that suggest strong π interactions between 
Ag(I), Met230, and Trp191. Panels (C) and (D) depict a second bimetallic Ag(I) site with a weak 
metallocene interaction between Ag3 and Phe284. Cys128 is a ligand to both Ag(I) atoms at 
distances consistent with previously reported Ag(I)-thiolate complexes. 
 
The last Ag(I) binding site is also a binuclear site with a short Ag—Ag bond; however, unlike 
the active site Ag ions, the two Ag atoms are clearly resolved, and the Ag—Ag distance is a 3.06 
Å, which is more in line with previously reported Ag-thiol complexes, but certainly close enough 
to be considered a Ag—Ag bond. The two Ag ions (hereafter Ag3 and Ag4, Fig. 6.11C, D) each 
participate in a Ag—SCys bond and a metallocene-like interaction with Phe284 (Ag3) or (weakly) 
Phe219 (Ag4). In addition, each Ag ion has one O ligand from water (Ag3) and the backbone 
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carbonyl of Arg14 (again, weakly, Ag4). Sterics likely play a major role in the formation of this 
site due the presence of Phe219, Phe284, and Val10. Cys128 forms Ag—SCys bonds with both 
Ag(I) atoms at similar distances (~2.45 Å) consistent with thiolate bonds. The Ag3-Phe284 
interaction resembles a πoff(η
2) interaction, possibly a σ(η2) interaction since the centroid falls 
outside of the phenyl ring, centered between the C4—C5 bond of the phenyl ring. The long-range 
interaction between Ag4 and Phe219 is also centered between the same two ring carbons but is 
closer to an in-plane interaction and must largely be of σ character. 
 
6.6 X-ray absorption spectroscopy of Cu(I)-CuICcP 
Samples for XAS analysis were prepared by reconstituting Cu(I)-CuICcP as described above. 
Holo-protein was concentrated to 1-2 mM in 30% (w/v%), and rapidly frozen in a thin, x-ray-
transparent cassette in liquid nitrogen. Data were collected on the same beamline as described in 
Chapter 3 with the following modifications: samples were calibrated against a Cu foil standard for 
every scan, a 3 μm Z-1 Ni filter was used for collection, and the energy cutoff was raised to 13 
keV. X-ray absorption near edge (XANES) and extended fine structure (EXAFS) were processed 
in the Demeter software package (Athena and Artemis)15. The XANES spectrum (Fig. 6.12A) of 








Figure 6.12. X-ray absorption K-edge spectra of Cu(I)-CuICcP. The XANES are shown in (A) 
and are indicative of 3-coordinate Cu(I). The Fourier transform and k3-weighted EXAFS (inset) 
are shown in (B) for the second fit given in Table 6.2. Some scattering intensity is present at ~4 Å, 
likely contributions from Cu-Fe and Cu-NHeme scattering from the nearby heme prosthetic group, 
but these paths were not included in the first shell model. 
 
Two reasonable models of the primary coordination sphere were fit to the EXAFS (Table 6.2, 
Fig. 6.12B). The first fit requires two close SCys scattering atoms at a distance (2.22 Å) consistent 
with tight Cu-S binding and a second source of S scattering at a longer distance (2.82 Å). Inclusion 
of a low-occupancy water oxygen improved the fit. This second fit matches closely to the 3-
coordinate XANES; however, an exogenous sulfur ligand is required. If this were indeed the case, 
excess DTT could be the source if it were not completely removed from the protein sample before 
Cu reconstitution. The second model is more similar to the crystal structure with one close SCys 
scattering atom (2.15 Å), one more distant, weakly bound SCys (2.74 Å) and between 1-2 waters 
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(modeled best as 1.5 waters) of similar distance (~2.36 Å). This fit has mostly 3-coordinate 
character as well and is consistent with a low-occupancy water that was observed in the crystal 
structure. In either case, the EXAFS suggest that W51C rotates closer to any bound Cu(I) than is 
suggested by the crystal structure and does indeed act as a ligand to Cu(I), despite the indications 
of the Cu(I)-soaked crystal structure that it does not. In all fits, however, at a coordination number 
of at least 3 is required. The crystal structure suggests that the third ligand is most likely an oxygen 
atom from the backbone carbonyl of R48C. If this were the case, the chelating effect of the 
carbonyl of R48C helps to explain why Cu(I) was associated with R48C and not W51C when at 
low occupancy in the crystal structure. The presence of the third ligand does have implications for 
the potential function of CuICcP as a structural and functional model of SiRA. A trigonal planar 
3-coordinate geometry is strongly preferred by Cu(I) over Cu(II), which prefers a 4-coordination 
tetrahedra geometry; however, the Lewis acidity of any metal ion in the CuICcP R48C/W51C 
could be lowered by the presence of additional electron density supplied by the carbonyl oxygen. 
If Cu(I)-CuICcP is indeed 3-coordinate, it is also not an exact structural model of the 2-coordinate 
SiRA Cu(I) atom. 
 
6.7 Rational design of substrate binding site residues in CuICcP 
Briefly, the base CuICcP construct was assayed for sulfite reduction activity and found to have 
minimal activity similar to WT-CcP. Therefore, new mutations were required to increase activity 
and test whether CuICcP could become a functional model of Mcc SiRA. The shared features of 
the siroheme-SiR and MccA active sites include the “2-Lys, 1-Arg” motif in the substrate binding 
pocket. In the case of SiRA, this motif is fulfilled by residues Lys208, Arg366, and Lys393, which 
are proposed to play essential roles in the dehydration of sulfite to sulfide as with previously 
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proposed SiR mechanisms. Because the CcP residue Arg48 has been mutated into a cysteine as a 
part of the copper binding site, it is unavailable to mimic the role of Arg366 in the MccA model, 
unlike in SiRCcP, which retains Arg48 in a position analogous to the SiRHP residue Ar83. This 
fundamental difference in the base design necessitated a systematic search for appropriate sites to 
model the catalytic residues in CuICcP.  
To determine the relative positions of the conserved active site residues in SiRA, a 
computational model of a truncated SiRA monomer was constructed by removing the C-terminal 
region from residue 594-C-term, inclusive. This region comprises a long set of three helices that 
participate in trimer formation. Removal of the C-terminal region also necessitated omitting the 
8th heme. The same parameters used for CuICcP were applied to the native SiRA structure, and the 
NLys/Arg—Ssulfite distances for the conserved residues were measured over a 5 ns simulation for 
residues K208, R366, and K393. Additionally, the same measurements were applied to Y123, 
Y285, and Y301, the Tyr shown to position a water molecule and which likely play a crucial role 
in sulfite dehydration during sequential reduction2. These distances served as a guide for 
determining the appropriate bond-lengths between the substrate and putative mutant residues in 
the Cu1CcP scaffold. I limited the pool of potential residues based on the active site structure of 
SiRA using the Cα positions of the basic residues for structural alignment with Cu
ICcP. From the 
measured distances to the SiRA heme-Fe, an 11 Å sphere was described around the heme-Fe in 
CuICcP that should contain the comparable backbone positions for Lys and Arg of the proper 
distance from a bound sulfite molecule. This approach gave several possible orientations of the 
active site; though, mutation of Gly55 is likely the most promising position to place the catalytic 
Arg in the appropriate relative position to both sulfite and the bound copper atom. A larger number 
of possible positions exist for the Lys residues: His(Ala)52, Ser81, Gly84, Leu85, and Ser185 were 
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all viable Lys positions that have reasonable NLys/Arg—Ssulfite distances. Of the two substrate-
coordinating Tyr residues, Y285 and Y301, an intermediate position could be reasonably modeled 
by mutation of CcP residue S185, and the putative proton-donating Tyr123 could be reasonably 
modeled by mutation of Leu144 or Pro145. 
 
 
Figure 6.13. Process to locate potential mutation sites in CuICcP to mimic the conserve active site 
residues of W. succinogenes SiRA (B) Active site of SiRA with the first coordination sphere drawn 
as while sticks and the second coordination sphere colored green; reproduced from reference18. 
 
New constructs of CuICcP based on these models were designed and purified; however, many 
of the constructs either proved difficult to obtain in high yield or to reconstitute with heme b. 
Designed and purified constructs are listed in Table 6.3. Molecular dynamics simulation of S81K 
found that the mutant residue preferred to orient to solvent, as did a trial mutant for S81Y; G84K 
was found to orient away from heme. The remaining options, H(A)52K/R, G55R, L85K, and 
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S185Y were iteratively constructed and purified. Other options, including L144Y and G55K and 
the set of basic residues in the SiRCcP construct (P145K), were not initially constructed but remain 
viable options for future designs. Due to the easy of crystallization for the base construct, it is 
likely that three dimensional structures can be obtained for the active site designs that will provide 





From the expression profiles of the active site constructs, it seems that the problem site is L85K 
in terms of stability except in the case of the G55R/L85K double mutant, which expression and 
could incorporate heme normally. Inclusion of H52K in the double mutant, however, seemed to 
destabilize the protein, and heme incorporation was poor, yielding a mixture of heme species with 
low occupancy, possibly due to the increased positive charges without R48, which forms a 
stabilizing hydrogen bond with the propionic acid moieties of heme. S185Y could be incorporated 
without effect to protein purification in any permutation of the scaffold. 
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The mutant S185Y, despite lacking significant sulfite reduction activity, was also assayed for 
oxygen reduction activity. Owing to the structural similarity of the active sites by including of a 
heme-Cu center and an active site Tyr, and given previous studies from our lab on the importance 
of the active site Tyr F33Y and G65Y for the functional CuBMb models, it was possible that a 
heme-Cu-Tyr active site alone may be sufficient to impart oxygen reduction activity. The mutants 
CuICcP and S185Y-CuICcP were assayed for activity in the oxygen reduction reaction (ORR), for 
which the products are either water or reactive oxygen species (ROS), using a Clark electrode as 
previously described for CuBMb mutants
19. The proportion of reduced oxygen that generates ROS 




Figure 6.14. Comparison of the predicted position of S185Y mutation in CuICcP with the position 
of Y285 in SiRA (PDB: 4rkn)2 and the Tyr-dependent oxygen reduction activity of S185Y-
CuICcP. By alignment of the Cu atoms, the position of native SiRA Tyr285 overlaps well with the 
predicted position of the CuICcP S185Y mutation. Addition of one Tyr residue to the CuICcP 
active site results in a 60% flip from ROS to water production while the overall ORR rate remains 




It was found in the myoglobin models CuBMb and FeBMb of HCO that addition of an active 
site Tyr was necessary to confer oxidase activity20; whereas, the metal ion played a relatively minor 
(but important) role in weakening the O—O bind for heterolytic cleavage6. Furthermore, the 
position of the active site Tyr was found to be less important than the mere fact of its existence: 
namely, G65Y-CuBMb was much more active than F33Y-CuBMb and produced a higher 
proportion of water over ROS despite F33Y occupying a position that is a better structural mimic 
of the native HCO His-Tyr crosslinked residue. The results of the assay are given in Fig. 6.14 and, 
surprisingly, they follow closely with the initial experimental results of CuBMb. F33Y-CuBMb was 
initially reported with turnover rates of 5.4 μmol O2 min
-1, about 2-fold higher than WTswMb, and 
with 20-30% of O2 consumed transforming to ROS. In Cu
ICcP, the initial rates are similar to 
WTswMb (1.18 μmol O2 min
-1 with >90% ROS. With the addition of S185Y, the total O2 
consumption rate is 1.46 μmol O2 min
-1 with only 30% ROS. Inclusion of an active site Tyr residue 
in CuICcP changes the proportion of water produced in ORR by 60%. This dramatic change 
suggests that there is a minimal structural connection between heme-Cu active centers and that the 
conserved active site Tyr play similar roles, either as proton sources/hydrogen bonding partners 
for organized water molecules or as oxidizable residues that can donate an electron as a tyrosyl 
radical to the substrate. Indeed, both the numerous studies of CuBMb and now Cu
ICcP suggest that 
an active site Tyr dramatically improves heterolytic cleavage of oxygen bonds regardless of the 






6.8 Revisiting CuBCcP as a model heme-Cu center 
Nearly twenty years ago, one of the first biosynthetic models of heme-copper oxidase was 
designed in CcP, called CuBCcP. The original report examined only the binding of Cu(II) and 
Zn(II), finding that there was some apparent binding of both metal ions but that only Cu(II) was 
retained following gel filtration chromatography21. To make the Cu binding site, four mutations 
were made to introduce three His residues: R48H, W51H, H52A, and S81H, very similar to the 
set of mutations required to make CuICcP. No three-dimensional structure of the Cu(II)-CuBCcP 
complex was reported due to the inability to crystallize the protein. However, it was also 
discovered around this time that CuBCcP was a poor ORR catalyst, about half the activity of the 
base CuBMb model, and had poorer oxygen affinity. Thus, more effort was devoted to the CuBMb 
model, and CuBCcP was largely forgotten. Nevertheless, there is a great potential benefit to having 
a full suite of multi-electron reductases designed in a single protein scaffold: contributions from 
scaffold architecture can be almost entirely ignored when considering the minimal necessary 
changes to change one active center to another, something that is always a complex consideration 
when modifying a native protein or even when making comparisons to native proteins from small 
molecules and biosynthetic models. The intriguing connection between the heme-Cu centers of 
SiRA and HCO cannot be overstated, and neither can the differences between the SiRA and SiRHP 
active sites that lead to vastly different turnover rates and substrate selectivity. To be able to 
produce in a single protein scaffold—cytochrome c peroxidase—functional models of three unique 
active sites that all warrant meticulous comparison to each other is practically a dream-come-true 





Figure 6.15. UV-visible absorption spectra of the titration of (A) Zn(II) and (B) Cu(II) into 
CuBCcP, showing nearly identical changes in spectra. Reported as a paramagnetic quenching 
phenomenon between heme and the non-heme Cu, this mechanism is not possibly with Zn(II). 
Figure reprinted with permission from reference21. 
 
Despite the potential weakness of a 3-coordinate Cu(I) center in CuICcP, the weakest link and 
by far the largest unknown in this endeavor is the viability of CuBCcP. Revisiting the reported 
Zn(II) and Cu(II) binding spectra from the original publication, there is no clear difference between 
the so-called binding titration of Cu(II) compared to Zn(II); both appear to be a form of quenching 
or simply binding to an alternative site that distorts the heme geometry. To the point, Zn(II) could 
not interact magnetically with the heme Fe by paramagnetic quenching, so Cu(II) is likely binding 
to the same site as Zn(II), and neither is coupling to the heme in a way that could produce identical 
spectra. Upon close examination of the WT-CcP crystal structure, S81H seems unlikely to be able 
to assume the predicted conformation to yield a CuB-like binding site: Ser81 is positioned in a 
short helical turn loop, stabilized by hydrogen bonding, and rotated to that the functional group 
would “up,” away from heme or out toward the bulk solvent. To local rigidity of the Ser81 site 
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makes it unlikely to be able to migrate toward the other mutant His residues even if induced to do 
so by addition of Cu. 
 
Figure 6.16. Electron density maps (2Fc-Fo) of CuBCcP both (A) as-prepared and (B-E) with 
crystals soaked in 5 mM Cu(II). The structure of (A) E-CuBCcP and (B) Cu(II)-CuBCcP overlay 
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Figure 6.16 (cont.) nearly exactly except for the inclusion of Cu atoms in the latter structure. (B,C) 
Two Cu atoms are present in ~0.7 occupancy at the interface of residues S81H and D146. (D,E) 
An additional two Cu atom are found between residues D34/D35 and H60/D148; the H60/D148 
site is not the same protein-protein interface found in the Cu(II)-CuICcP structure. (F) Proposed 
alternate structure that may yield a CuB-like binding site that is compatible with the inclusion of 
S185Y (yellow, outlined). The P145H mutation could assume a conformation that is similar to the 
P145K mutation that was found to be stable in SiRCcP. 
 
Using conditions recently determined to yield excellent results for CuICcP, crystals of E-
CuBCcP and Cu(II)-CuBCcP, obtained by soaking crystals with CuSO4, were grown and diffracted 
to high resolution (~2.1-2.2 Å) by the same method used for CuICcP. Refinement parameters are 
given in Table 6.1. Conditions for crystal growth were similar to CuICcP with the key difference 
that crystals were only obtained by adding to the preformed drop a solution of CoCl2 from an 
additive screening kit (Hampton Research) to a final concentration of 10 mM, and high-quality 
crystals were obtained in 1-2 weeks. Crystals were not obtained by pre-mixing CoCl2 with the well 
buffer. The solved three-dimensional structure of E-CuBCcP and Cu(II)-CuBCcP were practically 
identical save for the inclusion of Cu(II) atoms in the latter structure. Absence of metal nuclei from 
the E-CuBCcP structure was taken to mean that CoCl2 did not co-crystallize with the protein. The 
critical feature of the E-CuBCcP structure is the position of S81H: the third mutant His residue is 
locked in a salt bridge with As146 and oriented toward the bulk solvent. No evidence of alternate 
conformations was present in the 2Fc-Fo or Fc-Fo maps. The crystallographic position of S81H 
matches closely with the predicted position based on the orientation of the native Ser81. The 
location of Cu ions in Cu(II)-soaked CuBCcP tracks closely with the positions Cu atoms found in 
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Cu(I)-soaked CuICcP (Fig. 6.16). Copper atoms are found again coordinated between His60 and 
Asp148 (instead of Asp135 due to a difference in the unit cell protein-protein interface) and 
between Asp34 and Asp35, but there is an additional pair of Cu atoms coordinated between 
Asp146 and S81H. The position of S81H does not change significantly from the Cu-free structure, 
and it is possible that the salt-bridge between S81H and D146 blocks Cu(II) from entering the 
heme cavity; however, even by rotating the functional group about the Cα to face optimally toward 
the other two mutant His residues, the Cu-His distance would still be ~1 Å too distant to form a 
bond Cu—NHis bond. 
The crystal structure of CuBCcP reveals the likely explanation for the confusing Cu(II) binding 
spectra: S81H is simply not in a position that can coordinate Cu(II). Ideally, as we shown with 
CuBMb, the Cu binding site should be able to support binding of both Cu(I) and Cu(II), but only a 
single pair of His would not provide a stable Cu(II)-binding site even if Cu(I) can potentially bind 
by linear coordination. The likely origin of the apparent heme absorption change is a change in 
electrostatics around the heme, potentially by binding to the propionic acid moieties; though, 
Cu(II) was not found in this position in the crystal structure. Further examination of the CuBCcP 
structure, combined with the knowledge gained from making the P145K mutation in SiRCcP (see 
Chapter 5), revealed a P145H mutation as a plausible alternative to S81H (Fig. 6.16F). The 
aromatic His sidechain may stack with heme, similar to R48C and W51C, stabilizing it to orient 
toward the interior of the heme binding pocket. An L144H mutation was also suggested by Jeffrey 
Sigman around the time of the original CuBCcP publication, and it is unclear which—if either—






In an attempt to make a structural and functional biosynthetic model of the recently 
characterize multi-cytochrome c sulfite reductase SiRA (Mcc SiRA), a triple mutant of CcP 
(R48C/W51C/H52A) was created, called CuICcP, to create a Cu-(SCys)2 binding site in the same 
protein scaffold used to make a biosynthetic model of siroheme-[4Fe-4S] sulfite reductase. The 
CuICcP construct was found to bind Cu(I) in an essentially 1:1 ratio with heme by both colorimetric 
assays and mass spectrometry; however, x-ray crystal structures of the metallated protein suggest 
that the Cu(I) adopts a 3-coordinate geometry between the two mutant thiol groups and the 
backbone carbonyl of R48C. The 3-coordinate nature of the Cu binding site is further supported 
by XANES and EXAFS. In the process of determining the 3D structure of CuICcP, a set of highly 
unusual Ag(I) metallocene binding sites were observed in Ag(I)-CuICcP including a first-of-its-
kind Trp-Ag(I)-Met binding site with Ag(I) coordinated to the Trp191 indole ring. The initial 
design of CuICcP was found to have minimal sulfite reduction activity, but inclusion of an active 
site Tyr (S185Y) was able to impart a significant amount of oxygen reduction activity similar to 
the biosynthetic CuBMb model. Further, on the basis of the similarities of the two heme-Cu centers, 
a re-examination of the structure of CuBCcP revealed that the S81H mutation is most likely not 
able to participate in Cu binding. 
 
6.10 Conclusions 
A structural model of Mcc SiRA was constructed in CcP, driving further toward the goal of 
generating biosynthetic models of both classes of SiR, despite their non-homologous folds, in a 
single protein scaffold. It remains to be seen whether the main point of structural contrast between 
the two sites, the likely 3-coordinate binding of Cu(I) in CuICcP as opposed to 2-coordinate 
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binding in native SiRA, has a strong impact on catalysis. If, as suggested by analysis of its crystal 
structure, the Cu(I) atom serves only as a redox-inactive Lewis acid to weaken the sulfur-oxygen 
bond in sulfite, the effect is likely to be minimal and leaves open the possibility of replacing Cu(I) 
with other transition metals or using hydrogen bonding in the second coordination sphere to tune 
the Lewis acidity of the non-heme metal. Non-heme metal substitution has so far proven 
impossible in native SiRA as not even the native Cu(I) could be reconstituted to restore activity in 
demetallated enzyme. The benefit of an even minimally functional SiRA model is the capacity to 
easily replace the non-heme metal or even the heme. A central question regarding the difference 
in activity between SiRA and siroheme-[4Fe-4S] SiR is the nature of the active heme: how is SiRA 
able to achieve SiR catalysis without siroheme (using heme c)? Is the non-heme metal necessary 
for this activity, and does it compensate in some way for the difference in electronic structure 
between sirohydrochlorin and protoporphyrin? These questions remain to be answered, but a 
biosynthetic model of SiRA is a promising approach to address them due to the modular nature of 
such constructs. Even more critical insights may be drawn by the direct comparison of SiRCcP to 
CuICcP, to very different active sites with identical scaffolds, with a disregard for overall protein 
structure that could not be ignored in the native enzymes. 
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DESIGN OF A BINUCLEAR PURPLE CU CENTER IN CYTOCHOME C PEROXIDASE: 
AN ALL Α-HELICAL NON-CUPREDOXIN SCAFFOLD FOR CUA 
 
Scaffold-induced effects in the second, third, and long-range spheres of protein-ligand 
interaction are important for producing certain remarkable effects observed in naturally evolved 
metalloprotein electron transfer (ET) centers. These subtle effects also present the greatest obstacle 
to creating functional models of biological metal redox centers. In this final chapter, I will describe 
the creation and characterization of the first example of a purple CuA center in a non-cupredoxin, 
natural protein scaffold—cytochrome c peroxidase (CcP)—by making only two mutations. The all 
α-helical binding site of this artificial CuA center shares the core Cu-binding ligands of native 
CuA—two His and two Cys residues arranged to create a diamond core motif that promotes a Cu-
Cu covalent bond—with virtually no structural homology to the cupredoxin fold. 
 
7.1. Structure and function of CuA: a purple binuclear Cu center  
The most well-studied ET centers, the blue copper proteins (type-I, or T1 Cu centers), exhibit 
high reduction potentials (Eº´), axial EPR signals with small Cu hyperfine coupling (A||, ~180 
MHz), and their namesake blue color from intense charge transfer (CT) bands1,2. These properties 
emerge from strong covalency of the inner sphere, particularly of the Cu—SCys bond, and a strained 
conformation of the Cu binding site enforced by the protein architecture—the so-called induced 
rack effect3—that creates a compromise between the optimal geometries of Cu(II) and Cu(I). The 
resulting strained trigonal monopyramidal conformation facilitates a nuclear reorganization energy 
of <1 eV to transition from Cu(II) to Cu(I)1,4 and allows rapid, reversible switching of the Cu(II/I) 
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redox pair. Though there have been many successful artificial redox catalysts based on biological 
redox centers both as small molecules and in natural and de novo protein scaffolds5,6, only a two 
examples of artificial blue copper centers have achieved properties approaching those of a 
biological T1 center. One such model was achieved by combining a di[2-(2-pyridyl)ethyl]amine 
ligand with a protein thiolate ligand7, and the other was previously created in a four-helical bundle. 
 
 
Figure 7.1. X-ray crystal structure of the CuA subunit of terminal oxidase in Thermus thermophilus 
with the diamond core Cu2S2 of CuA shown as an inset. The protein fold of all CuA subunits, like 
that of T1 Cu centers, is a Greek key β-barrel. Of the Cu-binding residues, both Cys, one His, and 
the axial Met and backbone carbonyl are located on a single loop. Reprinted with permission from 
reference8. 
 
There has been considerable success reproducing the closely related purple copper center (CuA) 
found in ET subunits in cytochrome c oxidase (COX) and nitrous oxide reductase (N2OR). The 
CuA center is a mixed-valence covalently bound Cu(II)/Cu(I) pair in the oxidized state with the 
single unpaired electron highly delocalized between nearly equivalent Cu nuclei [Cu(1.5)-
Cu(1.5)]9. The CuA copper binding domain is closely homologous to the Cu binding loops of T1 
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centers10, having a conserved 2His, 1Cys, and one distant (~2.8 Å) Met sequence. The CuA 
sequence has a second Cys positioned between the consensus Cys and the adjacent His residue to 
complete the Cu2S2 diamond core (Fig. 7.1). Like the T1 centers, CuA presents a small Cu—Cu 
hyperfine coupling constant (A|| ~ 120 MHz) and high Eº´ (~250 mV vs NHE) in addition to strong 
Cu—SCys covalency and intense CT bands. Artificial CuA centers have been created by 
transplanting the loop region containing the second Cys residue from native CuA into the Cu 
binding loops of the blue Cu proteins amicyanin11 and azurin12–15 and have provided insight into 
key structural and electronic properties of Cu redox centers16–19. A purple Cu center was similarly 
restored in cytochrome o quinol oxidase (CyoA)20, a vestigial copper binding loop whose ET 
function had been lost. Characteristic electronic, vibrational, and magnetic features of the CuA 
binuclear center are summarized in Figure 7.2. 
 
 
Figure 7.2. Representative electronic, paramagnetic, and vibrational spectra of native binuclear 
Cu centers. (A) The paramagnetic spectra of CuA contains a 7-line (sometimes unresolved) 
hyperfine splitting due to Cu—Cu coupling and A|| hyperfine constants (~120 MHz) that are 
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Figure 7.2 (cont.) smaller than mononuclear T1 centers (~180 MHz)21. (B) Resonance Raman 
spectra of COX and N2OR CuA have low energy ν(Cu-S) of ~345 cm
-1 indicative of tetrahedrally 
distorted T1 centers (typically ~360 cm-1) with lower Cu-S covalency due to the [Cu(1.5)-Cu(1.5)] 
bond17. (C) Comparison of magnetic circular dichroism (MCD) spectra from a mixed-valence Cu-
Cu model to native CuA. Relative to the mixed-valence model, the Cu-Cu interaction in CuA has 
significantly more π overlap due to the short Cu-Cu distance (2.4 Å) and also strong σ-bonding 
character, evidenced by the high-energy ψ→ψ* band. The S→Cu CT band is much lower in energy 
in CuA than the complex and is a consequence of lower Cu-S covalency and weak axial (Met) 
interaction, giving CuA a largely 3-coordinate character
18. (Images reprinted with permission). 
 
A critical common feature of these protein scaffolds is the presence of the cupredoxin domain, 
a Greek-key β-barrel composed of rigid antiparallel strands connected by short loops that constitute 
the copper binding sites. Decades of research have shown that elements of this domain can be 
flexibly transposed between cupredoxins to result in similar T1, CuA, and even red copper 
centers22. A number of small molecule complexes have successfully created valence delocalized 
Cu—Cu centers; however, these complexes have not reproduced the characteristic electronic 
(MCD and UV-visible absorption) or paramagnetic spectra of protein-bound Cu—Cu centers. One 
example of an artificial CuA center was reported by Tanaka and colleagues as from a modified 
version of the four-helical maquette in which they had previously engineered a T1 center23. This 
CuA-like species was confirmed to be a mixed-valence binuclear center that exhibited 
spectroscopic features consistent with natural and artificial CuA centers; though, it was highly 
susceptible to Cys oxidation, and its redox properties were not reported. Within natural protein 
scaffolds, there have been no successfully designed artificial binuclear copper centers without use 
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of the cupredoxin fold—specifically the Cu-binding loop—that could completely reproduce the 
characteristic features and high Eº´ of natural cupredoxin centers18,24–26. This body of work would 
suggest that there are properties imparted by the cupredoxin loop in its native fold that are unique 
and absolutely required to induce the specific entatic state of T1 and purple Cu centers. However, 
the success of the helical maquette system—despite its instability—confirmed that other scaffolds 
could support cupredoxin-like metal centers. What follows in this chapter is a new example of an 
all-helical CuA center in a natural protein. 
 
7.2. A CcP double mutant (R48C/W51C) forms a CuA-like binuclear Cu center 
The CcP purple Cu center was discovered accidentally in the course of designing mutants with 
the intention of perturbing the designed Cu-(SCys)2 binding site of Cu
ICcP (see Chapter 6). The 
native residue His52 was restored to CuICcP by quick-change mutagenesis to determine whether 
a “red copper”-type T2 center would be more stable, easier to characterize, or would improve 
sulfite reduction activity. The R48C/W51C-CcP mutant was constructed and purified as previously 
described27 (see Chapter 3 for a detailed description of the purification protocol used for mutant 
CcP). The sequences of the primers for the Ala52→His mutation are given below with the mutated 
codon highlighted: 
 
Listing 1: Primers for quick-change mutagenesis for R48C/W51C-CcP 
Forward primer: 5'-CTT GCT TGC CAT ATT TCA GGG AC-3' 




 The yield of this procedure, as is typical of CcP, was predominantly apo-protein. The mass 
spectrum (ESI-MS) is shown in Fig. 7.3. The presence and intensity of a Soret UV-visible 
absorption band at 410 nm corresponded to, typically, 3-7% hemoprotein content; though, the 
amount of hemoprotein could be reduced to <2% by rigorous ion exchange chromatography (QFF 
column). The double-mutant apo-protein alone was tested for whether it could bind Cu(II). Sub-
stoichiometric equivalents of CuSO4 were added to a solution of purified apo-protein in phosphate 
buffer, yielding an anomalous absorption spectrum. Upon addition of Cu(II), absorption at ~380 
nm rapidly increased (Fig 7.4). Continued addition of Cu(II) up to ~2.0 equivalents resulted in a 
gradual transition to a second species with absorption maxima at ~500 nm and ~850 nm. The 
intensity of the Soret band from residual hemoprotein was nearly equal in magnitude to the new 
species but did not appear to shift with the addition of Cu(II), so the initial heme spectrum could 





Figure 7.3. Mass spectrum (ESI-TOF) of purified R48C/W51C-CcP prepared by buffer exchange 
into ammonium acetate buffer (pH 7.0). Predicted mass from sequence: 33594 Da; Experimental 
mass: 33596 Da (minor peak of +22 Da, likely Na+). 
 
The heme-subtracted difference spectra revealed two distinct species. The first species, 
obtained by adding sub-stoichiometric equivalents of Cu(II), has λmax = 375 nm, a shoulder at 455 
nm, and a broad but well-defined peak at ~640 nm, resembling a red copper species. Subsequent 
isolation of this species by gradual addition of Cu(II) at 10ºC, however, revealed it to be vividly 
iridescent green in color. The intense transition at 375 nm is indicative of Cu-S charge transfer 
with highly axial, strong Cu-S σ interactions and weakened Cu-S π interactions (~450 nm) and is 
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similar to spectra of “red” Cu species28,29. The green color is apparently due to the d→d transitions 
being lower in energy (641 nm) than in reported red Cu species. 
 
 
Figure 7.4. Aerobic titration of CuSO4 into apo-R48C/W51C-CcP (difference spectrum, inset). 
 
The second species, which appeared rapidly after addition of ~0.5 equivalents of Cu(II) and 
coupled to the rapid disappearance of the green species, has absorption maxima at 355 nm, 486 
nm with a ~530 nm shoulder, and 841 nm, all of which strongly resemble the purple binuclear 
CuA. Continued addition of >2 equivalents of Cu(II) only resulted in gradual bleaching of the final 
species. Based on the intensity of the absorption bands, the apparent red/pink color of Cu-
reconstituted protein is likely due to the small but relatively intense heme absorption (ε410nm ~100 
mM-1 cm-1) mixed with the weaker absorbance of the ostensibly “purple” Cu center (~2-4 mM-1 
cm-1). Based on the apparent CuA spectrum, the R48C/W51C-CcP mutant was renamed to 
“CuACcP.” While initial Cu(II) reconstitution was conducted aerobically (Fig. 7.4), prior reports 
invoking air-sensitive reconstitution mechanisms (vide infra) suggested that anaerobic 
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reconstitution is preferred, and indeed, a greater yield and faster development of the purple species 
was obtained from anaerobic reconstitution of apo-CuACcP in Tris buffer (50 mM, pH 7.4). All 
subsequent preparations (unless otherwise indicated) were conducted anaerobically. 
 
 
Figure 7.5. UV-visible absorption spectra of the full anaerobic reconstitution of CuACcP by 
addition of 2.5 molar equivalents of Cu(II). (A) Raw spectra; (B) difference spectra with heme 
absorption subtracted; (C) isolated spectra of the two identified Cu-bound species. Complete 
reconstitution occurs within 5 minutes at 20°C. Arrows in (B) indicate the trajectory of absorbance 
change, and asterisks indicate isosbestic points. (C) The early green species and stable purple 
species are shown in their respective colors with absorption peaks indicated. 
 
Mixtures or sequential addition of Cu(II) followed by Cu(I) yielded more of the final purple 
species by ~1.26 fold, further suggesting that the purple species is a mixed-valence [Cu(II)-Cu(I)] 
or possibly delocalized {Cu1.5+}2 species. Lower yield of purple Cu species with Cu(II)-only 
reconstitution implied that the in situ generation of Cu(I) was either less efficient or that apo-
protein becomes oxidized in the process so that it cannot bind Cu. Less protein precipitates as a 
result of mixed valence Cu reconstitution as evidenced by the low absorption at <300 nm in the 
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difference spectrum (Fig. 7.6). Solutions of Cu(I) were prepared by comproportionation of Cu(II) 
and metallic copper: ~1 g of thin copper wire, cleaned in 10 mM EDTA and thoroughly washed, 
was immersed in an anaerobic solution of 10 mM CuSO4 in water and 5% acetonitrile by volume 
(~1 M acetonitrile) and allowed to equilibrate overnight before use. Cu(I) concentration was 
determined to be ~20 mM by bathocuproine assay. 
 
 
Figure 7.6.  Final difference spectra obtained by reconstituting apo-CuACcP with either CuSO4 alone (black 
trace) or by adding alternating sub-equivalents (0.10 eq.) of CuSO4 followed by an equal amount of Cu(I) 
stabilized in 1 M acetonitrile (red trace). Both spectra are normalized to the maximum absorbance of the 
Cu(II)-only reconstitution. 
 
X-band constant wave (CW) electron paramagnetic resonance (EPR) spectra were collected to 
further characterize the early green species and the final purple species (Fig. 7.7). The purple 
species is axial (g|| > g) and similar to other reported mixed-valence CuA centers
30. A simulated 
fit of the spectrum could be obtained by modeling a binuclear center of two equivalent Cu1.5+ with 
an extremely small Cu—Cu hyperfine coupling constant, Az = 11.95 MHz (Table 7.1). This Az 
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value is ~5-fold smaller than the native CuA species that most closely resembles the spectrum for 
the purple CuACcP species, the soluble CuA subunit (called PdII) of P. denitrificans
17. Even in 
PdII, however, a well-defined seven-line hyperfine pattern is clearly discernable in the g||, but this 
feature is not resolved in CuACcP. Such an ultra-small hyperfine splitting may well obscure the 
typical seven-line pattern in the CuACcP species, but silencing of the splitting implies that the 
coordination environment of both coppers in the binuclear center is be more equivalent than in 
native CuA. A similar effect has been reported for the axial Met to His mutation in CuAAz, which 
resulted in replacement of the axial Met with water and creation of a high-symmetry site with the 
trans carbonyl ligand19. 
We also obtained EPR spectra of the green intermediate by mixing apo-protein with 0.6 
equivalents of Cu(II) and rapidly freezing the solution (<10s). The green species has features of a 
T2 center (Table 7.1) and well resolved N—Cu hyperfine splitting in g. Due to the rapid formation 
of the binuclear species, however, ~30% abundance of the binuclear species is apparent in the 
sample despite reconstitution with sub-equivalents of Cu(II). This mixture of species was included 
in the simulation of the T2 species, and no additional species were required to fit the data. The 
large Az hyperfine constant (505.7 MHz) of the CuACcP green species is more similar to a red Cu 
center22,28,29 than the tetragonally distorted T1 “green” Cu centers31, apparent color 
notwithstanding. The presence of nitrogen hyperfine features means there is at least one His ligand 
in addition to SCys thiolate coordination, presumably the restored His52. The structure of wild type 
CcP would make the 2-His, 1-Cys ligation of a nitrosocyanin-like red Cu center extremely unlikely 
(the closest His ligand to His52 is His175 at a distance of ~4.5 Å for a mono-Cu species). A Cu(II)-
(SCys)2NHis-solvent complex like the green mononuclear Cu(II) intermediate isolated from Thermus 
thermophilus cytochrome ba3 oxidase CuA,





Figure 7.7. EPR spectra of the binuclear species (top) of CuACcP and the green intermediate 
(bottom) following anaerobic reconstitution with Cu(II). Spectra have been normalized to their 
minima. Experimental data are drawn as black lines, and simulated spectra as red lines. Samples 








7.3. CuACcP redox potential 
The reduction potentials of CuA centers vary less than the T1 centers, whose reduction potential 
varies widely depending on the axial ligand. In CuA, the axial Met is strictly conserved, and all 
measured reduction potentials for CuA are in close agreement within the range of 200-300 mV 
(SHE) and centered near ~260 mV8. The reduction potentials (Eº´) of model CuA centers have been 
accurately determined by titration with [Ru(NH3)5Py]·ClO4
13. The reagent was freshly prepared, 
and a redox titration was performed on Cu-reconstituted CuACcP as previously described
13. The 
results of the titration are given in Fig. 7.8 and show a steady decrease in absorbance at 831 nm as 
the metal center is reduced, finally saturating at ca. 20 equivalents of the Ru-complex. The 
midpoint potential of the Ru complex shifts as the ionic strength of the solution changes as a result 
of the titration, so a linear extrapolation to the equilibrium constant at [Ru(NH3)5Py]
2+ = 0 mM is 
required to determine the midpoint potential of the target species. The fit to the linear region of the 
equilibrium constant K is shown in Fig. 7.8D, from which it was determined that Eº´ of the 
binuclear Cu center is 251 mV (vs. SHE). Reduction potentials for native CuA from COX and 
CuAAz measured by the same method were found to be 240 mV and 254 mV, respectively
13, and 
these measured values are in general agreement with other determinations33–37. Therefore, the 






Figure 7.8. (A) Electronic absorption spectrum of the final product in [Ru(NH3)5Py]·ClO4 
synthesis. (B) Voltammogram of the complex measured under the same conditions as the redox 
titration (Ag/AgCl reference electrode calibrated to NHE -307 mV). (C) Scatter plot of the 
absorbance of the CuACcP sample at 831 nm during redox titration by [Ru(NH3)5Py]·ClO4 
complex with the electronic absorption spectrum of the titration in the NIR region (inset). The 
broad peak at 831 nm is unimpacted by the absorption from the Ru2+ complex and was therefore 
chosen as a point of reference. (D) Scatter plot of K for the CuACcP redox titration. The value of 
K used to determine the reduction potential of CuACcP copper center was the value for a linear fit 






7.4. Determination of CuACcP structure by X-ray absorption spectroscopy 
X-ray absorption near-edge (XANES) and extended fine structure (EXAFS) spectra of the 
binuclear purple species and T2 green species in CuACcP were collected to determine whether the 
structures of these species are similar to previously studied CuA structure or any of its precursors. 
CuACcP hemoprotein reconstituted with Cu(II) was also examined since the hemoprotein made up 
a small percentage of the total protein in all samples and was observed to bind Cu(II) (see below). 
XANES and EXAFS data were collected at the same beamline and analyzed as described in detail 
in Chapter 3 with slight modifications: samples were calibrated against a Cu foil standard for every 
scan, a 3 μm Z-1 Ni filter was used for collection, and the energy cutoff was raised to 13 keV. 
XANES and EXAFS data were processed and analyzed with the Demeter software package 
(Athena and Artemis)38. 
The XANES spectra (Fig. 7.9) of all species display a pre-edge peak (8982 eV) that is least 
intense for the Cu2+-hemoprotein, more and equally intense for both the T2 and CuA (oxidized) 
species, and the most intense for CuA reduced with ascorbic acid. The increase in pre-edge intensity 
and corresponding decrease in the first post-edge peak (8994 eV) are indicative of an increasing 
degree of Cu(I) character with the greatest Cu(I) character belonging to the ascorbate-reduced CuA 
species (blue trace, Fig. 7.9) and the greatest Cu(II) character displayed by Cu(II)-hemoprotein. 
The pre-edge feature also suggests that both the T2 species and the purple binuclear species have 
some mixing of 3-coordinate and 4-coordinate Cu(II) character; whereas, upon reduction the 
purple binuclear species is significantly more 3-coordinate, perhaps indicating the weakening or 
loss of axial ligands and leaving primarily the [NHis-2SCys]Cu coordination to conform to the 





Figure 7.9. XANES region of the x-ray absorption spectra of all Cu-reconstituted CuACcP species 







Figure 7.10. Fourier transform and EXAFS (inset) of the mononuclear T2 intermediate (prepared 
with 0.6 equivalents of Cu(II)). Experimental data are shown as solid black lines, and fits are 
shown as red lines. 
 
 
Figure 7.11. Fourier transform and EXAFS (inset) of (A) oxidized (as prepared) CuACcP 
reconstituted with 2.0 equivalents of Cu(II) and (B) subsequently reduced with ascorbate. 
Experimental data are shown as solid black lines, and fits are shown as red lines. Parameters used 







Figure 7.12. Putative Cu-binding site geometry of Cu-reconstituted CuACcP. Sulfur atoms, Cu 
atoms, and nitrogen atoms are depicted as yellow, green, and blue spheres, respectively. Two axial 
ligands are presumed to be present, one of which may be supplied by the backbone carbonyl of 
Cys51 and the other by water, but they were not well-resolved in the XAS data. 
 
EXAFS fit parameters for the green T2 species and both the oxidized and reduced CuA species 
are given in Table 7.2. The EXAFS of the T2 species (Fig. 7.10) indicate a mononuclear Cu center 
that is best fit with a coordination N = 3 consisting of one Sγ (Cys) ligand, one N (His) atom, and 
one oxygen atom (likely water) in the first shell. It should be noted that, though this model of N 
and O distances resulted in the best fit and is more consistent with typical His-Cu distances, the 
assignment of O and N atoms at the resolution obtained from this sample is not definitive. 
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For the purple CuA species (Fig. 7.11), good fits for samples in both the [Cu(II),Cu(I)] and 
[Cu(I),Cu(I)] oxidation states were obtained by modeling both species as binuclear Cu—Cu 
centers with 1 Cu, 2 SCys, and 1 NHis scattering atoms per Cu. Importantly, the best fits modeled a 
Cu—Cu distance of 2.46 Å in the chromogenic oxidation state, ostensibly [Cu(II),Cu(I)] or a 
mixed valence [Cu(1.5),Cu(1.5)] center, which is Cu—Cu distance consistent with previously 
studied native and biosynthetic models of CuA. In the reduced species (all cuprous), the best fit is 
obtained with a slight shortening of both the Cu-SCys and Cu-NHis bond distances while the Cu—
Cu bond lengthens by 0.15 Å, changes that are consistent with increased electron density on the S 
atoms upon reduction and may be an indication of loss of covalency. The Cu—S and Cu—Cu 
bond lengths determined by EXAFS are consistent with prior measurements and crystal structures 
of native CuA centers for the Cu—Cu distance is typically 2.4-2.5 Å
32,39–44. From the EXAFS data, 
a putative model of the CuACcP copper-binding site can be constructed as in Fig. 7.12. Of note is 
that, because the Cu—NHis distances could be determined with high certainty to be ~1.9 Å, even 
in the reduced state, the position of His175, the only nearby His available to act as a ligand aside 
from His52, would still be 1.1 Å too distant to form the experimentally determined ligand-metal 
bond distances without significant deviation from His175, His52, or both from the available 
hemoprotein crystal structures of CcP. Both C48 and C51 are presumed to form the Cu2S2 diamond 
core with the participation of His52, so His52 is not likely to move significantly closer to His175. 
His175, however, is oriented by a set of strong hydrogen bonds linking it to D235 and W191 in 
the CcP hemoprotein structure. It would seem more likely that His175 migrates closer to His52, 
but in the absence of a 3D structure of CuACcP in any form, how it would do so and what hydrogen 




7.5. Mutation of the CuACcP primary Cu ligands 
In order to determine the critical residues involved in Cu-binding and formation of both the 
green T2 intermediate and the CuA center of CuACcP, each of the residues Cys48, Cys51, and 
His52 were mutated to Ala and His175 to both Ala and Phe to systematically study the effect on 
Cu binding. All of these CuA knockdown mutants were capable of binding at least one equivalent 
of Cu, but neither of the Cys→Ala mutants bound a second equivalent of Cu to form CuA. Instead, 
both R48A and W51A formed “red” Cu mononuclear centers that were similar to each other but 
distinct from the previously described green T2 intermediate (Fig. 7.13). In both Cys→Ala 
mutants, Cu-Cys charge transfer bands form with maxima at ~380 nm, similar to 2Cys CuACcP, 
but with the ~450 nm shoulder severely reduced or, in the case of R48A, entirely absent. Likewise, 
the d→d transition at ~620 nm is prevalent in the R48A mutant but diminished nearly to absence 
in the W51A mutant. 
The intensity of all charge transfer bands for both Cys→Ala  mutants is much weaker than 
when both Cys are present. In both cases, approx. 3-5 equivalents of Cu(II) are required to reach 
saturation (though, for the W51A mutant, a stable saturation point was not reached before a large 
excess of aqueous Cu(II) was apparent in the different spectrum). Neither Cu center was 
particularly stable, each decaying within a few tens of minutes to ~1 hour after reconstitution. EPR 
spectra of the Cys→Ala mutants show that both species are highly similar mixtures of at least two 
T2 species that lack N hyperfine splitting (Fig. 7.14), suggesting that coordination by His52 is lost 
in both species. Owing to the apparent lack of His coordination and relative instability of the 
Cys→Ala mutants, it is likely that Cu(II) is bound to the protein only by a single Cys residue, 
similar to the early intermediate capture complex identified in native CuA and CuAAz, which has 
similar spectroscopic features and is presumed to have a single Cu-Cys interaction14,32. The two 
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Figure 7.13. Difference spectra of reconstitution of (A) W51A- and (B) R48A-CuACcP by titration 
of sub-equivalents of Cu(II). Up to 10 equivalents of Cu(II) were added to the W51A mutant 
without saturation, but an excess of aqueous Cu(II) was apparent in the difference spectrum. The 
absorption spectrum of W51A-CuACcP lacked a strong d→d charge transfer band at ~600 nm. The 
R48A mutant displayed saturating binding behavior up to ~4.5 equivalents of Cu(II) and a strong 
d→d band similar to the spectrum of the 2Cys CuACcP, but the ~455 nm shoulder on the ~375 nm 






Figure 7.14. X-band CW EPR spectra of R48A- and W51A-CuACcP mutants. The paramagnetic 
spectra of both species are nearly identical and are composed of at least two distinct T2 species. 
Shown in (A), both Cys→Ala mutants in comparison to CuSO4 in Tris buffer. The difference 
spectra between the Cys→Ala mutants and free Cu(II) does not account for either of the T2 
species. In (B), both mutants are shown in comparison to the CuACcP hemoprotein reconstituted 
with Cu(II). Vertical lines indicate close overlap between the g|| of the mutants and the 
hemoprotein, suggesting that hemoprotein contamination may account for part of the spectrum. It 
is also likely that two conformations of Cu-SCys are available to each mutant based on Cys 
rotamers, making the resulting spectra highly similar. 
 
Mutation of His52 to Ala produced an interesting result: addition of one equivalent of Cu(II) 
to apo-H52A-CuACcP resulted in formation of a highly unstable species with UV-vis absorption 
features nearly identical to the green T2 intermediate (Fig. 7.15). Addition of sub-equivalents of 
Cu(II) revealed that the decay of this species accelerated with an increasing concentration of Cu(II) 
without formation of any CuA-like species. At greater than 0.5 equivalents of Cu(II), the increase 
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in absorption from Cu(II) binding decreased with increasing Cu(II) concentration before rapidly 
decreasing to baseline until continued addition of Cu(II) yielded no increase in absorption above 
baseline. This behavior suggests that not only is Cu(II) leaving the protein binding pocket but that 
an irreversible process is taking place. Likely, the protein is becoming oxidized by Cu(II), a process 
that is supported by its apparent acceleration with increasing Cu(II) concentration; alternatively 
(or, perhaps in addition), Cu(I) could bind to the protein, saturating the available binding site. If 
protein oxidation were to proceed via Cys oxidation to cystine disulfides, two equivalents of Cu(I) 
would be generated for every equivalent of oxidized protein. 
 
 
Figure 7.15. Reconstitution of apo H52A-CuACcP (Cu
ICcP) with Cu(II). (A) Time-dependent 
reconstitution by rapid addition of 1 equivalent of Cu(II) and (B) the single-wavelength rate of 
formation and decay of the resultant “red” Cu species. (C) Formation and decay of the “red” Cu 
species with addition of sub-equivalents of Cu(II). The rate of decay accelerated with increasing 




The similarity of the Cu(II)-bound species of H52A mutant to the green T2 intermediate is 
strong evidence that the intermediate is a Cu(II)-(SCys)2NHis complex, that the electronic absorption 
pattern is determined largely by the Cu(II)-(SCys)2 interaction, that His52 is necessary to stabilize 
the complex, and that all three residues (C48, C51, and H52) are required in order to form CuA. 
Probably the (SCys)2NHis motif, as it is locked in place by the α-helix that contains the two Cys 
residues, acts as a chelate complex for rapid Cu(II) capture. 
 
 
Figure 7.16. Electronic absorption spectra (UV-vis) of H175F and H175A mutants of CuACcP. 
Both species form transient T2 intermediates and binuclear Cu species that differ from the native 
H175 spectra. The H175F mutant (left) has a T2 intermediate (green) that is nearly identical to the 
native H175 spectrum. The spectrum of the binuclear species (violet) has ~490 nm Cu-S charge 
transfer peak with less splitting and a blue shifted Cu-Cu ψ→ψ* peak than in H175, suggesting a 
shorter Cu-Cu distance. The spectra of the H175A mutant (center) are similar but with red-shifted 
T2 intermediate charge transfer and Cu-Cu peaks relative to H175. (right) Reconstituting the 
H175A mutant in the presence of 2 equivalents of imidazole (dotted lines) produces ~50% more 
binuclear species with a significantly blue-shifted ψ→ψ* peak (864 nm → 842 nm) than without 
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Figure 7.16 (cont.) the added ligand (solid lines). The maximum absorption of the transient T2 
species is equal regardless of the presence of imidazole. 
 
In the crystal structure of native CcP, His175, the proximal heme ligand in native CcP that, 
would be considered too distant to form a CuA center by naïve inspection. Nevertheless, His175 is 
the only nearby His, meaning it is the only candidate residue to form a symmetrical CuA center as 
in the native and model cupredoxins. His175 was mutated to Ala to completely remove any 
potential binding and to Phe, as a non-bonding His structural analogue, to determine whether 
His175 is indeed a ligand to the binuclear species in CuACcP. When these mutants were 
reconstituted with Cu(II), a transient purple species (lasting only for several minutes) formed after 
proceeding through a species highly similar to the green T2 intermediate but with broad 
background absorption (Fig. 7.16). These results were surprising, but they are consistent with the 
reported effects of mutating His120 in CuAAz that demonstrated that an (unidentified) endogenous 
ligand could take the place of the second His to form a stable binuclear center45–47. The binuclear 
species that forms in either H175A- or H175F-CuACcP is not stable and decayed too quickly to 
reliably capture. However, the binuclear species in H175F mutant was notably more stable than in 
H175A, indicating that sterics play a role in maintaining Cu—Cu bond stability. The stability of 
the more conformationally open H175A mutant could be increased by the addition of 2 equivalents 
of imidazole to Cu(II) reconstitution, increasing the yield of the binuclear species by 1.5-fold and 
causing a blue shift of the ψ→ψ* peak from 864 nm to 842 nm, which is the same as native H175 
(further addition of imidazole gave only negligible improvements). From the formation of a purple 
binuclear species (albeit transient) in the H175A/F mutants by the addition of only Cu(II), clearly 
the Cu capture and reduction mechanism does not depend on the second, non-chelating His. 
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Further, the Cu—Cu derived ψ→ψ* transition remains at ~840 nm in both H175A/F mutants, 
indicating that the Cu—Cu bond distance is determined mostly by the structure of the 
Cys48…Cys51-His52 helix and helix terminal loop with little influence from more distant His175. 
However, significant loss of stability of the binuclear center with replacement of His175 by non-
bonding residues does indicate that His175 is a coordinating residue for the binuclear center that 
is necessary for stability and that, when His175 is removed (unlike CuAAz), no nearby residues 
are available to replace it. 
 
7.6. Kinetics of Cu species formation in CuACcP 
The formation of the green T2 intermediate is very rapid, and further careful titrations revealed 
it to be unstable even at very low Cu(II) concentrations (<0.10 molar equivalents), slowly 
converting to the purple species regardless of total Cu(II) concentration. Stopped-flow UV-vis 
spectroscopy at a controlled low temperature (15°C) was used to investigate whether other short-
lived intermediates might be involved in the formation of the green intermediate, such as the 
transient Cu(II)-SCys-X3 capture complex observed in both Tt CuA and CuAAz
14,32, or formation of 
the final purple species, such as parallel pathways as described for CuAAz
14,15. Solutions of either 
1 or 2 equivalents of Cu(II) were rapidly mixed with apo-protein, and the resulting absorption 
spectra were collected for a period of 10s, 50s, or 1000s under both aerobic and anaerobic 
conditions. Anaerobicity was achieved by repeatedly washing the stopped flow instrument with a 
high concentration of aqueous dithionite to scavenge molecular oxygen followed by thorough 
washing with oxygen-free buffer maintained under continuous argon flow. The difference spectra 





Figure 7.17. Stopped-flow difference spectra at 10 s (A-C), 50 s (D-F), and 500 s (G-I) of apo-
CuACcP with 1 eq. (A, D, G) or 2 eq. (B, E, H) of Cu(II) added under aerobic conditions and 2 eq. 
of Cu(II) added under anaerobic conditions (C, F, I). Time-dependent traces of wavelengths 
associated with either green (410/456 nm) or purple (486 nm, 945 nm) species with minimal 
overlap are shown in the insets. Concentration of apo-protein after 1:1 mixing was 150 µM, and 
all experiments were conducted at 15°C. 
 
For one equivalent of Cu(II), the spectra collected over the first 10s after mixing show a single 
species previously identified as the green intermediate appearing and quickly reaching half-
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saturation by ca. 100 ms. Due to limitations of the spectrometer at energies higher than ~400 nm, 
the species was monitored by its d→d transition band at 644 nm. The first species remains stable 
until ca. 23.5s, beyond which absorbance of the ~840 nm feature becomes apparent. At longer 
time intervals, no additional species could be identified. 
When 2 equivalents of Cu(II) were added, there was little observable difference between 
aerobic and anaerobic conditions over the first 10s regarding the formation of the green species or 
the initial formation of the purple species. Regardless of whether 1 or 2 equivalents of Cu(II) were 
added, the same maximum amount of the green species was formed, and in both cases the onset of 
absorbance at 486 and 844 nm occurred at ca. 3s, or approx. 10-fold more rapidly than with only 
1 equivalent of Cu(II). This sharp increase in the rate of binuclear species formation implied a 
second order process as the rate-limiting step. By 50s the concentration of the purple species had 
reached about half-maximum with no absorbance attributable to additional intermediates, and by 
500s both the aerobic and anaerobic samples had essentially reached saturation to nearly equal 
final concentrations of the purple species. Isosbestic points in the same locations as indicated in 
Fig. 7.5 are visible over all the time intervals and copper concentrations that were examined. These 
results differ from stopped-flow studies of purple binuclear Cu species formation in Tt CuA, which 
involved two intermediates: a transient T2 capture complex and a long-lived T2 green Cu 
intermediate32. The results of CuACcP stopped flow analysis also differ from results of the same 
experiment performed with CuAAz, which under anaerobic conditions was found to involve two 
intermediates similar to the Tt CuA, and under aerobic conditions a T1 species also formed
14,15. 
Kinetics of Cu incorporation into CuACcP from the stopped flow absorbance vs time data for 
two equivalents of Cu(II) under aerobic conditions were modeled by global fitting analysis 
performed by SpecFit/32. Several plausible models were attempted for the in situ generation of 
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Cu(I) necessary to form the final mixed-valence purple species. The two closely positioned Cys 
residues in the Cu binding site allow the formation of oxidized apo-protein disulfide bonds that 
provide two reducing equivalents per protein monomer. Disulfide formation that yields two 
equivalents of Cu(I) could proceed by reaction of apo-protein with two equivalents of Cu(II), as 




Attempts to fit the data by this mechanism, which is the commonly accepted mechanism for 
generation of Cu(I) from Cu(II) by CuA proteins in vitro, did not converge for the critical Cu(II)-
mediated step, as shown in the fit statistics above. This result is not unexpected: formation of the 
T2 species is very rapid and leaves very little apo-protein available to provide reducing 
equivalents. Another possible pathway is by disproportionation of protein-bound Cu(II) to 
generate an oxidizing equivalent and Cu(I). Disproportionation that removes oxidizing equivalents 
onto the protein scaffold via Cys oxidation could proceed by reaction between a Cu(II)-bound T2 









Alternatively, disproportionation could occur by the interaction of two T2 intermediates to 
yield a protein sulfhydryl radical, a purple binuclear species by concerted Cu(I) transfer/Cys 




Of the latter two mechanisms, only Model 3 converged or could give reasonable errors and 
unambiguous rate constants. The Model 3 calculated trajectories of the T2 and CuA species fit 
quite well to the experimental data for T2 intermediate formation and reasonably well to the purple 
species (Fig. 7.18). The disproportionation step was calculated to be rate determining. Further, this 
fit matched well with the formation of the purple species being concomitant with the disappearance 
of the T2 species without any apparent lag. Any model that requires sacrificial equivalents of 
217 
 
oxidized apo-protein predicts that reconstitution with a mixture of Cu(II) and Cu(I) would yield a 
higher concentration of the binuclear species, which is in indeed the case, and fits well with Model 
3. This model alone, however, cannot explain why the rate of purple species formation is slower 
when only one equivalent of Cu(II) is added despite the rate of formation and maximal 
concentration of T2 species being approximately equal when two equivalents of Cu(II) were 
added. The rate of binuclear species formation according to Model 3 is determined by the 
concentration of T2 species, and additional Cu(II) would not accelerate this process once T2 
saturation had been achieved. However, the calculated rate constants for the relevant steps (k2 and 
k3) do not overlap, but they are similar (see Table 7.5). It is possible that under Cu-replete 
conditions, the Cu(II)-mediated oxidation of the sulfhydryl radical (k3) is rate limiting. Extinction 
coefficients for the major peaks as determined by Model 3 are given in Table 7.6 and are consistent 






Figure 7.18. Global spectral analysis of Cu reconstitution of CuACcP by a concerted Cu(II) 
disproportionation model (Model 3). (A) kinetic traces of species included in the fitting model. (B) 
Two chromogenic species were identified as the green T2 intermediate and the binuclear purple 
Cu species. Due to limitations of the stopped-flow UV spectrometer, only data of wavelength > 
360 nm could be obtained. Peak wavelengths and extinction coefficients for the T2 and binuclear 
species derived from this simulated fit are given in Table 1. Rate constants for each process are 
given in Table S1. The reconstitution outcome predicted by this model is ~60% CuA formed from 
apo-protein, complete consumption of the green T2 intermediate, and accumulation of Cu(I). (C, 





Kinetic analyses of Cu(II) binding in CuACcP show that the first equivalent of Cu(II) binds at 
least two orders of magnitude more rapidly than in CuAAz biosynthetic model and even native 
CuA
14,32. The rigid structure of the green T2 intermediate binding site apparently provides an 
excellent Cu(II)-chelating pocket and allows the protein to bypass the early “capture” complex, 
the conversion of which to a long-lived T2 intermediate in the cupredoxin scaffolds is a slow 
process32. Interestingly, both the green and purple species formed in the presence of one equivalent 
of Cu(II), even though the rates of formation are slower (by approximately 10-fold) than in the 
presence of two equivalents and the maximum concentrations of the green T2 intermediate that 
formed first were approximately equal. This observation directly implicates an interaction between 
the T2 species in the process of binuclear species formation, and this mechanism (Model 3) 
provides the best fit to the time-dependent evolution of the binuclear species; though, since the 
Cu(II) binding site is presumably buried inside the protein scaffold, the mechanism of Cu transfer 
cannot be determined from the kinetics data. Additionally, the amount of binuclear species 
recovered by alternating addition of Cu(I) is less than the amount of oxidized apo-protein predicted 
by the kinetic model (ca. 35%). The ~25% increase of the binuclear species yield is similar to what 
has been achieved in CuAAz reconstituted with a mixture of Cu(II) and Cu(I), which is thought to 
proceed through a similar mechanism when reconstituted with Cu(II), and is a closer match to the 
predicted outcome of Models 1 and 2. The rate of T2 intermediate conversion to the binuclear 
species through Cu(II) alone is predicted to be sufficiently rapid compared to Cu(I) binding that a 
significant amount of apo-protein oxidation could still occur even in the Cu(I/II) mixture. It is 
worth noting that the earlier reported model of an all-helical CuA center was not reported to proceed 
through a mononuclear intermediate and, like CuAAz, could form a T1 center
23, suggesting that it 
may undergo a different formation pathway than native CuA centers. 
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7.7. Cu-bound CuACcP hemoprotein is a T2 mononuclear Cu center 
The parameters for the best fit of the EXAFS of the Cu(II)-hemoprotein (Cu(II)-CuACcP-HP) 
are given in Table 7.7, and the Fourier transform and fit are shown in Fig. 7.19. One Cys, one His, 
and two water molecules are included in the first shell. Both the Cys and His residues are modeled 
at unusually long distances (2.46-2.48 Å), but the Cu-FeHeme distance is reasonable. The closer of 
the two waters is modeled at a distance consistent with it acting as a µ-bridging ligand between 
the heme-Fe and bound Cu(II) ion, an unusual heme-Cu binding motif. Inclusion of heme-Fe and 
two heme pyrroline N atoms in the second scattering shell dramatically improved the fit and 
reinforce the position of the Cu atom relative to the heme Fe. A second model that resulted in a 
reasonable fit included 2 Cys residues, but this model could not accommodate NHis. The 2-Cys 
model is also included in Table 7.8. A definitive structure of Cu(II)-CuACcP-HP could not be 
determined from the XAS data alone, but a likely position of the bound Cu(II) in the solution 
structure would lie between the heme Fe and Cys48 with SCys48, NHis52, and a pair of water 




Figure 7.19. Fourier transform and EXAFS (inset) of the Cu(II)-reconstituted CuACcP-
hemoprotein. Experimental data are shown as solid black lines, and fits are shown as red lines. 
 
An x-ray crystal structures were obtained for CuACcP-HP and Cu(II)-CuACcP-HP at high-
resolution (1.54 Å). Electron density maps of the heme binding site of the hemoprotein are shown 
in Fig. 7.20 and for the Cu(II) reconstituted hemoprotein in Fig. 7.21. Table 7.8 contains the 
solution statistics for each structure. The structures were solved by molecular replacement against 
the structure of WT-CcP (PDB: 2cp) with Phenix and WinCoot. Crystals were grown aerobically 
at 4°C by hanging drop vapor diffusion. Rigorously purified CuACcP-HP was mixed 1:1 (4 μL 
drops) with well buffer that contained 10-20% (w/v%) polyethylene glycol, average molecular 
weight 2000 or 3350 and 100-200 mM potassium iodide or potassium thiocyanate. Identical trays 
were set up with the addition of 0.5 mM ZnCl2 or CuSO4 to obtain metallated structures. Crystals 
grew in 12-24 hours and were harvested quickly thereafter in 20-30% glycerol plus well buffer or 
mother liquor and snap frozen on nylon loops in liquid nitrogen; no crystals grew from the wells 







Figure 7.20. Image of typical CuACcP-HP crystals (left) and the 2Fo-Fc map. Thiocyanate anion 





Figure 7.21. Results of x-ray crystallography for Cu(II)-CuACcP-HP. (A) Image of crystals 
collected for diffraction. (B) 2Fo-Fc map of the highest resolution diffracting crystal (1.54 Å 
resolution). The Cu atom is clearly visible above heme, as is a μ-bridging water and a second water 
ligand in a 4-coordinate distorted tetrahedral geometry. (C) Cartoon representation of the solved 
crystal structure showing the surrounding protein scaffold. In this structure, neither mutant Cys 
residue is a ligand to bound Cu. (D) Overlay of Cu(II)-CuACcP-HP with the structure of WT-CcP 
(PDB: 2cyp). The Sγ-position of mutant residues R48C and W51C overlap nearly exactly with the 
corresponding Cγ of native CcP, and the heme and its proximal His bond are also not perturbed. 
 
The crystallization conditions that the yielded Cu-metallated structure contained potassium 
thiocyanate, and the thiocyanate anion is present in the structure at the heme site as a ligand to 
Cu(II). A bridging water is also present; however, the solution orientation is almost certainly 
different in the absence of thiocyanate. The Cu-NHis bond is somewhat long at 2.11 Å while the 
thiocyanate ion forms a short Cu-C bond (1.83 Å). The solvent-exposed water has a bond length 
(2.15 Å) similar to NHis while the μ-bridging water has a short 1.89 Å bond and has an FeHeme-OWat 
distance of 2.12 Å, suggesting an aquo rather than hydroxy ligand. The Oμ, water, and thiocyanate 
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ligands form a trigonal plane, tetragonally distorting coordination from H52. The pyrroline NHeme 
that falls between the thiocyanate ion and solvent-exposed water is close enough (3.28 Å) to act 
as a weak axial ligand. 
 
7.8. Binding of other transition metals to CuACcP 
In addition to Cu, R48C/W51C-CcP was reconstituted with other first-row transition metals: 
Mn(II), Fe(II/III), Co(II), Zn(II), and also the heavy metals Ag(I) and Hg(II) as analogues to Cu(I) 
and Cu(II). There was evidence of either Mn(II), Fe(II)/Fe(III), or Ni(II) binding by UV-visible 
absorption; however, Cr(II), Co(II), and Zn(II) all caused either shifts in the hemoprotein 
absorption or the appearance of new spectroscopic features (Fig. 7.22). Addition of Cr(II) to the 
CuACcP apo-protein resulted in a decrease in residual heme absorption, decrease in a peak at 656 
nm, and the appearance of a new peak at 466 nm. Similarly, addition of Co(II) resulted in a set of 
three new broadly absorbing peaks at 355 nm and from 500-700 nm with low peaks at 580 nm and 
624 nm. These new absorption peaks appeared concomitantly with relative decrease in heme Soret 
band intensity. Addition of Zn(II) to the apo-protein did not yield measurable results, but addition 
of Zn(II) to CuACcP-HP gave results of a heme Soret blue shift and decrease in intensity that are 
similar to the effects of adding Zn(II) to WT-CcP. In all cases except Zn(II), the decrease in heme 
absorption intensity can be attributed to paramagnetic quenching of heme absorption by a nearby 
non-heme metal ion; however, a similar effect as a result of Zn(II) binding suggests that distortion 
of the heme binding pocket (either by charge or sterics) as a result of non-heme metal binding 
plays some role. The apparent binding of many divalent first-row transition metals is likely due to 
the available thiol sulfurs from the R48C/W51C mutations. Binding of Cr(II) and Co(II) leave 
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open the possibility that CuACcP may be able to accommodate a broad range of metal clusters 
beyond the binuclear CuA species. 
 
 
Figure 7.22. Reconstitution of CuACcP with Cr(II) (A), Co(II) (B), and Zn(II) (C). 
 
Mercury and silver (Hg(II) and Ag(I)) were also added to CuACcP as air-stable analogues for 
Cu(I/II) with the idea that they might serve as long-term stable replacements for Cu during 
screening for protein crystallization conditions. Mercury/silver replacement of the CuAAz has been 
reported and demonstrated by ESI-TOF MS, showing that one equivalent of each metal can bind 
to a designed CuA center
48. Both Hg(II) and Ag(I) were added to CuACcP following the methods 
applied to CuAAz as well as by many permutations of Hg(II) and Ag(I) concentration and the order 
in which each metal was added to the protein. Titration results are shown in Fig. 7.23, as are mass 
spectra for the resulting samples after removal of excess metal by gel filtration chromatography. 
The predicted mass of [Hg(II)-Ag(I)]-CuACcP is 33903 Da, and for every method attempted, only 
a minor peak of this species was ever found. The major species obtained were consistently either 
a single bound Hg(II) atom or Hg(II) with 1 or 2 bound Cl anions; Hg2 was also found as a major 
species. The bimetallic Hg species is quite stable, and it is unclear whether the Hg2+ ions simply 
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do not dissociate under titration conditions or recombine in the protein; it is also unknown whether 
one or both mutant Cys residues bind Hg, either as SCys-[Hg2Cl1,2] or HgCl1,2-Hg(SCys)2. CuACcP 
apparently had a much lower affinity for Ag(I) as it was rarely detected even when added in 5-fold 
excess to Hg(II). Silver ions either do not bind strongly to the CuA site, or they are easily displaced 
by Hg(II) immediately or by rearrangement in the binding site. Despite attempts at high-throughput 
screening, no crystals of apo-CuACcP or of CuACcP in the presence of Cu(II/I) or Hg(II)/Ag(I) 
were ever obtained. 
 
 
Figure 7.23. UV-visible absorption spectra and ESI-TOF mass spectra of Hg(II) and Ag(I) binding 
to CuACcP. Isosbestic points present during addition of Hg(II) suggest that only a single pair of 
species has influence on the heme absorption spectrum while addition of Ag(I) resulted in broad 
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increases in absorption but principally at ~350 nm. ESI-TOF mass spectra indicate that the 
dominant species that result from these reconstitutions are [Hg2-Clx] with very little Ag(I) retained. 
 
7.9. Discussion 
Perhaps the most unusual aspect of the engineered binuclear CuA copper center in CuACcP is 
that there is virtually no structural homology between the CuA center in CcP, a heme peroxidase 
formed of mainly α-helices, and all previously characterized CuA subunits, which are exclusively 
cupredoxin folds. However, the arrangement of the Cu-binding residues is common between these 
two unrelated folds: the cupredoxin fold consists of a loop that contains three of the primary 
coordinating residues, one His and both Cys residues, as well as the weakly bound axial Met and 
carbonyl. It is this loop that is conserved in T1 Cu centers and provides the rigid scaffold 
responsible for their unique geometry. The second His is located on a separate loop with the 
surrounding structure composed of β-sheets. From a coarse perspective, the structure of the Cu-
binding site in CuACcP is similar. Both Cys residues and His52 in CuACcP are contained within 
the same α-helix in a rigid conformation, and His175 is located on a second α-helix oriented 
parallel to the first. This arrangement of the primary coordination sphere creates a spatially—if not 
necessarily structurally—homologous binding site for CuA. Mutations of both His residues make 
it clear that the His-Cys2 Cu(II) chelating site is critically important for recruiting the first 
equivalent of Cu, and the same is true of the conserved loop residues of CuA and T1 centers. In 
CuACcP, the Cu-binding site is more deeply recessed into the protein scaffold, and the α-helical 
structure creates a more rigid framework than the cupredoxin binding loop. This more rigid 
structure—and inability of either mutant Cys to flip outward to the bulk solvent—apparently 
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allows CuACcP to bypass the SCys-X3 capture complex while still binding Cu(II) rapidly and with 
high affinity. 
Nevertheless, binding of a binuclear Cu center in the CuACcP site is still far from easily 
predicted, in no small part due to the great distance between His52 and His175 in their 
conformations prescribed by the native CcP crystal structure. The reactivity of heme peroxidases 
is tuned by hydrogen bonding to the proximal His. In CcP, this tuning is accomplished by Asp235 
hydrogen bonding to His175 and Trp191, and this hydrogen bonding triad also helps to position 
His175 for heme coordination. For His175 to coordinate a binuclear Cu center with a Cu-Cu 
distance consistent with the XAS data (~2.4 Å), His175 would need to migrate ~1-2 Å closer to 
His52 from its native position. There has, up to this point, been no published structure of CcP apo-
protein or any structure lacking the native heme to describe the conformation of His175 in the 
absence of heme. Molecular dynamics modeling of CuACcP with His/Ala/Phe in position 175 all 
found that the helix containing His175 migrated toward the distal His52 sufficiently to allow 
coordination to CuA, breaking the hydrogen bonding network between His175, Trp191, and the 
protein backbone. Without heme, the His175-Asp235 hydrogen bond severs rapidly, leaving both 
His175 and the Phe175 mutant to assume the same stable conformation. The behavior of 
His175Ala sheds some light on the matter as the final positions for the proximal helix in 
His/Ala/Phe175 all overlay, suggesting that the apo-protein prefers a more collapsed conformation 
and rearranges when heme is in the scaffold. When collapsed, His175 is sufficiently close to His52 
to stabilize the Cu2S2 core of CuA. 
The electronic, x-ray absorption, and Raman spectra of CuACcP all point to a longer and 
weaker Cu-Cu bond than in cupredoxin CuA centers. The EPR spectra, however, show that the 
binuclear center is mixed valence, and it has similar redox properties to cupredoxins. An important 
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outcome of this model, therefore, is the straightforward demonstration that a highly specialized 
protein fold is not uniquely necessary to induce specific physical and chemical properties in a 
metal redox center. Broadly speaking, this observation is not surprising: protein folds are 
frequently repurposed in nature to accomplish highly disparate functions, and the existence of 
structural super families alone is evidence of this functional plasticity. However, purposefully 
building a metal binding site, particularly a multi-nuclear metal center, in a non-native scaffold 
remains hugely challenging, and it is generally considered too difficult (or structurally forbidden) 
to attempt in non-homologous protein scaffolds. Yet recent success with symmetrical binding sites 
in de novo proteins and by using broader elements of protein scaffold structure such as cavity and 
backbone structure49 combined with years of success at creating heme and other planar cofactor 
catalysts by incorporating them into generically hydrophobic “slots” have shown that strict 
biomimicry is not necessary to build metal sites with properties similar to their natural 
counterparts. In the case of CuACcP, the minimally necessary components for a mixed valence 
binuclear Cu center were three of the primary binding residues arranged to provide a rigidly 
trigonal binding site for the first Cu with the fourth residue positioned to provide space, symmetry, 
and stability to the second Cu, which seems to be the major role for the analogous His in native 
CuA. The properties that contribute to the rate of ET—Eº´, reorganization energy, and valence 
orbital structure—are the results of fine-tuning in the protein scaffold, as has been demonstrated 
definitively for T1 centers50,51, which can be accomplished independently of the fold. 
 
7.10. Conclusions 
Using a non-homologous hemoprotein as a scaffold, it was possible to create a binuclear Cu 
binding site with electronic, redox, and ET properties that closely mimic the properties of native 
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CuA centers. Creating this site demonstrates a radically minimalist approach to the necessary and 
sufficient elements to design a complex metal binding site inside a protein scaffold and the degree 
to which local interactions and fine-tuning shape the unique properties of ET centers over the 
global structure of the protein scaffold. Long range actions such as domain movement and signal 
transduction through conformational changes are certainly important for many enzymes and may 
be used as redox-dependent “on-off” switches by destabilizing metal centers, and such large effects 
are extremely difficult to reproduce by rational design. However, this design of a multi-nuclear 
redox center in a protein scaffold without the aid of exogenous ligands shows that it is possible to 
design complex metal binding sites in proteins that achieve biomimicry without rigidly adhering 
to the structural elements of their natural counterparts. In principle, this work demonstrates that 
complex metal sites can be engineered heuristically in arbitrary protein scaffolds that have suitable 
cavities by first using basic principles of primary coordination to achieve metal binding and then 
fine-tuning desirable properties. This approach frees designed or modified metal sites from the 
restrictions of the native protein scaffold that has been optimized to preserve a particular function. 
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